[
  {
    "source_url": "https://medex.com.bd/brands/19025/cefurim-cv-500-mg-tablet",
    "name": "Cefurim CV",
    "dosage_form": "Tablet",
    "generic": "Cefuroxime Axetil + Clavulanic Acid",
    "strength": "500 mg+125 mg",
    "company": "Somatec Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 55.00",
      "strip_price": "৳ 220.00",
      "pack_size_info": "(2 x 4: ৳ 440.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 55.00",
          "pack_size_info": "(2 x 4: ৳ 440.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 220.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(125 mg+31.25 mg)/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/19023/cefurim-cv-125-mg-suspension?ref=1"
      },
      {
        "text": "250 mg+62.5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/19024/cefurim-cv-250-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/227/cefuroxime-axetil-clavulanic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cefurim CV is indicated for the treatment of infections caused by sensitive bacteria. Cefurim CV is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli.",
          "Acute bacterial exacerbation of chronic bronchitis and secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Uncomplicated skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Uncomplicated urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Uncomplicated Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.",
          "Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Haemophilus influenzae (including ampicillin-resistant strains) & Klebsiella spp.",
          "Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis & Staphylococcus aureus (penicillinase and non-penicillinase producing strains)",
          "Switch therapy (Injectable to oral)"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a bactericidal second generation cephalosporin antibiotic which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process. Clavulanic acid is a naturally derived beta lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta lactam antibiotics which binds irreversibly to beta-lactamase enzymes and inactivates them. Clavulanic acid gives protection of Cefuroxime from degradation by beta lactamase enzymes and provides a solution for the treatment of bacterial infections caused by beta lactam resistant bacteria.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the area under the serum concentration versus time curve by 50%. Drug that reduces gastric acidity may result in a lower bioavailability of Cefuroxime and tend to cancel the effect of postprandial absorption.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime-Clavulanic Acid is contraindicated in patients with known allergy to cephalosporin & in patients with Pseudomembranous Colitis.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally Cefuroxime-Clavulanic Acid is well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth of nonsusceptible microorganisms. Rarely (<0.2%) renal dysfunction, anaphylaxis, angioedema, pruritis, rash and serum sickness like urticaria may appear.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "While all antibiotics should be avoided in the first trimester if possible. However, Cefuroxime-Clavulanic Acid can be safely used in later pregnancy to treat urinary and other infections. Cefuroxime-Clavulanic Acid is excreted into the breast milk in small quantities. However, the possibility of sensitizing the infant should be kept in mind.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light and moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Adolescents and adults (13 years and older)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/tonsillitis",
        "information": ": 250 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 250 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial exacerbation of chronic bronchitis",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Secondary bacterial infections of acute bronchitis",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated skin and skin structure infections",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated urinary tract infections",
        "information": ": 250 mg b.i.d. for 7-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated Gonorrhoea",
        "information": ": 1000 mg b.i.d. Single dose",
        "instructions": []
      },
      {
        "medication_type": "Community acquired pneumonia",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "MDR Typhoid Fever",
        "information": ": 500 mg b.i.d. for 10-14 days",
        "instructions": []
      },
      {
        "medication_type": "Early Lyme disease",
        "information": ": 500 mg b.i.d. for 20 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Paediatric Patients (3 months to 12 years)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/Tonsillitis",
        "information": ": 20 mg/kg/day b.i.d for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute otitis media",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Impetigo",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cefuroxime-Clavulanic Acid tablet may be taken without regard of food.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cefurim CV 500 mg+125 mg Tablet?",
        "answer": [
          "Cefuroxime is the cephalosporin antibiotic and Clavulanic acid is a beta-lactamase inhibitor. Cefurim CV 500 mg+125 mg Tablet is indicated for the treatment of infections caused by sensitive bacteria."
        ]
      },
      {
        "question": "What is Cefurim CV 500 mg+125 mg Tablet used for?",
        "answer": [
          "Cefurim CV 500 mg+125 mg Tablet is used to treat pharyngitis, tonsillitis, sinusitis, bronchitis, SSTI, UTI, gonorrhoea, pneumonia, typhoid fever."
        ]
      },
      {
        "question": "How long does it take for Cefurim CV 500 mg+125 mg Tablet to take effect?",
        "answer": [
          "Cefurim CV 500 mg+125 mg Tablet starts working within 2-3 hours after taking it."
        ]
      },
      {
        "question": "How long do the effects of this medicine last?",
        "answer": [
          "The effect of Cefurim CV 500 mg+125 mg Tablet lasts for an average duration of 4-8 hours."
        ]
      },
      {
        "question": "Cefurim CV 500 mg+125 mg Tablet it safe to consume alcohol while taking this medicine?",
        "answer": [
          "Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption."
        ]
      },
      {
        "question": "Is Cefurim CV 500 mg+125 mg Tablet a habit forming medicine?",
        "answer": [
          "No habit-forming tendencies were reported for Cefurim CV 500 mg+125 mg Tablet."
        ]
      },
      {
        "question": "Can this medicine be taken during pregnancy?",
        "answer": [
          "Cefurim CV 500 mg+125 mg Tablet is safe to use in pregnancy to treat bacterial infections. However, it is recommended to use this medicine only after consulting your doctor."
        ]
      },
      {
        "question": "Can Cefurim CV 500 mg+125 mg Tablet be taken while breast-feeding?",
        "answer": [
          "Cefurim CV 500 mg+125 mg Tablet is safe to use during breastfeeding. It enters into breast milk at low levels."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "You have been prescribed Cefurim CV 500 mg+125 mg Tablet medicine to treat bacterial infections, even if they have developed resistance.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect. Taking probiotics may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.",
          "Stop taking Cefurim CV 500 mg+125 mg Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.",
          "Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:02:39.316Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b4e",
    "original_record": {
      "input_index": 4353,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b4e"
        },
        "name": "Cefurim CV",
        "strength": "500 mg+125 mg",
        "generic": "Cefuroxime Axetil + Clavulanic Acid",
        "company": "Somatec Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/19025/cefurim-cv-500-mg-tablet",
        "_page": 138,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32496/cefurino-250-mg-tablet",
    "name": "Cefurino",
    "dosage_form": "Tablet",
    "generic": "Cefuroxime Axetil",
    "strength": "250 mg",
    "company": "Doctor TIMS Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 175.00",
      "pack_size_info": "(2 x 7: ৳ 350.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(2 x 7: ৳ 350.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 175.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/226/cefuroxime-axetil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "It is indicated for the treatment of infections caused by sensitive bacteria. It is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli",
          "Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No potentially hazardous interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse effects to Cefurino have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefurino should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cefurino has shown, that is not likely to be a problem at the recommended to dose levels.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5 o C",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Second generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet or Suspension- Adolescents and adults (13 years and older)- Paediatric Patients (3 months to 12 years)- Parenteral-",
        "instructions": [
          "Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days",
          "Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days",
          "Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days",
          "Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days",
          "Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days",
          "Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days",
          "Uncomplicated Gonorrhoea: 1000 mg Single dose",
          "Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days",
          "MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days",
          "Early Lyme disease: 500 mg b.i.d. for 20 days",
          "Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days",
          "Acute otitis media: 30 mg/kg/day b.i.d for 10 days",
          "Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days",
          "Impetigo: 30 mg/kg/day b.i.d for 10 days"
        ]
      },
      {
        "medication_type": "Adult",
        "information": ": 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 30 - 100 mg/kg/day given in 2 or 3 equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Surgical prophylaxis",
        "information": ": 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days.",
        "instructions": []
      },
      {
        "medication_type": "Acute exacerbations of chronic bronchitis",
        "information": ": 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.)",
        "instructions": []
      },
      {
        "medication_type": "In Gonorrhoea",
        "information": ": Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In Meningitis:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 3 gm IV injection three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In bone and joint infections:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1.5 gm IV injection four times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:30.049Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b50",
    "original_record": {
      "input_index": 4354,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b50"
        },
        "name": "Cefurino",
        "strength": "250 mg",
        "generic": "Cefuroxime Axetil",
        "company": "Doctor TIMS Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/32496/cefurino-250-mg-tablet",
        "_page": 138,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32497/cefurino-plus-500-mg-tablet",
    "name": "Cefurino Plus",
    "dosage_form": "Tablet",
    "generic": "Cefuroxime Axetil + Clavulanic Acid",
    "strength": "500 mg+125 mg",
    "company": "Doctor TIMS Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 50.00",
      "strip_price": "৳ 350.00",
      "pack_size_info": "(2 x 7: ৳ 700.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 50.00",
          "pack_size_info": "(2 x 7: ৳ 700.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 350.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(125 mg+31.25 mg)/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/32498/cefurino-plus-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/227/cefuroxime-axetil-clavulanic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cefurino Plus is indicated for the treatment of infections caused by sensitive bacteria. Cefurino Plus is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli.",
          "Acute bacterial exacerbation of chronic bronchitis and secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Uncomplicated skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Uncomplicated urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Uncomplicated Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.",
          "Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Haemophilus influenzae (including ampicillin-resistant strains) & Klebsiella spp.",
          "Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis & Staphylococcus aureus (penicillinase and non-penicillinase producing strains)",
          "Switch therapy (Injectable to oral)"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a bactericidal second generation cephalosporin antibiotic which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process. Clavulanic acid is a naturally derived beta lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta lactam antibiotics which binds irreversibly to beta-lactamase enzymes and inactivates them. Clavulanic acid gives protection of Cefuroxime from degradation by beta lactamase enzymes and provides a solution for the treatment of bacterial infections caused by beta lactam resistant bacteria.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the area under the serum concentration versus time curve by 50%. Drug that reduces gastric acidity may result in a lower bioavailability of Cefuroxime and tend to cancel the effect of postprandial absorption.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime-Clavulanic Acid is contraindicated in patients with known allergy to cephalosporin & in patients with Pseudomembranous Colitis.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally Cefuroxime-Clavulanic Acid is well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth of nonsusceptible microorganisms. Rarely (<0.2%) renal dysfunction, anaphylaxis, angioedema, pruritis, rash and serum sickness like urticaria may appear.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "While all antibiotics should be avoided in the first trimester if possible. However, Cefuroxime-Clavulanic Acid can be safely used in later pregnancy to treat urinary and other infections. Cefuroxime-Clavulanic Acid is excreted into the breast milk in small quantities. However, the possibility of sensitizing the infant should be kept in mind.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light and moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Adolescents and adults (13 years and older)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/tonsillitis",
        "information": ": 250 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 250 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial exacerbation of chronic bronchitis",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Secondary bacterial infections of acute bronchitis",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated skin and skin structure infections",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated urinary tract infections",
        "information": ": 250 mg b.i.d. for 7-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated Gonorrhoea",
        "information": ": 1000 mg b.i.d. Single dose",
        "instructions": []
      },
      {
        "medication_type": "Community acquired pneumonia",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "MDR Typhoid Fever",
        "information": ": 500 mg b.i.d. for 10-14 days",
        "instructions": []
      },
      {
        "medication_type": "Early Lyme disease",
        "information": ": 500 mg b.i.d. for 20 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Paediatric Patients (3 months to 12 years)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/Tonsillitis",
        "information": ": 20 mg/kg/day b.i.d for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute otitis media",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Impetigo",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cefuroxime-Clavulanic Acid tablet may be taken without regard of food.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cefurino Plus 500 mg+125 mg Tablet?",
        "answer": [
          "Cefuroxime is the cephalosporin antibiotic and Clavulanic acid is a beta-lactamase inhibitor. Cefurino Plus 500 mg+125 mg Tablet is indicated for the treatment of infections caused by sensitive bacteria."
        ]
      },
      {
        "question": "What is Cefurino Plus 500 mg+125 mg Tablet used for?",
        "answer": [
          "Cefurino Plus 500 mg+125 mg Tablet is used to treat pharyngitis, tonsillitis, sinusitis, bronchitis, SSTI, UTI, gonorrhoea, pneumonia, typhoid fever."
        ]
      },
      {
        "question": "How long does it take for Cefurino Plus 500 mg+125 mg Tablet to take effect?",
        "answer": [
          "Cefurino Plus 500 mg+125 mg Tablet starts working within 2-3 hours after taking it."
        ]
      },
      {
        "question": "How long do the effects of this medicine last?",
        "answer": [
          "The effect of Cefurino Plus 500 mg+125 mg Tablet lasts for an average duration of 4-8 hours."
        ]
      },
      {
        "question": "Cefurino Plus 500 mg+125 mg Tablet it safe to consume alcohol while taking this medicine?",
        "answer": [
          "Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption."
        ]
      },
      {
        "question": "Is Cefurino Plus 500 mg+125 mg Tablet a habit forming medicine?",
        "answer": [
          "No habit-forming tendencies were reported for Cefurino Plus 500 mg+125 mg Tablet."
        ]
      },
      {
        "question": "Can this medicine be taken during pregnancy?",
        "answer": [
          "Cefurino Plus 500 mg+125 mg Tablet is safe to use in pregnancy to treat bacterial infections. However, it is recommended to use this medicine only after consulting your doctor."
        ]
      },
      {
        "question": "Can Cefurino Plus 500 mg+125 mg Tablet be taken while breast-feeding?",
        "answer": [
          "Cefurino Plus 500 mg+125 mg Tablet is safe to use during breastfeeding. It enters into breast milk at low levels."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "You have been prescribed Cefurino Plus 500 mg+125 mg Tablet medicine to treat bacterial infections, even if they have developed resistance.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect. Taking probiotics may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.",
          "Stop taking Cefurino Plus 500 mg+125 mg Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.",
          "Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:04:31.159Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b51",
    "original_record": {
      "input_index": 4355,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b51"
        },
        "name": "Cefurino Plus",
        "strength": "500 mg+125 mg",
        "generic": "Cefuroxime Axetil + Clavulanic Acid",
        "company": "Doctor TIMS Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/32497/cefurino-plus-500-mg-tablet",
        "_page": 138,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31465/cefusil-cv-500-mg-tablet",
    "name": "Cefusil CV",
    "dosage_form": "Tablet",
    "generic": "Cefuroxime Axetil + Clavulanic Acid",
    "strength": "500 mg+125 mg",
    "company": "Silco Pharmaceutical Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 60.00",
      "strip_price": "৳ 240.00",
      "pack_size_info": "(2 x 4: ৳ 480.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 60.00",
          "pack_size_info": "(2 x 4: ৳ 480.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 240.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "250 mg+62.5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/31464/cefusil-cv-250-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/227/cefuroxime-axetil-clavulanic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cefusil CV is indicated for the treatment of infections caused by sensitive bacteria. Cefusil CV is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli.",
          "Acute bacterial exacerbation of chronic bronchitis and secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Uncomplicated skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Uncomplicated urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Uncomplicated Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.",
          "Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Haemophilus influenzae (including ampicillin-resistant strains) & Klebsiella spp.",
          "Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis & Staphylococcus aureus (penicillinase and non-penicillinase producing strains)",
          "Switch therapy (Injectable to oral)"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a bactericidal second generation cephalosporin antibiotic which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process. Clavulanic acid is a naturally derived beta lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta lactam antibiotics which binds irreversibly to beta-lactamase enzymes and inactivates them. Clavulanic acid gives protection of Cefuroxime from degradation by beta lactamase enzymes and provides a solution for the treatment of bacterial infections caused by beta lactam resistant bacteria.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the area under the serum concentration versus time curve by 50%. Drug that reduces gastric acidity may result in a lower bioavailability of Cefuroxime and tend to cancel the effect of postprandial absorption.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime-Clavulanic Acid is contraindicated in patients with known allergy to cephalosporin & in patients with Pseudomembranous Colitis.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally Cefuroxime-Clavulanic Acid is well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth of nonsusceptible microorganisms. Rarely (<0.2%) renal dysfunction, anaphylaxis, angioedema, pruritis, rash and serum sickness like urticaria may appear.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "While all antibiotics should be avoided in the first trimester if possible. However, Cefuroxime-Clavulanic Acid can be safely used in later pregnancy to treat urinary and other infections. Cefuroxime-Clavulanic Acid is excreted into the breast milk in small quantities. However, the possibility of sensitizing the infant should be kept in mind.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light and moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Adolescents and adults (13 years and older)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/tonsillitis",
        "information": ": 250 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 250 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial exacerbation of chronic bronchitis",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Secondary bacterial infections of acute bronchitis",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated skin and skin structure infections",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated urinary tract infections",
        "information": ": 250 mg b.i.d. for 7-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated Gonorrhoea",
        "information": ": 1000 mg b.i.d. Single dose",
        "instructions": []
      },
      {
        "medication_type": "Community acquired pneumonia",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "MDR Typhoid Fever",
        "information": ": 500 mg b.i.d. for 10-14 days",
        "instructions": []
      },
      {
        "medication_type": "Early Lyme disease",
        "information": ": 500 mg b.i.d. for 20 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Paediatric Patients (3 months to 12 years)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/Tonsillitis",
        "information": ": 20 mg/kg/day b.i.d for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute otitis media",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Impetigo",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cefuroxime-Clavulanic Acid tablet may be taken without regard of food.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cefusil CV 500 mg+125 mg Tablet?",
        "answer": [
          "Cefuroxime is the cephalosporin antibiotic and Clavulanic acid is a beta-lactamase inhibitor. Cefusil CV 500 mg+125 mg Tablet is indicated for the treatment of infections caused by sensitive bacteria."
        ]
      },
      {
        "question": "What is Cefusil CV 500 mg+125 mg Tablet used for?",
        "answer": [
          "Cefusil CV 500 mg+125 mg Tablet is used to treat pharyngitis, tonsillitis, sinusitis, bronchitis, SSTI, UTI, gonorrhoea, pneumonia, typhoid fever."
        ]
      },
      {
        "question": "How long does it take for Cefusil CV 500 mg+125 mg Tablet to take effect?",
        "answer": [
          "Cefusil CV 500 mg+125 mg Tablet starts working within 2-3 hours after taking it."
        ]
      },
      {
        "question": "How long do the effects of this medicine last?",
        "answer": [
          "The effect of Cefusil CV 500 mg+125 mg Tablet lasts for an average duration of 4-8 hours."
        ]
      },
      {
        "question": "Cefusil CV 500 mg+125 mg Tablet it safe to consume alcohol while taking this medicine?",
        "answer": [
          "Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption."
        ]
      },
      {
        "question": "Is Cefusil CV 500 mg+125 mg Tablet a habit forming medicine?",
        "answer": [
          "No habit-forming tendencies were reported for Cefusil CV 500 mg+125 mg Tablet."
        ]
      },
      {
        "question": "Can this medicine be taken during pregnancy?",
        "answer": [
          "Cefusil CV 500 mg+125 mg Tablet is safe to use in pregnancy to treat bacterial infections. However, it is recommended to use this medicine only after consulting your doctor."
        ]
      },
      {
        "question": "Can Cefusil CV 500 mg+125 mg Tablet be taken while breast-feeding?",
        "answer": [
          "Cefusil CV 500 mg+125 mg Tablet is safe to use during breastfeeding. It enters into breast milk at low levels."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "You have been prescribed Cefusil CV 500 mg+125 mg Tablet medicine to treat bacterial infections, even if they have developed resistance.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect. Taking probiotics may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.",
          "Stop taking Cefusil CV 500 mg+125 mg Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.",
          "Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:04:32.371Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b57",
    "original_record": {
      "input_index": 4356,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b57"
        },
        "name": "Cefusil CV",
        "strength": "500 mg+125 mg",
        "generic": "Cefuroxime Axetil + Clavulanic Acid",
        "company": "Silco Pharmaceutical Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/31465/cefusil-cv-500-mg-tablet",
        "_page": 138,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29455/cefuson-500-mg-tablet",
    "name": "Cefuson",
    "dosage_form": "Tablet",
    "generic": "Cefuroxime Axetil",
    "strength": "500 mg",
    "company": "Jayson Pharmaceutical Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 45.00",
      "strip_price": "৳ 135.00",
      "pack_size_info": "(2 x 3: ৳ 270.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 45.00",
          "pack_size_info": "(2 x 3: ৳ 270.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 135.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg (Tablet)",
        "href": "https://medex.com.bd/brands/29454/cefuson-250-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/226/cefuroxime-axetil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "It is indicated for the treatment of infections caused by sensitive bacteria. It is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli",
          "Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No potentially hazardous interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse effects to Cefuson have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefuson should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cefuson has shown, that is not likely to be a problem at the recommended to dose levels.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5 o C",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Second generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet or Suspension- Adolescents and adults (13 years and older)- Paediatric Patients (3 months to 12 years)- Parenteral-",
        "instructions": [
          "Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days",
          "Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days",
          "Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days",
          "Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days",
          "Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days",
          "Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days",
          "Uncomplicated Gonorrhoea: 1000 mg Single dose",
          "Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days",
          "MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days",
          "Early Lyme disease: 500 mg b.i.d. for 20 days",
          "Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days",
          "Acute otitis media: 30 mg/kg/day b.i.d for 10 days",
          "Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days",
          "Impetigo: 30 mg/kg/day b.i.d for 10 days"
        ]
      },
      {
        "medication_type": "Adult",
        "information": ": 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 30 - 100 mg/kg/day given in 2 or 3 equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Surgical prophylaxis",
        "information": ": 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days.",
        "instructions": []
      },
      {
        "medication_type": "Acute exacerbations of chronic bronchitis",
        "information": ": 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.)",
        "instructions": []
      },
      {
        "medication_type": "In Gonorrhoea",
        "information": ": Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In Meningitis:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 3 gm IV injection three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In bone and joint infections:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1.5 gm IV injection four times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:33.346Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b59",
    "original_record": {
      "input_index": 4357,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b59"
        },
        "name": "Cefuson",
        "strength": "500 mg",
        "generic": "Cefuroxime Axetil",
        "company": "Jayson Pharmaceutical Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/29455/cefuson-500-mg-tablet",
        "_page": 139,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7209/cefuxet-250-mg-tablet",
    "name": "Cefuxet",
    "dosage_form": "Tablet",
    "generic": "Cefuroxime Axetil",
    "strength": "250 mg",
    "company": "Chemist Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(4 x 4: ৳ 400.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(4 x 4: ৳ 400.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7210/cefuxet-500-mg-tablet?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/7211/cefuxet-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/226/cefuroxime-axetil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "It is indicated for the treatment of infections caused by sensitive bacteria. It is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli",
          "Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No potentially hazardous interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse effects to Cefuxet have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefuxet should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cefuxet has shown, that is not likely to be a problem at the recommended to dose levels.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5 o C",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Second generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet or Suspension- Adolescents and adults (13 years and older)- Paediatric Patients (3 months to 12 years)- Parenteral-",
        "instructions": [
          "Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days",
          "Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days",
          "Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days",
          "Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days",
          "Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days",
          "Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days",
          "Uncomplicated Gonorrhoea: 1000 mg Single dose",
          "Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days",
          "MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days",
          "Early Lyme disease: 500 mg b.i.d. for 20 days",
          "Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days",
          "Acute otitis media: 30 mg/kg/day b.i.d for 10 days",
          "Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days",
          "Impetigo: 30 mg/kg/day b.i.d for 10 days"
        ]
      },
      {
        "medication_type": "Adult",
        "information": ": 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 30 - 100 mg/kg/day given in 2 or 3 equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Surgical prophylaxis",
        "information": ": 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days.",
        "instructions": []
      },
      {
        "medication_type": "Acute exacerbations of chronic bronchitis",
        "information": ": 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.)",
        "instructions": []
      },
      {
        "medication_type": "In Gonorrhoea",
        "information": ": Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In Meningitis:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 3 gm IV injection three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In bone and joint infections:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1.5 gm IV injection four times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:34.417Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b5e",
    "original_record": {
      "input_index": 4358,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b5e"
        },
        "name": "Cefuxet",
        "strength": "250 mg",
        "generic": "Cefuroxime Axetil",
        "company": "Chemist Laboratories  Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/7209/cefuxet-250-mg-tablet",
        "_page": 139,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30047/celipress-200-mg-tablet",
    "name": "Celipress",
    "dosage_form": "Tablet",
    "generic": "Celiprolol Hydrochloride",
    "strength": "200 mg",
    "company": "Eskayef Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(4 x 10: ৳ 320.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(4 x 10: ৳ 320.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "400 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30789/celipress-400-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1801/celiprolol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Celipress belongs to a group of medicines called beta-blockers. It works by slowing your heart rate or lowering your blood pressure. It is used to treat high blood pressure (hypertension).",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Celiprolol is a vasoactive beta-1 selective adrenoceptor antagonist with partial beta-2 agonist activity. The beta-2 agonist activity is thought to account for its mild vasodilating properties. It lowers blood pressure in hypertensive patients at rest and on exercise. The effects on heart rate and cardiac output are dependent on the pre-existing background level of sympathetic tone. Under conditions of stress such as exercise, celiprolol attenuates chronotropic and inotropic responses to sympathetic stimulation. However, at rest minimal impairment of cardiac function is seen.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "Do not take Celiprolol Hydrochloride if you:",
        "items": [
          "are allergic to celiprolol hydrochloride or any of the ingredients of this medicine. Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue",
          "have suffered an allergic reaction to a beta-blocker (propranolol, sotalol, timolol etc.) in the past",
          "suffer from an irregular/very slow heartbeat (known as bradycardia) or low blood pressure (hypotension)",
          "suffer from heart failure which is not under control (heart failure is a condition in which your heart is not pumping blood as well as it should), have an abnormal heart rhythm, difficulty breathing and swollen ankles",
          "suffer from missed heart beats (heart block) or other heart problems or you suffer from hardened arteries",
          "have severe kidney problems",
          "have, or have had, episodes of asthma, wheezing or other severe breathing problems",
          "have a rare tumour called a phaeochromocytoma that is not being treated",
          "have abnormal levels of acid in your blood (metabolic acidosis), usually as a result of severe illness",
          "are already taking theophylline (an anti-asthma medicine).",
          "have late stage peripheral arterial occlusive disease or Raynaud’s syndrome."
        ]
      }
    ],
    "side_effects": [
      {
        "title": "Serious side effects",
        "information": ": Allergic reaction: a rash, swallowing or breathing problems, swelling of your face, lips, throat or tongue. You get flu like symptoms, swollen or painful joints, increased sensitivity to sunlight, hair loss, abdominal pain, anaemia. This may mean you have a condition called Systemic Lupus Erythematosus (SLE). These symptoms will usually go away after Celipress has been stopped. These are very serious side effects. If you have them you may have had a serious allergic reaction to Celipress. You may need urgent medical attention or hospitalization.",
        "items": []
      },
      {
        "title": "Common side effects",
        "information": "(may affect up to 1 in 10 people): Dizziness or light headedness, weakness, or fainting especially when standing up from a lying position. These could be signs of low blood pressure. Skin rashes, excessive itching",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advise before taking this medicine. If your doctor cannot find any safer alternative you may be given Celiprolol Hydrochloride. If you take Celiprolol Hydrochloride during pregnancy, you should tell your midwife. In the new born of the treated mother, activity of these kind of medicines remains for several days. The effects can include slow heart beat, heart failure or having trouble breathing. Therefore close monitoring of the neonate is recommended for the first 3 to 5 days of life. If you are already taking Celiprolol Hydrochloride and have just found out you are pregnant, you should talk to your doctor immediately. You should not breast-feed if you are taking Celiprolol Hydrochloride. If you are breast-feeding or planning to breast-feed you should talk to your doctor or pharmacist before taking this medicine.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Take special care and consult your doctor before taking Celipress if you:",
        "items": [
          "have liver or kidney problems",
          "have Prinzmetal’s angina (chest pain while resting)",
          "have poor blood circulation e.g. Raynaud’s, Burger’s Disease. Symptoms of Raynaud’s disease include fingers and toes changing colour when cold and tingling or painful on warming up. Your doctor will closely monitor you while taking this medicine.",
          "have inadequate circulation of blood through the coronary arteries.",
          "have ever had a skin condition known as psoriasis. Your doctor will stop this medicine if you have.",
          "have asthma or breathing problems due to long term lung problems (called bronchitis or emphysema)",
          "have a thyroid problem as the effects of an overactive thyroid gland (thyrotoxicosis) may be hidden by beta blocker medicine",
          "have a history of severe allergies, particularly to other medicines, including anaphylactic reactions",
          "need anti-allergic treatment eg. following a wasp or bee sting; your doctor may wish to interupt your Celipress treatment to prevent a possible allergic reaction.",
          "are diabetic. Patients with diabetes should be aware that the symptoms of low blood pressure (hypoglycaemia) may be hidden by beta blocker medicines",
          "have any heart failure that is under control with medication. Your doctor will give this medicine under strict medical surveillance",
          "have a slow or irregular heartbeat."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Use in children",
        "information": ": Celipress is not recommended for use in children.",
        "items": []
      },
      {
        "title": "Use in elderly",
        "information": ": Your doctor may decide to lower your dose of Celipress if necessary.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "You may have symptoms such as slow heart beats, low blood pressure, feeling dizzy or weak, difficulty in breathing, wheezing or heart problems. Contact your doctor or go to the nearest hospital causalty department immediately. Take this leaflet or some tablets with you so your doctor will know what you have taken.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep container in the outer carton. Do not store above 25°C. Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Always take this medicine exactly as your doctor has told you. Swallow the tablets whole with a glass of water. Take the tablets preferably first thing in the morning, one hour before food or two hours after food. To help you remember to take your medicine, try to get into the habit of taking it at the same time each day, preferably first thing in the morning.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Beta-blockers",
    "dosage": [
      {
        "medication_type": "Adults including the elderly",
        "information": ": the recommended starting dose is 200 mg of Celiprolol Hydrochloride once a day. If needed after 2 to 4 weeks, your doctor will increase your dose to 400 mg once a day. The maximum dose is 400 mg once a day. If you have the impression that the effect of Celiprolol Hydrochloride tablets is too strong or too weak, talk to your doctor or pharmacist.",
        "instructions": []
      },
      {
        "medication_type": "Adults with liver or kidney problems",
        "information": ": if you have kidney problems, your doctor may give you a lower dose than stated above and increase it as needed. A reduction in dosage by half may be appropriate in patients with moderate impairment of kidney function (creatinine clearance in the range of 15-40 ml per minute). Celiprolol Hydrochloride is not recommended for patients with severely impaired kidney function (creatinine clearance less than 15 ml per minute). Use of low doses of Celiprolol Hydrochloride is recommended in patients with liver problems.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:35.376Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b6a",
    "original_record": {
      "input_index": 4359,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b6a"
        },
        "name": "Celipress",
        "strength": "200 mg",
        "generic": "Celiprolol Hydrochloride",
        "company": "Eskayef Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30047/celipress-200-mg-tablet",
        "_page": 139,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/18747/cemaxi-200-mg-capsule",
    "name": "Cemaxi",
    "dosage_form": "Capsule",
    "generic": "Cefixime Trihydrate",
    "strength": "200 mg",
    "company": "Guardian Healthcare Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": "(18's pack: ৳ 540.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 30.00",
          "pack_size_info": "(18's pack: ৳ 540.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "100 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/18748/cemaxi-100-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/217/cefixime-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cemaxi is an orally active cephalosporin antibiotic which has marked in-vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organism. It is indicated for the treatment of the following acute infections when caused by susceptible microorganisms.",
        "items": []
      },
      {
        "title": "Upper Respiratory Tract Infections (URTI)",
        "information": ": e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. Lower Respiratory Tract Infections-e.g. bronchitis.",
        "items": []
      },
      {
        "title": "Urinary Tract Infections",
        "information": ": e.g. cystitis, cystourethritis, pyelonephritis. Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumonia, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. Cemaxi is highly stable in the presence of beta-lactamase enzymes.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefixime is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It kills bacteria by interfering in the synthesis of bacterial cell wall. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "In common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulant therapy.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with known hypersensitivity to cephalosporin antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cemaxi is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self limiting in nature. Gastrointestinal disturbances: The most frequent side-effects seen with Cemaxi are diarrhoea and stool changes; diarrhoea has been more commonly associated with higher doses. Other gastrointestinal side-effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting and flatulence. Pseudomembraneous colitis has been reported. Central nervous system: headache and dizziness. Hypersensitivity reactions: allergies in the form of rash, pruritis, urticaria, drug fever and arthralgia have been observed. These reactions usually subsided upon discontinuation of therapy. Hematological and clinical chemistry: thrombocytopenia, leukopenia and eosinophilia have been reported. These reactions were infrequent and reversible. Mild transient change in liver and renal function tests have been observed. Miscellaneous: other possible reactions include genital pruritis and vaginitis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cemaxi should be given with caution to patients who have shown hypersensitivity to other drugs. Cephalosporin should be given with caution to penicillin-sensitive patients, as there is some evidence of partial cross-allergenicity between the penicillins and the cephalosporins. Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If an allergic effect occurs with Cemaxi, the drug should be discontinued and the patient treated with appropriate agents if necessary. Cemaxi should be administered with caution in patients with markedly impaired renal function. Treatment with broad spectrum antibiotics alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated diarrhoea. Use in pregnancy and lactation: There are no adequate and well-controlled studies in pregnant women. Cemaxi should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Gastric Lavage may be indicated; otherwise, no specific antidote exists. Cemaxi is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cemaxi did not differ from the profile seen in patients treated at the recommended doses.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30ºC temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C16H15N5O7S2",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-217-cefixime-trihydrate-chemical-structure-3Mg9h2a2PuSZaJk4Uj0Z.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Absorption of Cefixime is not significantly modified by the presence of food. The usual course of treatment is 7 days. This may be continued for up to 14 days if required.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 10 years",
        "information": ": The recommended adult dosage is 200-400 mg daily according to the severity of the infection, given either as a single dose or in two divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed and dosage should be adjusted in severe renal impairment.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": The recommended dosage for children is 8 mg/kg/day administered as a single dose or in two divided doses. As a general guide for prescribing in children the following daily doses in terms of volume of suspension are suggested:",
        "instructions": [
          "6 months up to 1 year: 3.75 ml daily",
          "Children 1-4 years: 5 ml daily",
          "Children 5-10 years: 10 ml daily"
        ]
      },
      {
        "medication_type": "In typhoid",
        "information": ": the recommended children dose is 5 mg/kg body weight twice daily for 10-14 days.",
        "instructions": []
      },
      {
        "medication_type": "Children weighing more than 50 kg or older than 10 years",
        "information": ": Should be treated with the recommended adult dose 200-400 mg daily depending on the severity of infection.",
        "instructions": []
      },
      {
        "medication_type": "Children aged less than 6 months",
        "information": ": The safety and efficacy of Cefixime has not been established in children aged less than 6 months.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Renal Impairment",
        "information": ": Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearances of 20 ml/min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory peritoneal dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearances of less than 20 ml/min.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cemaxi 200 mg Capsule?",
        "answer": [
          "Cemaxi 200 mg Capsule is an antibiotic used to treat bacterial infection. This medicine does not work for viral infections like flu. It works by preventing them from forming the bacterial protective covering (cell wall) which is essential for their development."
        ]
      },
      {
        "question": "What are the uses of Cemaxi 200 mg Capsule?",
        "answer": [
          "Cemaxi 200 mg Capsule is used for the treatment and prevention from conditions such as Urinary Tract Infection, Tonsillitis, Pharyngitis, and Bronchitis. Apart from these, it can also be used to treat conditions of Fungal and Gonococcal Infections."
        ]
      },
      {
        "question": "What are the Side Effects of Cemaxi 200 mg Capsule?",
        "answer": [
          "Cemaxi 200 mg Capsule has some commonly reported side effects. Some of these side-effects may be serious. These are Diarrhea, Abdominal pain, Dark or clay-colored stools, Swelling of the face, lips, eyelids, tongue, hands, and feet, Dizziness, Acid or sour stomach, excessive gas in the stomach, Heartburn, Indigestion, Redness of the skin, Chest pain, Sore throat, and Unusual tiredness."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Cemaxi 200 mg Capsule?",
        "answer": [
          "This medication should be kept in a cool dry place and in its original pack. Make sure Cemaxi 200 mg Capsule remains unreachable to children and pets. Proper disposal of the expired and unused medications is important to avoid health problems."
        ]
      },
      {
        "question": "Will Cemaxi 200 mg Capsule work for treating cold and flu?",
        "answer": [
          "This medication belongs to an antibiotic class of drugs, hence Cemaxi 200 mg Capsule won't work for colds, flu, or other viral infections. If you use antibiotics when they are not needed, it increases your risk of getting an infection later that resists antibiotic treatment."
        ]
      },
      {
        "question": "Is there any special dietary instruction which I should follow?",
        "answer": [
          "Continue your normal diet unless your doctor asks you to change."
        ]
      },
      {
        "question": "Is Cemaxi 200 mg Capsule can be used to treat diarrhoea?",
        "answer": [
          "No, Cemaxi 200 mg Capsule is not prescribed to treat diarrhoea."
        ]
      },
      {
        "question": "Is it safe to give Cemaxi 200 mg Capsule to infants?",
        "answer": [
          "The safety of Cemaxi 200 mg Capsule, in case of newborns or infants aging less than 6 months, has not been positively established. Thus you need to consult a doctor before administering this medicine to an infant."
        ]
      },
      {
        "question": "Does Cemaxi 200 mg Capsule is a penicillin variant?",
        "answer": [
          "No, Cemaxi 200 mg Capsule is not a penicillin variant. This medication belongs to cephalosporin antibiotic and functions in a similar way to that of penicillin. Concurrent use of these two must be discussed with a doctor."
        ]
      },
      {
        "question": "Does Cemaxi 200 mg Capsule cause loose-motion?",
        "answer": [
          "Diarrhoea is a known side effect of Cemaxi 200 mg Capsule although it has been associated with higher doses only."
        ]
      },
      {
        "question": "Is constipation associated with Cemaxi 200 mg Capsule?",
        "answer": [
          "Constipation is an unusual side effect of Cemaxi 200 mg Capsule. In case, it causes persistent constipation and seems circumstantially related to the ingestion of this medication, must consult a doctor."
        ]
      },
      {
        "question": "Does Cemaxi 200 mg Capsule interact with contraception?",
        "answer": [
          "No such evidence suggested the effect of Cemaxi 200 mg Capsule on contraceptive medications."
        ]
      },
      {
        "question": "Can I take acetaminophen along with Cemaxi 200 mg Capsule?",
        "answer": [
          "No interactions have been clinically proven between Cemaxi 200 mg Capsule and Acetaminophen (Paracetamol). It is advisable to consult a doctor before concurrent use of these two medicines."
        ]
      },
      {
        "question": "How long does Cemaxi 200 mg Capsule take to work?",
        "answer": [
          "Cemaxi 200 mg Capsule start working as soon after you ingest it. However, it may take a few days to kill the harmful bacteria and relieve the symptoms completely. It is advised to complete the medication course for the suggested days."
        ]
      },
      {
        "question": "What if I do not get better after using Cemaxi 200 mg Capsule?",
        "answer": [
          "Inform your doctor if you do not feel better even after finishing the full course of treatment. You must also inform your doctor if the symptoms get worse while using this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Cemaxi 200 mg Capsule to cure your infection and improve your symptoms.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.",
          "Avoid consuming alcohol while taking Cemaxi 200 mg Capsule as it may cause increased side effects.",
          "Discontinue Cemaxi 200 mg Capsule and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:04:36.331Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b72",
    "original_record": {
      "input_index": 4360,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b72"
        },
        "name": "Cemaxi",
        "strength": "200 mg",
        "generic": "Cefixime Trihydrate",
        "company": "Guardian Healthcare Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/18747/cemaxi-200-mg-capsule",
        "_page": 139,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7532/cemix-3-100-mg-suspension",
    "name": "Cemix-3",
    "dosage_form": "Powder for Suspension",
    "generic": "Cefixime Trihydrate",
    "strength": "100 mg/5 ml",
    "company": "Seema Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 195.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 195.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "200 mg (Capsule)",
        "href": "https://medex.com.bd/brands/7531/cemix-3-200-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/217/cefixime-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cemix-3 is an orally active cephalosporin antibiotic which has marked in-vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organism. It is indicated for the treatment of the following acute infections when caused by susceptible microorganisms.",
        "items": []
      },
      {
        "title": "Upper Respiratory Tract Infections (URTI)",
        "information": ": e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. Lower Respiratory Tract Infections-e.g. bronchitis.",
        "items": []
      },
      {
        "title": "Urinary Tract Infections",
        "information": ": e.g. cystitis, cystourethritis, pyelonephritis. Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumonia, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. Cemix-3 is highly stable in the presence of beta-lactamase enzymes.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefixime is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It kills bacteria by interfering in the synthesis of bacterial cell wall. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "In common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulant therapy.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with known hypersensitivity to cephalosporin antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cemix-3 is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self limiting in nature. Gastrointestinal disturbances: The most frequent side-effects seen with Cemix-3 are diarrhoea and stool changes; diarrhoea has been more commonly associated with higher doses. Other gastrointestinal side-effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting and flatulence. Pseudomembraneous colitis has been reported. Central nervous system: headache and dizziness. Hypersensitivity reactions: allergies in the form of rash, pruritis, urticaria, drug fever and arthralgia have been observed. These reactions usually subsided upon discontinuation of therapy. Hematological and clinical chemistry: thrombocytopenia, leukopenia and eosinophilia have been reported. These reactions were infrequent and reversible. Mild transient change in liver and renal function tests have been observed. Miscellaneous: other possible reactions include genital pruritis and vaginitis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cemix-3 should be given with caution to patients who have shown hypersensitivity to other drugs. Cephalosporin should be given with caution to penicillin-sensitive patients, as there is some evidence of partial cross-allergenicity between the penicillins and the cephalosporins. Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If an allergic effect occurs with Cemix-3, the drug should be discontinued and the patient treated with appropriate agents if necessary. Cemix-3 should be administered with caution in patients with markedly impaired renal function. Treatment with broad spectrum antibiotics alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated diarrhoea. Use in pregnancy and lactation: There are no adequate and well-controlled studies in pregnant women. Cemix-3 should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Gastric Lavage may be indicated; otherwise, no specific antidote exists. Cemix-3 is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cemix-3 did not differ from the profile seen in patients treated at the recommended doses.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30ºC temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C16H15N5O7S2",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-217-cefixime-trihydrate-chemical-structure-3Mg9h2a2PuSZaJk4Uj0Z.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Absorption of Cefixime is not significantly modified by the presence of food. The usual course of treatment is 7 days. This may be continued for up to 14 days if required.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 10 years",
        "information": ": The recommended adult dosage is 200-400 mg daily according to the severity of the infection, given either as a single dose or in two divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed and dosage should be adjusted in severe renal impairment.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": The recommended dosage for children is 8 mg/kg/day administered as a single dose or in two divided doses. As a general guide for prescribing in children the following daily doses in terms of volume of suspension are suggested:",
        "instructions": [
          "6 months up to 1 year: 3.75 ml daily",
          "Children 1-4 years: 5 ml daily",
          "Children 5-10 years: 10 ml daily"
        ]
      },
      {
        "medication_type": "In typhoid",
        "information": ": the recommended children dose is 5 mg/kg body weight twice daily for 10-14 days.",
        "instructions": []
      },
      {
        "medication_type": "Children weighing more than 50 kg or older than 10 years",
        "information": ": Should be treated with the recommended adult dose 200-400 mg daily depending on the severity of infection.",
        "instructions": []
      },
      {
        "medication_type": "Children aged less than 6 months",
        "information": ": The safety and efficacy of Cefixime has not been established in children aged less than 6 months.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Renal Impairment",
        "information": ": Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearances of 20 ml/min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory peritoneal dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearances of less than 20 ml/min.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cemix-3 100 mg/5 ml Syrup?",
        "answer": [
          "Cemix-3 100 mg/5 ml Syrup is an antibiotic used to treat bacterial infection. This medicine does not work for viral infections like flu. It works by preventing them from forming the bacterial protective covering (cell wall) which is essential for their development."
        ]
      },
      {
        "question": "What are the uses of Cemix-3 100 mg/5 ml Syrup?",
        "answer": [
          "Cemix-3 100 mg/5 ml Syrup is used for the treatment and prevention from conditions such as Urinary Tract Infection, Tonsillitis, Pharyngitis, and Bronchitis. Apart from these, it can also be used to treat conditions of Fungal and Gonococcal Infections."
        ]
      },
      {
        "question": "What are the Side Effects of Cemix-3 100 mg/5 ml Syrup?",
        "answer": [
          "Cemix-3 100 mg/5 ml Syrup has some commonly reported side effects. Some of these side-effects may be serious. These are Diarrhea, Abdominal pain, Dark or clay-colored stools, Swelling of the face, lips, eyelids, tongue, hands, and feet, Dizziness, Acid or sour stomach, excessive gas in the stomach, Heartburn, Indigestion, Redness of the skin, Chest pain, Sore throat, and Unusual tiredness."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Cemix-3 100 mg/5 ml Syrup?",
        "answer": [
          "This medication should be kept in a cool dry place and in its original pack. Make sure Cemix-3 100 mg/5 ml Syrup remains unreachable to children and pets. Proper disposal of the expired and unused medications is important to avoid health problems."
        ]
      },
      {
        "question": "Will Cemix-3 100 mg/5 ml Syrup work for treating cold and flu?",
        "answer": [
          "This medication belongs to an antibiotic class of drugs, hence Cemix-3 100 mg/5 ml Syrup won't work for colds, flu, or other viral infections. If you use antibiotics when they are not needed, it increases your risk of getting an infection later that resists antibiotic treatment."
        ]
      },
      {
        "question": "Is there any special dietary instruction which I should follow?",
        "answer": [
          "Continue your normal diet unless your doctor asks you to change."
        ]
      },
      {
        "question": "Is Cemix-3 100 mg/5 ml Syrup can be used to treat diarrhoea?",
        "answer": [
          "No, Cemix-3 100 mg/5 ml Syrup is not prescribed to treat diarrhoea."
        ]
      },
      {
        "question": "Is it safe to give Cemix-3 100 mg/5 ml Syrup to infants?",
        "answer": [
          "The safety of Cemix-3 100 mg/5 ml Syrup, in case of newborns or infants aging less than 6 months, has not been positively established. Thus you need to consult a doctor before administering this medicine to an infant."
        ]
      },
      {
        "question": "Does Cemix-3 100 mg/5 ml Syrup is a penicillin variant?",
        "answer": [
          "No, Cemix-3 100 mg/5 ml Syrup is not a penicillin variant. This medication belongs to cephalosporin antibiotic and functions in a similar way to that of penicillin. Concurrent use of these two must be discussed with a doctor."
        ]
      },
      {
        "question": "Does Cemix-3 100 mg/5 ml Syrup cause loose-motion?",
        "answer": [
          "Diarrhoea is a known side effect of Cemix-3 100 mg/5 ml Syrup although it has been associated with higher doses only."
        ]
      },
      {
        "question": "Is constipation associated with Cemix-3 100 mg/5 ml Syrup?",
        "answer": [
          "Constipation is an unusual side effect of Cemix-3 100 mg/5 ml Syrup. In case, it causes persistent constipation and seems circumstantially related to the ingestion of this medication, must consult a doctor."
        ]
      },
      {
        "question": "Does Cemix-3 100 mg/5 ml Syrup interact with contraception?",
        "answer": [
          "No such evidence suggested the effect of Cemix-3 100 mg/5 ml Syrup on contraceptive medications."
        ]
      },
      {
        "question": "Can I take acetaminophen along with Cemix-3 100 mg/5 ml Syrup?",
        "answer": [
          "No interactions have been clinically proven between Cemix-3 100 mg/5 ml Syrup and Acetaminophen (Paracetamol). It is advisable to consult a doctor before concurrent use of these two medicines."
        ]
      },
      {
        "question": "How long does Cemix-3 100 mg/5 ml Syrup take to work?",
        "answer": [
          "Cemix-3 100 mg/5 ml Syrup start working as soon after you ingest it. However, it may take a few days to kill the harmful bacteria and relieve the symptoms completely. It is advised to complete the medication course for the suggested days."
        ]
      },
      {
        "question": "What if I do not get better after using Cemix-3 100 mg/5 ml Syrup?",
        "answer": [
          "Inform your doctor if you do not feel better even after finishing the full course of treatment. You must also inform your doctor if the symptoms get worse while using this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Cemix-3 100 mg/5 ml Syrup to cure your infection and improve your symptoms.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.",
          "Avoid consuming alcohol while taking Cemix-3 100 mg/5 ml Syrup as it may cause increased side effects.",
          "Discontinue Cemix-3 100 mg/5 ml Syrup and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:04:37.714Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b73",
    "original_record": {
      "input_index": 4361,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b73"
        },
        "name": "Cemix-3",
        "strength": "100 mg/5 ml",
        "generic": "Cefixime Trihydrate",
        "company": "Seema Pharmaceuticals Ltd.",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/7532/cemix-3-100-mg-suspension",
        "_page": 139,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7531/cemix-3-200-mg-capsule",
    "name": "Cemix-3",
    "dosage_form": "Capsule",
    "generic": "Cefixime Trihydrate",
    "strength": "200 mg",
    "company": "Seema Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": "(8's pack: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 30.00",
          "pack_size_info": "(8's pack: ৳ 240.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "100 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/7532/cemix-3-100-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/217/cefixime-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cemix-3 is an orally active cephalosporin antibiotic which has marked in-vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organism. It is indicated for the treatment of the following acute infections when caused by susceptible microorganisms.",
        "items": []
      },
      {
        "title": "Upper Respiratory Tract Infections (URTI)",
        "information": ": e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. Lower Respiratory Tract Infections-e.g. bronchitis.",
        "items": []
      },
      {
        "title": "Urinary Tract Infections",
        "information": ": e.g. cystitis, cystourethritis, pyelonephritis. Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumonia, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. Cemix-3 is highly stable in the presence of beta-lactamase enzymes.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefixime is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It kills bacteria by interfering in the synthesis of bacterial cell wall. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "In common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulant therapy.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with known hypersensitivity to cephalosporin antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cemix-3 is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self limiting in nature. Gastrointestinal disturbances: The most frequent side-effects seen with Cemix-3 are diarrhoea and stool changes; diarrhoea has been more commonly associated with higher doses. Other gastrointestinal side-effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting and flatulence. Pseudomembraneous colitis has been reported. Central nervous system: headache and dizziness. Hypersensitivity reactions: allergies in the form of rash, pruritis, urticaria, drug fever and arthralgia have been observed. These reactions usually subsided upon discontinuation of therapy. Hematological and clinical chemistry: thrombocytopenia, leukopenia and eosinophilia have been reported. These reactions were infrequent and reversible. Mild transient change in liver and renal function tests have been observed. Miscellaneous: other possible reactions include genital pruritis and vaginitis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cemix-3 should be given with caution to patients who have shown hypersensitivity to other drugs. Cephalosporin should be given with caution to penicillin-sensitive patients, as there is some evidence of partial cross-allergenicity between the penicillins and the cephalosporins. Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If an allergic effect occurs with Cemix-3, the drug should be discontinued and the patient treated with appropriate agents if necessary. Cemix-3 should be administered with caution in patients with markedly impaired renal function. Treatment with broad spectrum antibiotics alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated diarrhoea. Use in pregnancy and lactation: There are no adequate and well-controlled studies in pregnant women. Cemix-3 should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Gastric Lavage may be indicated; otherwise, no specific antidote exists. Cemix-3 is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cemix-3 did not differ from the profile seen in patients treated at the recommended doses.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30ºC temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C16H15N5O7S2",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-217-cefixime-trihydrate-chemical-structure-3Mg9h2a2PuSZaJk4Uj0Z.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Absorption of Cefixime is not significantly modified by the presence of food. The usual course of treatment is 7 days. This may be continued for up to 14 days if required.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 10 years",
        "information": ": The recommended adult dosage is 200-400 mg daily according to the severity of the infection, given either as a single dose or in two divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed and dosage should be adjusted in severe renal impairment.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": The recommended dosage for children is 8 mg/kg/day administered as a single dose or in two divided doses. As a general guide for prescribing in children the following daily doses in terms of volume of suspension are suggested:",
        "instructions": [
          "6 months up to 1 year: 3.75 ml daily",
          "Children 1-4 years: 5 ml daily",
          "Children 5-10 years: 10 ml daily"
        ]
      },
      {
        "medication_type": "In typhoid",
        "information": ": the recommended children dose is 5 mg/kg body weight twice daily for 10-14 days.",
        "instructions": []
      },
      {
        "medication_type": "Children weighing more than 50 kg or older than 10 years",
        "information": ": Should be treated with the recommended adult dose 200-400 mg daily depending on the severity of infection.",
        "instructions": []
      },
      {
        "medication_type": "Children aged less than 6 months",
        "information": ": The safety and efficacy of Cefixime has not been established in children aged less than 6 months.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Renal Impairment",
        "information": ": Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearances of 20 ml/min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory peritoneal dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearances of less than 20 ml/min.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cemix-3 200 mg Capsule?",
        "answer": [
          "Cemix-3 200 mg Capsule is an antibiotic used to treat bacterial infection. This medicine does not work for viral infections like flu. It works by preventing them from forming the bacterial protective covering (cell wall) which is essential for their development."
        ]
      },
      {
        "question": "What are the uses of Cemix-3 200 mg Capsule?",
        "answer": [
          "Cemix-3 200 mg Capsule is used for the treatment and prevention from conditions such as Urinary Tract Infection, Tonsillitis, Pharyngitis, and Bronchitis. Apart from these, it can also be used to treat conditions of Fungal and Gonococcal Infections."
        ]
      },
      {
        "question": "What are the Side Effects of Cemix-3 200 mg Capsule?",
        "answer": [
          "Cemix-3 200 mg Capsule has some commonly reported side effects. Some of these side-effects may be serious. These are Diarrhea, Abdominal pain, Dark or clay-colored stools, Swelling of the face, lips, eyelids, tongue, hands, and feet, Dizziness, Acid or sour stomach, excessive gas in the stomach, Heartburn, Indigestion, Redness of the skin, Chest pain, Sore throat, and Unusual tiredness."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Cemix-3 200 mg Capsule?",
        "answer": [
          "This medication should be kept in a cool dry place and in its original pack. Make sure Cemix-3 200 mg Capsule remains unreachable to children and pets. Proper disposal of the expired and unused medications is important to avoid health problems."
        ]
      },
      {
        "question": "Will Cemix-3 200 mg Capsule work for treating cold and flu?",
        "answer": [
          "This medication belongs to an antibiotic class of drugs, hence Cemix-3 200 mg Capsule won't work for colds, flu, or other viral infections. If you use antibiotics when they are not needed, it increases your risk of getting an infection later that resists antibiotic treatment."
        ]
      },
      {
        "question": "Is there any special dietary instruction which I should follow?",
        "answer": [
          "Continue your normal diet unless your doctor asks you to change."
        ]
      },
      {
        "question": "Is Cemix-3 200 mg Capsule can be used to treat diarrhoea?",
        "answer": [
          "No, Cemix-3 200 mg Capsule is not prescribed to treat diarrhoea."
        ]
      },
      {
        "question": "Is it safe to give Cemix-3 200 mg Capsule to infants?",
        "answer": [
          "The safety of Cemix-3 200 mg Capsule, in case of newborns or infants aging less than 6 months, has not been positively established. Thus you need to consult a doctor before administering this medicine to an infant."
        ]
      },
      {
        "question": "Does Cemix-3 200 mg Capsule is a penicillin variant?",
        "answer": [
          "No, Cemix-3 200 mg Capsule is not a penicillin variant. This medication belongs to cephalosporin antibiotic and functions in a similar way to that of penicillin. Concurrent use of these two must be discussed with a doctor."
        ]
      },
      {
        "question": "Does Cemix-3 200 mg Capsule cause loose-motion?",
        "answer": [
          "Diarrhoea is a known side effect of Cemix-3 200 mg Capsule although it has been associated with higher doses only."
        ]
      },
      {
        "question": "Is constipation associated with Cemix-3 200 mg Capsule?",
        "answer": [
          "Constipation is an unusual side effect of Cemix-3 200 mg Capsule. In case, it causes persistent constipation and seems circumstantially related to the ingestion of this medication, must consult a doctor."
        ]
      },
      {
        "question": "Does Cemix-3 200 mg Capsule interact with contraception?",
        "answer": [
          "No such evidence suggested the effect of Cemix-3 200 mg Capsule on contraceptive medications."
        ]
      },
      {
        "question": "Can I take acetaminophen along with Cemix-3 200 mg Capsule?",
        "answer": [
          "No interactions have been clinically proven between Cemix-3 200 mg Capsule and Acetaminophen (Paracetamol). It is advisable to consult a doctor before concurrent use of these two medicines."
        ]
      },
      {
        "question": "How long does Cemix-3 200 mg Capsule take to work?",
        "answer": [
          "Cemix-3 200 mg Capsule start working as soon after you ingest it. However, it may take a few days to kill the harmful bacteria and relieve the symptoms completely. It is advised to complete the medication course for the suggested days."
        ]
      },
      {
        "question": "What if I do not get better after using Cemix-3 200 mg Capsule?",
        "answer": [
          "Inform your doctor if you do not feel better even after finishing the full course of treatment. You must also inform your doctor if the symptoms get worse while using this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Cemix-3 200 mg Capsule to cure your infection and improve your symptoms.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.",
          "Avoid consuming alcohol while taking Cemix-3 200 mg Capsule as it may cause increased side effects.",
          "Discontinue Cemix-3 200 mg Capsule and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:04:38.898Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b74",
    "original_record": {
      "input_index": 4362,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b74"
        },
        "name": "Cemix-3",
        "strength": "200 mg",
        "generic": "Cefixime Trihydrate",
        "company": "Seema Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/7531/cemix-3-200-mg-capsule",
        "_page": 139,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6500/cemoxin-500-mg-capsule",
    "name": "Cemoxin",
    "dosage_form": "Capsule",
    "generic": "Amoxicillin Trihydrate",
    "strength": "500 mg",
    "company": "Central Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 6.50",
      "strip_price": null,
      "pack_size_info": "(50's pack: ৳ 325.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.50",
          "pack_size_info": "(50's pack: ৳ 325.00)"
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg (Capsule)",
        "href": "https://medex.com.bd/brands/6499/cemoxin-250-mg-capsule?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/6501/cemoxin-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/69/amoxicillin-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cemoxin is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include Cemoxin is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include",
        "items": [
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Skin and soft tissue infections (i.e. cellulitis, carbuncles, furunculosis, infected wounds, abscess)",
          "Genito-urinary tract infections (i.e. pyelonephritis, cystitis and urethritis)",
          "Venereal disease (i.e. acute uncomplicated gonorrhoea)",
          "In dental abscess, it is used as short-term therapy.",
          "It is also indicated in combination with Clarithromycin and Lansoprazole (as triple therapy), for the treatment of patients with H. pylori infection and duodenal ulcer disease and to reduce the risk of duodenal ulcer recurrence."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amoxicillin is a broad spectrum penicillin. It is effective against a wide range of Gram-positive and Gram-negative bacteria. It acts through the inhibition of biosynthesis of cell wall. Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. After an oral dose, peak plasma concentration of Amoxicillin is reached within 1 to 2 hours. Amoxicillin is widely distributed at varying concentration in body tissues and fluids.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent use of Cemoxin and Probenecid may result in increased and prolonged blood levels of Cemoxin. Cemoxin may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/progesterone contraceptives.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Amoxicillin is contraindicated in penicillin hypersensitive patients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects are mild and transient in nature. This may include diarrhoea, indigestion or occasionally rash. Pseudo-membranous colitis has been reported rarely.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Amoxicillin is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Amoxicillin has been shown to be excreted in human milk. So, caution should be exercised when Amoxicillin is administered to a lactating mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The possibility of superinfections with mycotic or bacterial pathogens should be kept in mind during therapy. If superinfections occur, Cemoxin should be discontinued and appropriate therapy should be instituted.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Reconstituted suspension can be administered by adding the required amount of suspension to milk, fruit juice, water. These preparations should then be taken immediately.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Broad spectrum penicillins",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": 250 mg three times daily, increasing up to 500 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(up to 10 years of age) : 125 mg three times daily, increasing up to 250 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Severe or recurrent purulent respiratory infection",
        "information": ": 3 gm every 12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Otitis media",
        "information": ": Recommended dose is 1 g three times daily for adult and 40 mg/kg body weight daily in 3 divided doses for children (max. 3 g daily).",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": Recommended dose is 500-1000 mg three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Dental abscess",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Urinary tract infections",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": Single dose of 2-3 gm with Probenecid 1 gm is recommended (Probenecid is contraindicated in children under 2 years).",
        "instructions": []
      },
      {
        "medication_type": "In renal impairment",
        "information": ": it may be necessary to reduce the total daily dosage.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:39.948Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b76",
    "original_record": {
      "input_index": 4363,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b76"
        },
        "name": "Cemoxin",
        "strength": "500 mg",
        "generic": "Amoxicillin Trihydrate",
        "company": "Central Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/6500/cemoxin-500-mg-capsule",
        "_page": 139,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3907/cenolon-55-mcg-nasal-spray",
    "name": "Cenolon",
    "dosage_form": "Nasal Spray",
    "generic": "Triamcinolone Acetonide",
    "strength": "55 mcg/spray",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 200.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "120 metered sprays",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1362/triamcinolone-acetonide-nasal-spray/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cenolon nasal spray is indicated for the treatment and prophylaxis of the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 6 years of age and older.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition of arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Firstly, however, these glucocorticoids bind to the glucocorticoid receptors which translocate into the nucleus and bind DNA (GRE) and change genetic expression both positively and negatively. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Triamcinolone Acetonide is a more potent derivative of Triamcinolone and is approximately 8 times more potent than prednisone. Corticosteroids are very effective in the treatment of allergic diseases in man. When given by intranasal spray, Triamcinolone Acetonide provides relief from allergy-induced watery nasal discharge (rhinorrhea), nasal congestion, postnasal drip, sneezing, and itching of the back of the throat.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "No specific contraindications but caution is required in patients with hypersensitivity to any constituents of the formulation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most commonly reported adverse reactions in clinical trials with Cenolon included those involving mucous membranes of the nose & throat. The most prevalent adverse reactions considered are rhinitis, headache, & pharyngitis. The nasopharyngeal adverse effects included epistaxis, nasal irritation, dry mucous membrane, naso-sinus congestion and sneezing although these are seen as frequently with placebo. As with other nasally inhaled corticosteroids, nasal septal perforation has been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well controlled studies in pregnant women with Triamcinolone. Because animal studies indicate a teratogenic effect, Triamcinolone should be used during pregnancy if the potential benefit justifies the potential benefit to fetus. It is not known whether Triamcinolone is excreted in human breast milk.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "If there is any reason to suppose that adrenal function is impaired, care must be taken while transferring patients from systemic steroid treatment to Cenolon. In clinical studies with Cenolon administered intranasally, the development of localized infections, on the nose, and pharynx with Candida albicans, has rarely occurred. When such an infection develops it may require treatment with appropriate local therapy and discontinuance of treatment with Cenolon. Because of the inhibitory effect of corticosteroids on wound healing in patients who have experienced recent nasal septal ulcers, nasal surgery of trauma, Cenolon should be used with caution until healing has occurred.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Like any other nasally administered corticosteroid, acute overdosing with Cenolon is unlikely in view of the total amount of active ingredient present",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a temperature not exceeding 25˚C. Protect from light and moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Corticosteroid, Glucocorticoids, Nasal Steroid Preparations",
    "dosage": [
      {
        "medication_type": "Adults and children 12 years of age and older",
        "information": ": The recommended dose is 220 µgm as 2 sprays in each nostril once daily. Once symptoms are controlled patients can be maintained on 110 µgm (1 spray in each nostril once daily). The minimum effective dose should be used to ensure continued control of symptoms.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric Patients aged 6 to 12 years",
        "information": ": The recommended dose is 110 µgm as 1 spray in each nostril once daily. Triamcinolone spray is not recommended for children under 6 years of age.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:41.003Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b7b",
    "original_record": {
      "input_index": 4364,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b7b"
        },
        "name": "Cenolon",
        "strength": "55 mcg/spray",
        "generic": "Triamcinolone Acetonide (Nasal Spray)",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Nasal Spray",
        "source_url": "https://medex.com.bd/brands/3907/cenolon-55-mcg-nasal-spray",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37042/cenomate-50-mg-tablet",
    "name": "Cenomate",
    "dosage_form": "Tablet",
    "generic": "Cenobamate",
    "strength": "50 mg",
    "company": "Everest Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 64.00",
      "strip_price": "৳ 640.00",
      "pack_size_info": "(1 x 10: ৳ 640.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 64.00",
          "pack_size_info": "(1 x 10: ৳ 640.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 640.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "12.5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/37041/cenomate-125-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/2220/cenobamate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cenomate is indicated for the treatment of partial-onset seizures in adult patients.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cenobamate is a positive GABA-A modulator which inhibits voltage-gated sodium channels. Inhibition of voltage-gated sodium channels increases the threshold for generating action potentials and decreases the number of action potentials. Its dual, complementary mechanisms of action may contribute to superior anti-seizure activity.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Phenytoin",
        "information": ": Gradually decrease phenytoin dosage by up to 50%",
        "items": []
      },
      {
        "title": "Phenobarbital and Clobazam",
        "information": ": Reduce dosage as needed when used concomitantly with Cenomate.",
        "items": []
      },
      {
        "title": "Lamotrigine, Carbamazepine",
        "information": ": Increase dosage as needed when used concomitantly with Cenomate.",
        "items": []
      },
      {
        "title": "CYP2B6 and CYP3A Substrates",
        "information": ": Increase dosage as needed when used concomitantly with Cenomate.",
        "items": []
      },
      {
        "title": "CYP2C19 Substrates",
        "information": ": Reduce dosage as needed when used concomitantly with Cenomate.",
        "items": []
      },
      {
        "title": "Oral Contraceptives",
        "information": ": Effectiveness of hormonal oral contraceptives may be reduced when administered concomitantly with Cenomate. Women should use additional or alternative non-hormonal birth control",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cenobamate is contraindicated in patients with a known-",
        "items": [
          "Hypersensitivity to either Cenobamate or to any excipients in Cenobamate.",
          "Familial Short QT syndrome"
        ]
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Somnolence, fatigue, dizziness or feeling sleepy, nausea, constipation, double vision, decreased appetite, diarrhea, or weakness may occur.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": A very serious allergic reaction to Cenomate is rare.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women with the use of Cenobamate. But it may cause fetal harm when administered to a pregnant woman. It should be used during pregnancy only if the potential benefits justify the potential risk to the fetus. There are no data on the presence of Cenobamate in human milk, the effects of Cenobamate on the breastfed infant, or the effects of Cenobamate on milk production.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Potential adverse effects such as Multiorgan hypersensitivity reaction, QT shortening, and Suicidal thoughts. Somnolence and fatigue should be periodically re-evaluated. During Cenomate therapeutic regimen, patients are advised not to drive or operate machinery. Cenomate should be gradually withdrawn to minimize the potential or increased seizure frequency. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) / Multi-Organ Hypersensitivity: Discontinue if no alternate etiology. QT Shortening: Use caution when administering Cenomate with other drugs that shorten the QT interval Suicidal Behavior and Ideation: Monitor patients for suicidal behavior and ideation. Neurological Adverse Reactions: Monitor for somnolence and fatigue and advise patients not to drive or operate machinery until they have gained sufficient experience on Cenomate. Concomitant use with other CNS depressants or alcohol may have additive effects. Withdrawal of Antiepileptic Drugs: Cenomate should be gradually withdrawn to minimize the potential of increased seizure frequency",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric use",
        "information": ": The safety and efficacy of Cenomate in children under 18 years have not yet been established.",
        "items": []
      },
      {
        "title": "Geriatric use",
        "information": ": Start at the low end of the dosing range.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": Cenomate should be used with caution and reduction of the target dose may be considered in patients with mild to moderate (creatinine clearance 30 to <90 ml/min) or severe (creatinine clearance <30 ml/min) renal impairment. The maximum recommended dose for patients with mild, moderate, or severe renal impairment is 300 mg/day. Cenomate should not be used in patients with end-stage renal disease or patients undergoing hemodialysis.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Use with caution in patients with mild to moderate hepatic impairment: lower maximum dose and additional dose reduction may be considered. The use of Cenomate in patients with severe hepatic impairment is not recommended.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of overdose, Cenomate should be discontinued and general supportive treatment given until clinical toxicity has been diminished or resolved.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Do not store above 30 degree C. Keep away from light and out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Adjunct anti-epileptic drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cenobamate can be taken with or without food, or as recommended by a physician. Recommended dosage for partial-onset seizures in adult-",
        "instructions": []
      },
      {
        "medication_type": "Initial Dosage",
        "information": ": For Week 1 and 2 dose is 12.5 mg once daily",
        "instructions": []
      },
      {
        "medication_type": "Titration Regimen",
        "information": ":",
        "instructions": [
          "For Week 3 and 4 dose is 25 mg once daily",
          "For Week 5 and 6 dose is 50 mg once daily",
          "For Week 7 and 8 dose is 100 mg once daily",
          "For Week 9 and 10 dose is 150 mg once daily"
        ]
      },
      {
        "medication_type": "Maintenance Dosage",
        "information": ": For Week 11 and thereafter dose is 200 mg once daily",
        "instructions": []
      },
      {
        "medication_type": "Maximum Dosage",
        "information": ": If needed based on clinical response and tolerability, the dose may be increased above 200 mg by increments of 50 mg once daily every two weeks to 400 mg once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:41.943Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b7c",
    "original_record": {
      "input_index": 4365,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b7c"
        },
        "name": "Cenomate",
        "strength": "50 mg",
        "generic": "Cenobamate",
        "company": "Everest Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/37042/cenomate-50-mg-tablet",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/10411/centamol-120-mg-suspension",
    "name": "Centamol",
    "dosage_form": "Oral Suspension",
    "generic": "Paracetamol",
    "strength": "120 mg/5 ml",
    "company": "Central Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/860/paracetamol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Centamol is indicated for fever, common cold and influenza, headache, toothache, earache, bodyache, myalgia, neuralgia, dysmenorrhoea, sprains, colic pain, back pain, post-operative pain, postpartum pain, inflammatory pain and post vaccination pain in children. It is also indicated for rheumatic & osteoarthritic pain and stiffness of joints.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Paracetamol exhibits analgesic action by peripheral blockage of pain impulse generation. It produces antipyresis by inhibiting the hypothalamic heat-regulating centre. Its weak anti-inflammatory activity is related to inhibition of prostaglandin synthesis in the CNS. Paracetamol (Acetaminophen) is thought to act primarily in the CNS, increasing the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin (PG) synthesis. Unlike NSAIDs, acetaminophen does not inhibit cyclooxygenase in peripheral tissues and, thus, has no peripheral anti-inflammatory affects. While aspirin acts as an irreversible inhibitor of COX and directly blocks the enzyme's active site, studies have found that acetaminophen indirectly blocks COX, and that this blockade is ineffective in the presence of peroxides. This might explain why acetaminophen is effective in the central nervous system and in endothelial cells but not in platelets and immune cells which have high levels of peroxides. Studies also report data suggesting that acetaminophen selectively blocks a variant of the COX enzyme that is different from the known variants COX-1 and COX-2. This enzyme is now referred to as COX-3. Its exact mechanism of action is still poorly understood, but future research may provide further insight into how it works. The antipyretic properties of acetaminophen are likely due to direct effects on the heat-regulating centres of the hypothalamus resulting in peripheral vasodilation, sweating and hence heat",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Patients who have taken barbiturates, tricyclic antidepressants and alcohol may show diminished ability to metabolise large doses of Centamol. Alcohol can increase the hepatotoxicity of Centamol overdosage. Chronic ingestion of anticonvulsants or oral steroid contraceptives induce liver enzymes and may prevent attainment of therapeutic Centamol levels by increasing first-pass metabolism or clearance.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in known hypersensitivity to Paracetamol.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects of Centamol are usually mild, though haematological reactions including thrombocytopenia, leucopenia, pancytopenia, neutropenia, and agranulocytosis have been reported. Pancreatitis, skin rashes, and other allergic reactions occur occasionally.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Epidemiological studies in human pregnancy have shown no ill effects due to Paracetamol used in the recommended dosage, but patients should follow the advice of their doctor regarding its use. Paracetamol is excreted in breast milk, but not in a clinically significant amount. Available published data do not contraindicate breast feeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Care is advised in the administration of Centamol to patients with severe renal or severe hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease. Do not exceed the stated dose. Patients should be advised not to take other Centamol-containing products concurrently. Centamol should only be used by the patient for whom it is prescribed when clearly necessary. Administration of Centamol in doses higher than recommended may result in hepatic injury, including the risk of severe hepatotoxicity and death. Do not exceed the maximum recommended daily dose of Centamol. Use caution when administering Centamol in patients with the following conditions: hepatic impairment or active hepatic disease, alcoholism, chronic malnutrition, severe hypovolemia (e.g., due to dehydration or blood loss), or severe renal impairment (creatinine clearance < 30 ml/min). There were infrequent reports of life-threatening anaphylaxis requiring emergent medical attention. Discontinue Centamol IV immediately if symptoms associated with allergy or hypersensitivity occurs. Do not use Centamol IV in patients with Centamol allergy.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": The safety and effectiveness of Centamol IV for the treatment of acute pain and fever in pediatric patients ages 2 years and older is supported by evidence from adequate and well-controlled studies of Centamol IV in adults.",
        "items": []
      },
      {
        "title": "Geriatric use",
        "information": ": No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients.",
        "items": []
      },
      {
        "title": "Patients with Hepatic Impairment",
        "information": ": Centamol is contraindicated in patients with severe hepatic impairment or severe active liver disease and should be used with caution in patients with hepatic impairment or active liver disease. A reduced total daily dose of Centamol may be warranted.",
        "items": []
      },
      {
        "title": "Patients with Renal Impairment",
        "information": ": In cases of severe renal impairment (creatinine clearance < 30 ml/min), longer dosing intervals and a reduced total daily dose of Centamol may be warranted.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Liver damage is possible in adults who have taken 10 g or more of Centamol. Ingestion of 5 g or more of Centamol may lead to liver damage if the patient has following risk factors: If the patient is on long term treatment with Carbamazepine, Phenobarbitone, Phenytoin, Primidone, Rifampicin, St John’s Wort or other drugs that induce liver enzymes, or regularly consumes Ethanol in excess of recommended amounts, or is likely to be Glutathione deplete e.g. eating disorders, cystic fibrosis, HIV infection, starvation, cachexia.",
        "items": []
      },
      {
        "title": "Symptoms",
        "information": ": Symptoms of Centamol overdose in the first 24 hours are pallor, nausea, vomiting, anorexia and abdominal pain. Liver damage may become apparent 12 to 48 hours after ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe poisoning, hepatic failure may progress to encephalopathy, haemorrhage, hypoglycaemia, cerebral oedema and death. Acute renal failure with acute tubular necrosis, strongly suggested by loin pain, haematuria and proteinuria, may develop even in the absence of severe liver damage. Cardiac arrhythmias and pancreatitis have been reported. Immediate treatment is essential in the management of Centamol overdose. Treatment with activated charcoal should be considered if the overdose has been taken within 1 hour. Plasma Centamol concentration should be measured at 4 hours or later after ingestion (earlier concentrations are unreliable). Treatment with N-acetylcysteine may be used up to 24 hours after ingestion of Centamol. However, the maximum protective effect is obtained up to 8 hours post-ingestion. The effectiveness of the antidote declines sharply after this time. If required the patient should be given intravenous N-acetylcysteine, in line with the established dosage schedule. If vomiting is not a problem, oral Methionine may be a suitable alternative for remote areas, outside hospital. Management of patients who present with serious hepatic dysfunction beyond 24 hours from ingestion should be discussed with the NPIS or a liver unit.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C8H9NO2",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-860-paracetamol-chemical-structure-JLKHDuG7hxR2MserFZ27.svg"
    },
    "therapeutic_class": "Non-Opioid Analgesics",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ":",
        "instructions": [
          "Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.",
          "Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment it is wise not to exceed the dose beyond 2.6 gm/day."
        ]
      },
      {
        "medication_type": "Extended Release Tablet",
        "information": ":",
        "instructions": [
          "Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours (maximum of 6 tablets in any 24 hours).The tablet must not be crushed."
        ]
      },
      {
        "medication_type": "Syrup/Suspension",
        "information": ":",
        "instructions": [
          "Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.",
          "3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.",
          "1-5 years: 1 -2 teaspoonful 3 to 4 times daily.",
          "6-12 years: 2-A teaspoonful 3 to 4 times daily.",
          "Adults: 4-8 teaspoonful 3 to 4 times daily."
        ]
      },
      {
        "medication_type": "Suppository",
        "information": ":",
        "instructions": [
          "Children 3-12 months: 60-120 mg,4 times daily.",
          "Children 1-5 years: 125-250 mg 4 times daily.",
          "Children 6-12 years: 250-500 mg 4 times daily.",
          "Adults & children over 12 years: 0.5-1 gm 4 times daily."
        ]
      },
      {
        "medication_type": "Paediatric Drop",
        "information": ":",
        "instructions": [
          "Children Upto 3 months: 0.5 ml (40 mg)",
          "4 to 11 months: 1.0 ml (80 mg)",
          "7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days."
        ]
      },
      {
        "medication_type": "Tablet with actizorb technology",
        "information": ": It dissolves up to five times faster than standard Paracetamol tablets. It is a fast acting and safe analgesic with marked antipyretic property. It is specially suitable for patients who, for any reason, can not tolerate aspirin or other analgesics.",
        "instructions": [
          "Adults and children (aged 12 years and over): Take 1 to 2 Tablets every four to six hours as needed. Do not take more than 8 caplets in 24 hours.",
          "Children (7 to 11 years): Take ½-1 Tablet every four to six hours as needed. Do not take more than 4 caplets in 24 hours. Not recommended in children under 7 years."
        ]
      },
      {
        "medication_type": "IV Infusion",
        "information": ":",
        "instructions": [
          "Adults and adolescents weighing 50 kg and over: the recommended dosage of Paracetamol IV is 1000 mg every 6 hours or 650 mg every 4 hours, with a maximum single dose of Paracetamol IV of 1000 mg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 4000 mg per day.",
          "Adults and adolescents weighing under 50 kg: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day.",
          "Children >2 to 12 years of age: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day."
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Centamol 120 mg/5 ml Suspension?",
        "answer": [
          "Centamol 120 mg/5 ml Suspension is a medication that performs its action by obstructing the release of pain and fever chemical messengers."
        ]
      },
      {
        "question": "What are the uses of Centamol 120 mg/5 ml Suspension?",
        "answer": [
          "Centamol 120 mg/5 ml Suspension is used for the treatment and prevention of conditions and symptoms of diseases like Post immunization pyrexia, menstrual cramps and fever."
        ]
      },
      {
        "question": "What are the Side Effects of Centamol 120 mg/5 ml Suspension Centamol 120 mg/5 ml Suspension?",
        "answer": [
          "Allergic reaction, gastric ulcers, fatigue, anemia, nausea and vomiting are possible side effects."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Centamol 120 mg/5 ml Suspension?",
        "answer": [
          "Centamol 120 mg/5 ml Suspension should be stored at room temperature, away from heat and direct light. Keep it away from the reach of children and pets."
        ]
      },
      {
        "question": "Should I use Centamol 120 mg/5 ml Suspension empty stomach, before food or after food?",
        "answer": [
          "If you take Centamol 120 mg/5 ml Suspension with the food, the reactions that took place in the body carry-outs in a much effective manner."
        ]
      },
      {
        "question": "How long do I need to use Centamol 120 mg/5 ml Suspension before I see improvement in my conditions?",
        "answer": [
          "Centamol 120 mg/5 ml Suspension should be consumed, until the complete eradication of the disease. It is advised to use, till the time directed by your doctor."
        ]
      },
      {
        "question": "Is there any food or drink I need to avoid while taking Centamol 120 mg/5 ml Suspension?",
        "answer": [
          "You can follow your normal diet under the usage of Centamol 120 mg/5 ml Suspension."
        ]
      },
      {
        "question": "Will Centamol 120 mg/5 ml Suspension be more effective if taken in more than the recommended dose?",
        "answer": [
          "There is no need to take Centamol 120 mg/5 ml Suspension more than its recommended doses."
        ]
      },
      {
        "question": "Can I take other medications along with Centamol 120 mg/5 ml Suspension?",
        "answer": [
          "Do not use any OTC for cough, cold, allergy, or pain medication without consulting your doctor or pharmacist. Centamol 120 mg/5 ml Suspension contains many combination of medicines. If you use certain products together you may accidentally use too much of Centamol 120 mg/5 ml Suspension."
        ]
      },
      {
        "question": "Can I take Centamol 120 mg/5 ml Suspension with antibiotics?",
        "answer": [
          "There are hundreds of antibiotics used to treat infections, so once you receive your prescription, ask your doctor or pharmacist if you can also take Centamol 120 mg/5 ml Suspension at the same time that you take the antibiotic."
        ]
      },
      {
        "question": "Is Centamol 120 mg/5 ml Suspension an NSAID drug?",
        "answer": [
          "No, Centamol 120 mg/5 ml Suspension is not classified as an NSAID (nonsteroidal anti-inflammatory drug). It is classified as a miscellaneous analgesic for mild to moderate pain and fever."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Centamol 120 mg/5 ml Suspension should be taken with food or milk to prevent upset stomach.",
          "Take Centamol 120 mg/5 ml Suspension as per the dose and duration prescribed by your doctor. Long term use may lead to serious complications such as stomach bleeding and kidney problems.",
          "Do not take indigestion remedies (antacids) within two hours of taking Centamol 120 mg/5 ml Suspension.",
          "Avoid consuming alcohol while taking Centamol 120 mg/5 ml Suspension as it can increase your risk of stomach problems.",
          "Inform your doctor if you have liver disease as your dose may need to be adjusted.",
          "Your doctor may regularly monitor your kidney function, liver function and levels of blood components if you are taking Centamol 120 mg/5 ml Suspension for long-term treatment."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:04:43.052Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b80",
    "original_record": {
      "input_index": 4366,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b80"
        },
        "name": "Centamol",
        "strength": "120 mg/5 ml",
        "generic": "Paracetamol",
        "company": "Central Pharmaceuticals Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/10411/centamol-120-mg-suspension",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/22097/centomin-500-mg-tablet",
    "name": "Centomin",
    "dosage_form": "Tablet",
    "generic": "Metformin Hydrochloride",
    "strength": "500 mg",
    "company": "Centeon Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 40.00",
      "pack_size_info": "(10 x 10: ৳ 400.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(10 x 10: ৳ 400.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "850 mg (Tablet)",
        "href": "https://medex.com.bd/brands/22098/centomin-850-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/734/metformin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Centomin tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. Centomin tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.",
        "items": [
          "In adults: Centomin may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.",
          "In adults: Centomin may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.",
          "In children from 10 years of age and adolescents: Centomin may be used as monotherapy or in combination with insulin."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Metformin is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from those of sulfonylureas and it does not produce hypoglycemia. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No information is available about the interaction of Centomin and Furosemide when co-administered chronically. Nifedipine appears to enhance the absorption of Centomin. Centomin had minimal effects on Nifedipine. Cationic drugs (e.g., Amiloride, Digoxin, Morphine, Procainamide, Quinidine, Quinine, Triamterene, Trimethoprim, or Vancomycin) that are eliminated by renal tubular secretion theoretically have the potential for interaction with Centomin by competing for common renal tubular transport systems. Centomin had no effect on Cimetidine pharmacokinetics. Certain drugs tend to produce hyperglycemia and may lead to loss of glycemic control. These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, Estrogens, Oral contraceptives, Phenytoin, Nicotinic Acid, sympathomimetics, calcium channel blocking drugs, and Isoniazid.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to the active substance or to any of the excipients.",
          "Any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis).",
          "Severe renal failure (GFR <30 mL/min).",
          "Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock.",
          "Acute or chronic disease, which may cause tissue hypoxia such as: cardiac or respiratory failure, recent myocardial infarction, shock, Hepatic insufciency, acute alcohol intoxication, alcoholism."
        ]
      }
    ],
    "side_effects": [
      {
        "title": "Blood and lymphatic system disorders",
        "information": ": Not known: Hemolytic anemia",
        "items": []
      },
      {
        "title": "Metabolism and nutrition disorders",
        "information": ": Very rare: Lactic acidosis. Decrease of vitamin B12 absorption with a decrease of serum levels during long-term use of metformin. Consideration of such etiology is recommended if a patient presents with megaloblastic anemia. Cases of peripheral neuropathy in patients with vitamin B12 deficiency have been reported in post-marketing experience (frequency not known)",
        "items": []
      },
      {
        "title": "Nervous system disorder",
        "information": "s: Common: Taste disturbance. Not known: Encephalopathy",
        "items": []
      },
      {
        "title": "Gastrointestinal disorders",
        "information": ": Very common: Gastrointestinal disorders, such as nausea, vomiting, diarrhea, abdominal pain, and loss of appetite. These undesirable effects occur most frequently during the initiation of therapy and resolve spontaneously in most cases. To prevent them, it is recommended that metformin be taken in 2 or 3 daily doses during or after meals. A slow increase of the dose may also improve gastrointestinal tolerability.",
        "items": []
      },
      {
        "title": "Hepatobiliary disorders",
        "information": ": Very rare: Isolated reports of liver function test abnormalities or hepatitis resolving upon metformin discontinuation.",
        "items": []
      },
      {
        "title": "Skin and subcutaneous tissue disorders",
        "information": ": Very rare: Skin reactions, such as erythema, pruritus, urticaria.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Uncontrolled diabetes during pregnancy (gestational or permanent) is associated with an increased risk of congenital abnormalities and perinatal mortality. When the patient plans to become pregnant and during pregnancy, it is recommended that diabetes is not treated with metformin but insulin be used to maintain blood glucose levels as close to normal as possible, to reduce the risk of malformations of the foetus.",
        "items": []
      },
      {
        "title": "Breastfeeding",
        "information": ": Metformin is excreted into human breast milk. No adverse efects were observed in breastfed newborns/infants. However, as only limited data are available, breastfeeding is not recommended during metformin treatment. A decision on whether to discontinue breastfeeding should be made, taking into account the benefit of breastfeeding and the potential risk to adverse effects on the child.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Centomin is known to be substantially excreted by the kidney and the risk of Centomin accumulation and lactic acidosis increases with the degree of impairment of renal function. Centomin may lower vitamin B12 level. It also increases risk of hypoglycemia when use in combination with insulin or insulin secretagogue. Centomin is excreted by the kidney and regular monitoring of renal function is advised in all diabetics. Centomin therapy should be stopped 2-3 days before surgery and clinical investigations such as intravenous urography and intravenous angiography, and reinstated only after control or renal function has been regained. The use of Centomin is not advised in conditions which may cause dehydration or in patients suffering from serious infections or trauma. Patients receiving continuous Centomin therapy should have an annual estimation of Vitamin B-12 levels because of reports of decreased Vitamin B-12 absorption. During concomitant therapy with a sulphonylurea, blood glucose should be monitored because combined therapy may cause hypoglycaemia. Stabilization of diabetic patients with Centomin and insulin should be carried out in hospital because of the possibility of hypoglycaemia until the correct ratio of the two drugs has been obtained. Reduced renal clearance of Centomin has been reported during cimetidine therapy, so a dose reduction should be considered. As with a number of drugs, an interaction between Centomin and anticoagulants is a possibility and dosage of the latter may need adjustment.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Elderly",
        "information": ": Due to the potential for decreased renal function in elderly subjects, the metformin dosage should be adjusted based on renal function. Regular assessment of renal function is necessary.",
        "items": []
      },
      {
        "title": "Pediatric population",
        "information": ": The diagnosis of type 2 diabetes mellitus should be confirmed before treatment with metformin is initiated. No effect of metformin on growth and puberty has been detected during controlled clinical studies of one-year duration but no long-term data on these specific points are available. Therefore, a careful follow-up of the effect of metformin on these parameters in metformin-treated children, especially prepubescent children, is recommended.",
        "items": []
      },
      {
        "title": "Children aged between 10 and 12 years",
        "information": ": Particular caution is recommended when prescribing to children aged between 10 and 12 years.",
        "items": []
      },
      {
        "title": "Renal function",
        "information": ": As metformin is excreted by the kidney, creatinine clearance (this can be estimated from serum creatinine levels by using the Cockcroft-Gault formula) should be determined before initiating treatment and regularly thereafter: Decreased renal function in elderly subjects is frequent and asymptomatic. Special caution should be exercised in situations where renal function may become impaired, for example when initiating antihypertensive therapy or diuretic therapy and when starting therapy with a non-steroidal anti-inflammatory drug (NSAID). GFR should be assessed before treatment initiation and regularly thereafter. Centomin is contraindicate in patients with GFR<30 ml/min and should be temporarily discontinued in the presence of conditions that alter renal function.",
        "items": [
          "At least annually in patients with normal renal function,",
          "At least two to four times a year in patients with creatinine clearance at the lower limit of normal and in elderly subjects."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Hypoglycemia has not been seen with Centomin doses up to 85 gm, although lactic acidosis has occurred in such circumstances. Lactic acidosis is a medical emergency and must be treated in hospital. The most effective method to remove lactate and Centomin is hemodialysis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Biguanides",
    "dosage": [
      {
        "medication_type": "Metformin immediate release tablet",
        "information": ": Dosage of Metformin Hydrochloride must be individualized on the basis of both effectiveness and tolerance, while not exceeding the maximum recommended daily doses.",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": The usual starting dose of Metformin is 500 mg twice a day or 850 mg once a day, given with meals. Dosage increases should be made in increments of 500 mg weekly or 850 mg every 2 weeks, up to a total of 2000 mg per day, given in divided doses. For those patients requiring additional glycemic control, Glucomin may be given to a maximum daily dose of 2550 mg per day. Doses above 2000 mg may be better tolerated given three times a day with meals.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": The usual starting dose of Metformin is 500 mg twice a day, given with meals. Dosage increases should be made in increments of 500 mg weekly up to a maximum of 2000 mg per day, given in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Metformin extended release tablet",
        "information": ": Swallow Metformin XR tablet whole and never crush, cut or chew.",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": The usual starting dose of Metformin XR is 500 mg once daily with the evening meal. Dose should be increased in increments of 500 mg weekly, up to a maximum of 2000 mg once daily with the evening meal, alternatively increased to 1000 mg twice daily taken with meal. Patient receiving Metformin immediate release tablet may be switched to Metformin extended release tablet up to a maximum recommended daily dose.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": Metformin extended release tablet has not been studied in children.",
        "instructions": []
      },
      {
        "medication_type": "Renal impaired patient",
        "information": ": Do not use Metformin in patients with eGFR below 30 mL/min/1.73 m2. Asses risk/benefit of counting if eGFR falls below 45 mL/min/1.73 m2.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:44.029Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b86",
    "original_record": {
      "input_index": 4367,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b86"
        },
        "name": "Centomin",
        "strength": "500 mg",
        "generic": "Metformin Hydrochloride",
        "company": "Centeon Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/22097/centomin-500-mg-tablet",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/24808/centradol-50-mg-tablet",
    "name": "Centradol",
    "dosage_form": "Tablet",
    "generic": "Tapentadol Hydrochloride",
    "strength": "50 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(2 x 10: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(2 x 10: ৳ 240.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "75 mg (Tablet)",
        "href": "https://medex.com.bd/brands/26196/centradol-75-mg-tablet?ref=1"
      },
      {
        "text": "100 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/30139/centradol-er-100-mg-tablet?ref=1"
      },
      {
        "text": "100 mg (Tablet)",
        "href": "https://medex.com.bd/brands/33465/centradol-100-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1033/tapentadol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Centradol tablet is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Tapentadol is a centrally-acting synthetic analgesic. Although their clinical relevance is unclear, tapentadol is believed to have two main mechanisms of action. Tapentadol is a selective mu-opioid receptor (MOR) agonist: it binds to MOR with an affinity greater than or equal to ten-fold affinity compared to delta- and kappa-opioid receptors. Tapentadol also inhibits noradrenaline reuptake, thereby increasing noradrenaline levels and activating alpha-2 receptors to promote analgesia. Tapentadol is a weak serotonin reuptake inhibitor; however, this action does not contribute to its analgesic effect.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Increased risk of serotonin syndrome with other drugs that enhance monoaminergic neurotransmission (e.g. TCAs, triptans, SSRIs, serotonin and norepinephrine reuptake inhibitors). Enhanced sedative effect with benzodiazepines, barbiturates, antipsychotics, H1-antihistamines and other opioids. Increased potential for addiction with mixed μ-opioid agonists/antagonists (e.g. nalbuphine, pentazocine) or partial μ-opioid agonists (e.g. buprenorphine). Increased systemic exposure with strong inhibitors of UGT1A6, UGT1A9 and UGT2B7 isoenzymes. Decreased efficacy with strong enzyme inducers (e.g. rifampicin, phenobarbital).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This drug is contraindicated in patients with impaired Pulmonary Function, It is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment. This drug is contraindicated in any patient who has or is suspected of having paralytic ileus.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following treatment-emergent adverse events may happen: heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, hypersensitivity, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, urticaria, blood pressure decreased etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. This preparation should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates whose mothers have been taking Tapentadol should be monitored for respiratory depression.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Centradol should be administered with caution to patients with conditions accompanied by hypoxia, hypercapnia respiratory problems such as: asthma, chronic obstructive pulmonary disease etc. Besides this in case of patient with sleep apnea syndrome, myxedema, kyphoscoliosis, central nervous system (CNS) depression should have to be cautious prior administration of Centradol. Patients receiving other mu-opioid agonist analgesics, general anesthetics, phenothiazines, other tranquilizers, sedatives, hypnotics, or other CNS depressants (including alcohol) concomitantly with Centradol may exhibit additive CNS depression.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric use:",
        "information": "The safety and effectiveness of Centradol in pediatric patients less than 18 years of age have not been established.",
        "items": []
      },
      {
        "title": "Use in elderly patients:",
        "information": "In general, recommended dosing for elderly patients with normal renal and hepatic function is the same as for younger adult patients with normal renal and hepatic function. consideration should be given to starting elderly patients with the lower range of recommended doses.",
        "items": []
      },
      {
        "title": "Use in Renal Disease:",
        "information": "In patients with severe renal impairment, the safety and effectiveness of Centradol has not been established.",
        "items": []
      },
      {
        "title": "Use in Hepatic Disease",
        "information": ": Centradol should be used with caution in patients with moderate hepatic impairment. Centradol has not been studied in patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light and moisture. Keep the medicine out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Opioid analgesics",
    "dosage": [
      {
        "medication_type": null,
        "information": "As with many centrally-acting analgesic medications, the dosing regimen should be individualized according to the severity of pain being treated, the previous experience with similar drugs and the ability to monitor the patient. The dose is 50 mg, 75 mg, or 100 mg every 4 to 6 hours depending upon pain intensity. On the first day of dosing, the second dose may be administered as soon as one hour after the first dose, if adequate pain relief is not attained with the first dose. Subsequent dosing is 50 mg, 75 mg, or 100 mg every 4 to 6 hours and should be adjusted to maintain adequate analgesia with acceptable tolerability. Daily doses greater than 700 mg on the first day of therapy and 600 mg on subsequent days have not been studied and are not recommended.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:45.286Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b8a",
    "original_record": {
      "input_index": 4368,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b8a"
        },
        "name": "Centradol",
        "strength": "50 mg",
        "generic": "Tapentadol Hydrochloride",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/24808/centradol-50-mg-tablet",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33465/centradol-100-mg-tablet",
    "name": "Centradol",
    "dosage_form": "Tablet",
    "generic": "Tapentadol Hydrochloride",
    "strength": "100 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 250.00",
      "pack_size_info": "(3 x 10: ৳ 750.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(3 x 10: ৳ 750.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "50 mg (Tablet)",
        "href": "https://medex.com.bd/brands/24808/centradol-50-mg-tablet?ref=1"
      },
      {
        "text": "75 mg (Tablet)",
        "href": "https://medex.com.bd/brands/26196/centradol-75-mg-tablet?ref=1"
      },
      {
        "text": "100 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/30139/centradol-er-100-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1033/tapentadol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Centradol tablet is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Tapentadol is a centrally-acting synthetic analgesic. Although their clinical relevance is unclear, tapentadol is believed to have two main mechanisms of action. Tapentadol is a selective mu-opioid receptor (MOR) agonist: it binds to MOR with an affinity greater than or equal to ten-fold affinity compared to delta- and kappa-opioid receptors. Tapentadol also inhibits noradrenaline reuptake, thereby increasing noradrenaline levels and activating alpha-2 receptors to promote analgesia. Tapentadol is a weak serotonin reuptake inhibitor; however, this action does not contribute to its analgesic effect.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Increased risk of serotonin syndrome with other drugs that enhance monoaminergic neurotransmission (e.g. TCAs, triptans, SSRIs, serotonin and norepinephrine reuptake inhibitors). Enhanced sedative effect with benzodiazepines, barbiturates, antipsychotics, H1-antihistamines and other opioids. Increased potential for addiction with mixed μ-opioid agonists/antagonists (e.g. nalbuphine, pentazocine) or partial μ-opioid agonists (e.g. buprenorphine). Increased systemic exposure with strong inhibitors of UGT1A6, UGT1A9 and UGT2B7 isoenzymes. Decreased efficacy with strong enzyme inducers (e.g. rifampicin, phenobarbital).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This drug is contraindicated in patients with impaired Pulmonary Function, It is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment. This drug is contraindicated in any patient who has or is suspected of having paralytic ileus.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following treatment-emergent adverse events may happen: heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, hypersensitivity, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, urticaria, blood pressure decreased etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. This preparation should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates whose mothers have been taking Tapentadol should be monitored for respiratory depression.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Centradol should be administered with caution to patients with conditions accompanied by hypoxia, hypercapnia respiratory problems such as: asthma, chronic obstructive pulmonary disease etc. Besides this in case of patient with sleep apnea syndrome, myxedema, kyphoscoliosis, central nervous system (CNS) depression should have to be cautious prior administration of Centradol. Patients receiving other mu-opioid agonist analgesics, general anesthetics, phenothiazines, other tranquilizers, sedatives, hypnotics, or other CNS depressants (including alcohol) concomitantly with Centradol may exhibit additive CNS depression.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric use:",
        "information": "The safety and effectiveness of Centradol in pediatric patients less than 18 years of age have not been established.",
        "items": []
      },
      {
        "title": "Use in elderly patients:",
        "information": "In general, recommended dosing for elderly patients with normal renal and hepatic function is the same as for younger adult patients with normal renal and hepatic function. consideration should be given to starting elderly patients with the lower range of recommended doses.",
        "items": []
      },
      {
        "title": "Use in Renal Disease:",
        "information": "In patients with severe renal impairment, the safety and effectiveness of Centradol has not been established.",
        "items": []
      },
      {
        "title": "Use in Hepatic Disease",
        "information": ": Centradol should be used with caution in patients with moderate hepatic impairment. Centradol has not been studied in patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light and moisture. Keep the medicine out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Opioid analgesics",
    "dosage": [
      {
        "medication_type": null,
        "information": "As with many centrally-acting analgesic medications, the dosing regimen should be individualized according to the severity of pain being treated, the previous experience with similar drugs and the ability to monitor the patient. The dose is 50 mg, 75 mg, or 100 mg every 4 to 6 hours depending upon pain intensity. On the first day of dosing, the second dose may be administered as soon as one hour after the first dose, if adequate pain relief is not attained with the first dose. Subsequent dosing is 50 mg, 75 mg, or 100 mg every 4 to 6 hours and should be adjusted to maintain adequate analgesia with acceptable tolerability. Daily doses greater than 700 mg on the first day of therapy and 600 mg on subsequent days have not been studied and are not recommended.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:46.285Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b8b",
    "original_record": {
      "input_index": 4369,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b8b"
        },
        "name": "Centradol",
        "strength": "100 mg",
        "generic": "Tapentadol Hydrochloride",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/33465/centradol-100-mg-tablet",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30139/centradol-er-100-mg-tablet",
    "name": "Centradol ER",
    "dosage_form": "Tablet (Extended Release)",
    "generic": "Tapentadol Hydrochloride",
    "strength": "100 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": "৳ 200.00",
      "pack_size_info": "(1 x 10: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 20.00",
          "pack_size_info": "(1 x 10: ৳ 200.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "50 mg (Tablet)",
        "href": "https://medex.com.bd/brands/24808/centradol-50-mg-tablet?ref=1"
      },
      {
        "text": "75 mg (Tablet)",
        "href": "https://medex.com.bd/brands/26196/centradol-75-mg-tablet?ref=1"
      },
      {
        "text": "100 mg (Tablet)",
        "href": "https://medex.com.bd/brands/33465/centradol-100-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1033/tapentadol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Centradol ER tablet is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Tapentadol is a centrally-acting synthetic analgesic. Although their clinical relevance is unclear, tapentadol is believed to have two main mechanisms of action. Tapentadol is a selective mu-opioid receptor (MOR) agonist: it binds to MOR with an affinity greater than or equal to ten-fold affinity compared to delta- and kappa-opioid receptors. Tapentadol also inhibits noradrenaline reuptake, thereby increasing noradrenaline levels and activating alpha-2 receptors to promote analgesia. Tapentadol is a weak serotonin reuptake inhibitor; however, this action does not contribute to its analgesic effect.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Increased risk of serotonin syndrome with other drugs that enhance monoaminergic neurotransmission (e.g. TCAs, triptans, SSRIs, serotonin and norepinephrine reuptake inhibitors). Enhanced sedative effect with benzodiazepines, barbiturates, antipsychotics, H1-antihistamines and other opioids. Increased potential for addiction with mixed μ-opioid agonists/antagonists (e.g. nalbuphine, pentazocine) or partial μ-opioid agonists (e.g. buprenorphine). Increased systemic exposure with strong inhibitors of UGT1A6, UGT1A9 and UGT2B7 isoenzymes. Decreased efficacy with strong enzyme inducers (e.g. rifampicin, phenobarbital).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This drug is contraindicated in patients with impaired Pulmonary Function, It is also contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment. This drug is contraindicated in any patient who has or is suspected of having paralytic ileus.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following treatment-emergent adverse events may happen: heart rate increased, heart rate decreased, visual disturbance, abdominal discomfort, impaired gastric emptying, irritability, edema, drug withdrawal syndrome, hypersensitivity, involuntary muscle contractions, sensation of heaviness, hypoesthesia, paresthesia, disturbance in attention, sedation, dysarthria, memory impairment, ataxia, presyncope, syncope, coordination abnormal, seizure, urticaria, blood pressure decreased etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. This preparation should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates whose mothers have been taking Tapentadol should be monitored for respiratory depression.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Centradol ER should be administered with caution to patients with conditions accompanied by hypoxia, hypercapnia respiratory problems such as: asthma, chronic obstructive pulmonary disease etc. Besides this in case of patient with sleep apnea syndrome, myxedema, kyphoscoliosis, central nervous system (CNS) depression should have to be cautious prior administration of Centradol ER. Patients receiving other mu-opioid agonist analgesics, general anesthetics, phenothiazines, other tranquilizers, sedatives, hypnotics, or other CNS depressants (including alcohol) concomitantly with Centradol ER may exhibit additive CNS depression.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric use:",
        "information": "The safety and effectiveness of Centradol ER in pediatric patients less than 18 years of age have not been established.",
        "items": []
      },
      {
        "title": "Use in elderly patients:",
        "information": "In general, recommended dosing for elderly patients with normal renal and hepatic function is the same as for younger adult patients with normal renal and hepatic function. consideration should be given to starting elderly patients with the lower range of recommended doses.",
        "items": []
      },
      {
        "title": "Use in Renal Disease:",
        "information": "In patients with severe renal impairment, the safety and effectiveness of Centradol ER has not been established.",
        "items": []
      },
      {
        "title": "Use in Hepatic Disease",
        "information": ": Centradol ER should be used with caution in patients with moderate hepatic impairment. Centradol ER has not been studied in patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light and moisture. Keep the medicine out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Opioid analgesics",
    "dosage": [
      {
        "medication_type": null,
        "information": "As with many centrally-acting analgesic medications, the dosing regimen should be individualized according to the severity of pain being treated, the previous experience with similar drugs and the ability to monitor the patient. The dose is 50 mg, 75 mg, or 100 mg every 4 to 6 hours depending upon pain intensity. On the first day of dosing, the second dose may be administered as soon as one hour after the first dose, if adequate pain relief is not attained with the first dose. Subsequent dosing is 50 mg, 75 mg, or 100 mg every 4 to 6 hours and should be adjusted to maintain adequate analgesia with acceptable tolerability. Daily doses greater than 700 mg on the first day of therapy and 600 mg on subsequent days have not been studied and are not recommended.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:47.220Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b8c",
    "original_record": {
      "input_index": 4370,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b8c"
        },
        "name": "Centradol ER",
        "strength": "100 mg",
        "generic": "Tapentadol Hydrochloride",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet (Extended Release)",
        "source_url": "https://medex.com.bd/brands/30139/centradol-er-100-mg-tablet",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/35871/centrium-gold-tablet",
    "name": "Centrium Gold",
    "dosage_form": "Tablet",
    "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
    "strength": null,
    "company": "Biogen Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": null,
      "pack_size_info": "(1 x 30: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(1 x 30: ৳ 300.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/781/multivitamin-multimineral-a-z-gold-preparation/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Centrium Gold is indicated for the prevention and treatment of vitamins & minerals deficiencies. As a complete daily nutritional supplement, it is also indicated to meet the increased demand for vitamins and minerals in the conditions like physical and emotional stress, chronic diseases, infection illness, osteoporosis, injuries or wound, surgery, poor digestion, old age, pregnancy and lactation, poor appetite, excess dieting, exposure to environmental pollution, heavy exercise etc.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a film coated tablet, which combines 32 high potency vitamins and minerals. This preparation maintains a healthy body and active life-style.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally, Centrium Gold is well tolerated. Diarrhoea may occasionally occur during treatment with beta carotene and the skin may assume a slightly yellow discoloration. Vitamin C and vitamin E may cause diarrhoea and other gastrointestinal disturbances.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended by the consultation with physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Long term intake of high level of vitamin A (excluding that sourced from beta carotene) may increase the risk of osteoporosis in postmenopausal women.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Multi-vitamin & Multi-mineral combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet daily or as recommended by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:48.542Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b8e",
    "original_record": {
      "input_index": 4371,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b8e"
        },
        "name": "Centrium Gold",
        "strength": null,
        "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
        "company": "Biogen Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/35871/centrium-gold-tablet",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7755/cepdoxim-40-mg-suspension",
    "name": "Cepdoxim",
    "dosage_form": "Powder for Suspension",
    "generic": "Cefpodoxime Proxetil",
    "strength": "40 mg/5 ml",
    "company": "Alco Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 90.27",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 90.27",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "100 mg (Capsule)",
        "href": "https://medex.com.bd/brands/33756/cepdoxim-100-mg-capsule?ref=1"
      },
      {
        "text": "200 mg (Capsule)",
        "href": "https://medex.com.bd/brands/33757/cepdoxim-200-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/220/cefpodoxime-proxetil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cepdoxim is indicated for the treatment of infections caused by susceptible microorganism, listed below: Cepdoxim is indicated for the treatment of infections caused by susceptible microorganism, listed below:",
        "items": [
          "Acute otitis media caused by Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenza, Moraxella catarrhalis (including beta-lactamase producing strains).",
          "Pharyngitis/tonsillitis caused by Streptococcus pyogenes.",
          "Acute otitis media caused by Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenza, Moraxella catarrhalis (including beta-lactamase producing strains).",
          "Pharyngitis/tonsillitis caused by Streptococcus pyogenes.",
          "Acute maxillary sinusitis caused by Haemophilus influenzae (including beta-lactamase producing strains), Streptococcus pneumoniae and Moraxella catarrhalis.",
          "Community acquired pneumonia caused by S. pneumoniae or H. influenza (including beta-lactamase-producing strains).",
          "Acute bacterial exacerbation of chronic bronchitis caused by S. pneumoniae, H. influenzae (non-beta-lactamase-producing strains only), or M. catarrhalis.",
          "Skin and skin structure infections caused by Staphylococcus aureus, Streptococcus pyogenes.",
          "Uncomplicated urinary tract infections caused by E. coli, Klebsiella pneumoniae, Proteus mirabilis or Staphylococcus saprophyticus.",
          "Uncomplicated gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains).",
          "Rectal gonococcal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains)."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefpodoxime is an oral 3rd generation cephalosporin, which has good stability to beta lactamases and activity against Gram negative and Gram positive bacteria. It is indicated for the treatment of infections either before the infecting organism has been identified. It is a prodrug its active metabolite is Cefpodoxime. Approximately 29 to 33% of Cefpodoxime excreted unchanged in the urine in 12 hours. Cefpodoxime is indicated for the treatment of patients infected with susceptible strains of microorganisms which include a wide range of gram-positive & gram-negative bacteria. As it is highly stable in presence of β-lactamase enzyme, so it is more effective against gram-positive bacteria than other 3rd generation oral cephalosporins. The susceptible organisms include gram-positive bacteria eg. S. aureus (including penicillinase producing strains), S. saprophyticus, S. pneumoniae, S. pyogenes, S. agalactiae, P. magnus and gram-negative bacteria eg. E. coli, K. pneumoniae, H. influenzae (including β-lactamase producer & Ampicillin resistant strains), M. catarrhalis, N. gonorrhoeae (including penicillinase producing strains), P. mirabilis, C. diversus, H. parainfluenzae, K. oxytoca, P. vulgaris, P. rettgeri.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Antacids",
        "information": ": Concomitant administration of high doses of antacids (sodium bicarbonate and aluminium hydroxide) or H 2 blockers reduce peak plasma level by 24% to 42% and the extent of absorption by 27% to 32%, respectively.",
        "items": []
      },
      {
        "title": "Probenecid",
        "information": ": Renal excretion of cefpodoxime was inhibited by probenecid and resulted in an approximately 31% increase in AUC.",
        "items": []
      },
      {
        "title": "Nephrotoxic drugs",
        "information": ": Close monitoring of renal function is advised when Cepdoxim is administered concomitantly with compounds of known nephrotoxic potential.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefpodoxime Proxetil is contraindicated in patients with a known allergy to Cefpodoxime or to the cephalosporin group of antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cepdoxim has very few side effects. The side effects include diarrhea, nausea, skin & vaginal fungal infection, abdominal pain, headache, chest pain, myalgia, dyspepsia, dizziness, vertigo, cough etc. In children incidence of fungal skin rash is more than adults.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Cefpodoxime was neither teratogenic nor embryocidal in animal trial. There is, however, no adequate and well-controlled study of Cefpodoxime Proxetil use in pregnant woman. The drug should be used during pregnancy only if clearly needed. Because Cefpodoxime is excreted in human milk, a decision should be made wheather to discontinue breast-feeding or to discontinue the drug.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In patients with transient or persistent reduction in urinary output due to renal insufficiency, the total daily dose of Cepdoxim should be reduced. Cepdoxim, like other cephalosporins, should be administered with caution to patients receiving concurrent treatment with potent diuretics. As with other broad spectrum antibiotics, prolonged use of Cepdoxim may result in overgrowth of non-susceptible organisms. Repeated evaluation of the patient’s condition is essential.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Third generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and Adolescents (13 years and older)- Infants and Pediatric Patients (2 months to 12 years)-",
        "instructions": [
          "Pharyngitis/tonsillitis: 100 mg 12 hourly, 5 to 10 days",
          "Acute maxillary sinusitis: 200 mg 12 hourly, 10 day",
          "Community-acquired pneumonia: 200 mg 12 hourly, 14 days",
          "Acute bacterial exacerbations of chronic bronchitis: 200 mg 12 hourly, 10 days",
          "Skin and skin structure: 400 mg 12 hourly, 7 to 14 days",
          "Uncomplicated urinary tract infection: 100 mg 12 hourly, 7 days",
          "Uncomplicated gonorrhea: single dose of 200 mg",
          "Rectal gonococcal infections in women: single dose of 200 mg",
          "Acute otitis media: 5 mg/kg body weight 12 hourly, 5 days",
          "Pharyngitis /tonsillitis: 5 mg/kg body weight 12 hourly, 5 to 10 days",
          "Acute maxillary sinusitis: 5 mg/kg body weight 12 hourly, 10 days"
        ]
      },
      {
        "medication_type": "Patients with renal dysfunction",
        "information": ": For patients with severe renal impairment (creatinine clearance <30ml/min) the dosing intervals should be increased to 24 hourly.",
        "instructions": []
      },
      {
        "medication_type": "Patients with liver cirrhosis",
        "information": ": Cefpodoxime Proxetil pharmacokinetics in cirrhotic patients are similar to those in healthy subjects. Dose adjustment is not necessary in this population.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:49.772Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b93",
    "original_record": {
      "input_index": 4372,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b93"
        },
        "name": "Cepdoxim",
        "strength": "40 mg/5 ml",
        "generic": "Cefpodoxime Proxetil",
        "company": "Alco Pharma Ltd.",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/7755/cepdoxim-40-mg-suspension",
        "_page": 140,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6704/cephaxin-500-mg-capsule",
    "name": "Cephaxin",
    "dosage_form": "Capsule",
    "generic": "Cephalexin",
    "strength": "500 mg",
    "company": "Pharmadesh Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 10.53",
      "strip_price": null,
      "pack_size_info": "(20's pack: ৳ 210.60)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.53",
          "pack_size_info": "(20's pack: ৳ 210.60)"
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/6705/cephaxin-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/231/cephalexin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cephaxin is indicated for the treatment of the following infections when caused by susceptible organisms. Cephaxin is indicated for the treatment of the following infections when caused by susceptible organisms.",
        "items": [
          "Respiratory tract infections: Acute and chronic bronchitis and infected bronchiectasis.",
          "Genito-urinary tract infections: Acute and chronic nephritis, cystitis, urethritis and prostatitis, prophylaxis of recurrent urinary tract infections.",
          "Respiratory tract infections: Acute and chronic bronchitis and infected bronchiectasis.",
          "Genito-urinary tract infections: Acute and chronic nephritis, cystitis, urethritis and prostatitis, prophylaxis of recurrent urinary tract infections.",
          "Skin and soft tissue infections: Caused by staphylococci and/or streptococci.",
          "Ear, Nose and Throat infections: Otitis media, mastoiditis, sinusitis, follicular tonsillitis and pharyngitis.",
          "Bone infections: Caused by staphylococci and/or P. mirabilis."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephalexin is a semisynthetic analogue of Cephalosporin C. It kills bacteria by interfering in the synthesis of the bacterial cell wall. Peptidoglycan is a heteropolymeric structure that provides the cell wall with mechanical stability. The final stage in the synthesis of peptidoglycan involves the completion of the cross-linking and the terminal glycine residue of the Pentaglycine Bridge is linked to the fourth residue of the pentapeptide (d-alanin). The transpeptidase enzyme that performs this step is inhibited by penicillins and cephalosporins. As a result the bacterial cell wall is weakened, the cell swells and then ruptures. Cephalexin is a first generation cephalosporin that is active by mouth.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "Cephalen is contraindicated in patients with known hypersensitivity to the cephalosporin group of antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects include nausea, vomiting, diarrhoea and abdominal discomfort. Symptoms of pseudomembranous colitis may appear either during or after antibiotic treatment. Skin rash, angio oedema, rise in serum aminotransferases, eosinophilia, neutropenia have been reported very rarely. Superinfection with resistant micro organisms, particularly candida may follow the treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category B. Cefalexin may be used during pregnancy when it is considered essential. Cefalexin is found in the milk of nursing mothers, hence caution should be taken when it is administered to nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefalexin should be given with caution in patients with renal impairment. Under such condition, careful clinical observation should be made because safe dosage may be lower than the usually recommended. The urine of patients receiving Cefalexin may give a false positive reaction for glucose with copper reduction reagent. Positive results to Coombs’ test have been reported. Although there is no evidence of teratogenicity in animal tests, Cefalexin may be used during pregnancy when it is considered essential. Cefalexin is found in the milk of nursing mothers, hence caution should be taken when it is administered to nursing mothers.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Should be stored in cool and dry place.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ":",
        "instructions": [
          "The usual dose is 250 mg to 500 mg every 6 hour.",
          "For skin and soft tissue infections, streptococcal pharyngitis and uncomplicated cystitis, in patients over 15 years of age: 500 mg of the drug may be administered every 12 hour.",
          "In severe or deep seated infections the dose can be increased up to 3 g to 6 g daily."
        ]
      },
      {
        "medication_type": "Children",
        "information": ": The dosage range is 25-100 mg/kg/day in divided doses to a maximum of 4 g daily Children's Weight Recommended Dose:",
        "instructions": []
      },
      {
        "medication_type": "10 kg (22 Ibs)",
        "information": ": 62.5 mg to 125 mg qid or 125 mg to 250 mg bid",
        "instructions": []
      },
      {
        "medication_type": "20 kg (44 Ibs)",
        "information": ": 125 mg to 250 mg qid or 250 mg to 500 mg bid",
        "instructions": []
      },
      {
        "medication_type": "40 kg (88 Ibs)",
        "information": ": 250 mg to 500 mg qid or 500 mg to 1 g bid",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "For streptococcal pharyngitis, skin and soft tissue infections and in patients over 1 year of age the total daily dose may be divided and administered every 12 hour. In the therapy of otitis media 75-100 mg/kg/day in four divided doses may be required. In the treatment of β haemolytic streptococcal infections a therapeutic dosage of the drug should be given at least for 10 days.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:50.786Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b9b",
    "original_record": {
      "input_index": 4373,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b9b"
        },
        "name": "Cephaxin",
        "strength": "500 mg",
        "generic": "Cephalexin",
        "company": "Pharmadesh Laboratories Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/6704/cephaxin-500-mg-capsule",
        "_page": 141,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6839/cephid-250-mg-capsule",
    "name": "Cephid",
    "dosage_form": "Capsule",
    "generic": "Cephradine",
    "strength": "250 mg",
    "company": "Zenith Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 6.52",
      "strip_price": "৳ 32.60",
      "pack_size_info": "(6 x 5: ৳ 195.60)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.52",
          "pack_size_info": "(6 x 5: ৳ 195.60)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 32.60",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/6840/cephid-500-mg-capsule?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/6841/cephid-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cephid is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Cephid is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Cephid:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Cephid which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Cephid should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Cephid may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Cephid contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Cephid therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Cephid therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Cephid Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Cephid Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:52.007Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b9c",
    "original_record": {
      "input_index": 4374,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b9c"
        },
        "name": "Cephid",
        "strength": "250 mg",
        "generic": "Cephradine",
        "company": "Zenith Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/6839/cephid-250-mg-capsule",
        "_page": 141,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6841/cephid-125-mg-suspension",
    "name": "Cephid",
    "dosage_form": "Powder for Suspension",
    "generic": "Cephradine",
    "strength": "125 mg/5 ml",
    "company": "Zenith Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 80.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg (Capsule)",
        "href": "https://medex.com.bd/brands/6839/cephid-250-mg-capsule?ref=1"
      },
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/6840/cephid-500-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cephid is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Cephid is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Cephid:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Cephid which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Cephid should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Cephid may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Cephid contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Cephid therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Cephid therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Cephid Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Cephid Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:53.211Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9b9e",
    "original_record": {
      "input_index": 4375,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9b9e"
        },
        "name": "Cephid",
        "strength": "125 mg/5 ml",
        "generic": "Cephradine",
        "company": "Zenith Pharmaceuticals Ltd.",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/6841/cephid-125-mg-suspension",
        "_page": 141,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7534/cephoral-400-mg-capsule",
    "name": "Cephoral",
    "dosage_form": "Capsule",
    "generic": "Cefixime Trihydrate",
    "strength": "400 mg",
    "company": "Labaid Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 60.00",
      "strip_price": "৳ 420.00",
      "pack_size_info": "(1 x 7: ৳ 420.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 60.00",
          "pack_size_info": "(1 x 7: ৳ 420.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 420.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "200 mg (Capsule)",
        "href": "https://medex.com.bd/brands/7533/cephoral-200-mg-capsule?ref=1"
      },
      {
        "text": "100 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/7535/cephoral-100-mg-suspension?ref=1"
      },
      {
        "text": "200 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/18757/cephoral-ds-200-mg-suspension?ref=1"
      },
      {
        "text": "25 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/18758/cephoral-25-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/217/cefixime-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cephoral is an orally active cephalosporin antibiotic which has marked in-vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organism. It is indicated for the treatment of the following acute infections when caused by susceptible microorganisms.",
        "items": []
      },
      {
        "title": "Upper Respiratory Tract Infections (URTI)",
        "information": ": e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. Lower Respiratory Tract Infections-e.g. bronchitis.",
        "items": []
      },
      {
        "title": "Urinary Tract Infections",
        "information": ": e.g. cystitis, cystourethritis, pyelonephritis. Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumonia, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. Cephoral is highly stable in the presence of beta-lactamase enzymes.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefixime is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It kills bacteria by interfering in the synthesis of bacterial cell wall. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "In common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulant therapy.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with known hypersensitivity to cephalosporin antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cephoral is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self limiting in nature. Gastrointestinal disturbances: The most frequent side-effects seen with Cephoral are diarrhoea and stool changes; diarrhoea has been more commonly associated with higher doses. Other gastrointestinal side-effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting and flatulence. Pseudomembraneous colitis has been reported. Central nervous system: headache and dizziness. Hypersensitivity reactions: allergies in the form of rash, pruritis, urticaria, drug fever and arthralgia have been observed. These reactions usually subsided upon discontinuation of therapy. Hematological and clinical chemistry: thrombocytopenia, leukopenia and eosinophilia have been reported. These reactions were infrequent and reversible. Mild transient change in liver and renal function tests have been observed. Miscellaneous: other possible reactions include genital pruritis and vaginitis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cephoral should be given with caution to patients who have shown hypersensitivity to other drugs. Cephalosporin should be given with caution to penicillin-sensitive patients, as there is some evidence of partial cross-allergenicity between the penicillins and the cephalosporins. Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If an allergic effect occurs with Cephoral, the drug should be discontinued and the patient treated with appropriate agents if necessary. Cephoral should be administered with caution in patients with markedly impaired renal function. Treatment with broad spectrum antibiotics alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated diarrhoea. Use in pregnancy and lactation: There are no adequate and well-controlled studies in pregnant women. Cephoral should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Gastric Lavage may be indicated; otherwise, no specific antidote exists. Cephoral is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cephoral did not differ from the profile seen in patients treated at the recommended doses.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30ºC temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C16H15N5O7S2",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-217-cefixime-trihydrate-chemical-structure-3Mg9h2a2PuSZaJk4Uj0Z.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Absorption of Cefixime is not significantly modified by the presence of food. The usual course of treatment is 7 days. This may be continued for up to 14 days if required.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 10 years",
        "information": ": The recommended adult dosage is 200-400 mg daily according to the severity of the infection, given either as a single dose or in two divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed and dosage should be adjusted in severe renal impairment.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": The recommended dosage for children is 8 mg/kg/day administered as a single dose or in two divided doses. As a general guide for prescribing in children the following daily doses in terms of volume of suspension are suggested:",
        "instructions": [
          "6 months up to 1 year: 3.75 ml daily",
          "Children 1-4 years: 5 ml daily",
          "Children 5-10 years: 10 ml daily"
        ]
      },
      {
        "medication_type": "In typhoid",
        "information": ": the recommended children dose is 5 mg/kg body weight twice daily for 10-14 days.",
        "instructions": []
      },
      {
        "medication_type": "Children weighing more than 50 kg or older than 10 years",
        "information": ": Should be treated with the recommended adult dose 200-400 mg daily depending on the severity of infection.",
        "instructions": []
      },
      {
        "medication_type": "Children aged less than 6 months",
        "information": ": The safety and efficacy of Cefixime has not been established in children aged less than 6 months.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Renal Impairment",
        "information": ": Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearances of 20 ml/min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory peritoneal dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearances of less than 20 ml/min.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cephoral 400 mg Capsule?",
        "answer": [
          "Cephoral 400 mg Capsule is an antibiotic used to treat bacterial infection. This medicine does not work for viral infections like flu. It works by preventing them from forming the bacterial protective covering (cell wall) which is essential for their development."
        ]
      },
      {
        "question": "What are the uses of Cephoral 400 mg Capsule?",
        "answer": [
          "Cephoral 400 mg Capsule is used for the treatment and prevention from conditions such as Urinary Tract Infection, Tonsillitis, Pharyngitis, and Bronchitis. Apart from these, it can also be used to treat conditions of Fungal and Gonococcal Infections."
        ]
      },
      {
        "question": "What are the Side Effects of Cephoral 400 mg Capsule?",
        "answer": [
          "Cephoral 400 mg Capsule has some commonly reported side effects. Some of these side-effects may be serious. These are Diarrhea, Abdominal pain, Dark or clay-colored stools, Swelling of the face, lips, eyelids, tongue, hands, and feet, Dizziness, Acid or sour stomach, excessive gas in the stomach, Heartburn, Indigestion, Redness of the skin, Chest pain, Sore throat, and Unusual tiredness."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Cephoral 400 mg Capsule?",
        "answer": [
          "This medication should be kept in a cool dry place and in its original pack. Make sure Cephoral 400 mg Capsule remains unreachable to children and pets. Proper disposal of the expired and unused medications is important to avoid health problems."
        ]
      },
      {
        "question": "Will Cephoral 400 mg Capsule work for treating cold and flu?",
        "answer": [
          "This medication belongs to an antibiotic class of drugs, hence Cephoral 400 mg Capsule won't work for colds, flu, or other viral infections. If you use antibiotics when they are not needed, it increases your risk of getting an infection later that resists antibiotic treatment."
        ]
      },
      {
        "question": "Is there any special dietary instruction which I should follow?",
        "answer": [
          "Continue your normal diet unless your doctor asks you to change."
        ]
      },
      {
        "question": "Is Cephoral 400 mg Capsule can be used to treat diarrhoea?",
        "answer": [
          "No, Cephoral 400 mg Capsule is not prescribed to treat diarrhoea."
        ]
      },
      {
        "question": "Is it safe to give Cephoral 400 mg Capsule to infants?",
        "answer": [
          "The safety of Cephoral 400 mg Capsule, in case of newborns or infants aging less than 6 months, has not been positively established. Thus you need to consult a doctor before administering this medicine to an infant."
        ]
      },
      {
        "question": "Does Cephoral 400 mg Capsule is a penicillin variant?",
        "answer": [
          "No, Cephoral 400 mg Capsule is not a penicillin variant. This medication belongs to cephalosporin antibiotic and functions in a similar way to that of penicillin. Concurrent use of these two must be discussed with a doctor."
        ]
      },
      {
        "question": "Does Cephoral 400 mg Capsule cause loose-motion?",
        "answer": [
          "Diarrhoea is a known side effect of Cephoral 400 mg Capsule although it has been associated with higher doses only."
        ]
      },
      {
        "question": "Is constipation associated with Cephoral 400 mg Capsule?",
        "answer": [
          "Constipation is an unusual side effect of Cephoral 400 mg Capsule. In case, it causes persistent constipation and seems circumstantially related to the ingestion of this medication, must consult a doctor."
        ]
      },
      {
        "question": "Does Cephoral 400 mg Capsule interact with contraception?",
        "answer": [
          "No such evidence suggested the effect of Cephoral 400 mg Capsule on contraceptive medications."
        ]
      },
      {
        "question": "Can I take acetaminophen along with Cephoral 400 mg Capsule?",
        "answer": [
          "No interactions have been clinically proven between Cephoral 400 mg Capsule and Acetaminophen (Paracetamol). It is advisable to consult a doctor before concurrent use of these two medicines."
        ]
      },
      {
        "question": "How long does Cephoral 400 mg Capsule take to work?",
        "answer": [
          "Cephoral 400 mg Capsule start working as soon after you ingest it. However, it may take a few days to kill the harmful bacteria and relieve the symptoms completely. It is advised to complete the medication course for the suggested days."
        ]
      },
      {
        "question": "What if I do not get better after using Cephoral 400 mg Capsule?",
        "answer": [
          "Inform your doctor if you do not feel better even after finishing the full course of treatment. You must also inform your doctor if the symptoms get worse while using this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Cephoral 400 mg Capsule to cure your infection and improve your symptoms.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.",
          "Avoid consuming alcohol while taking Cephoral 400 mg Capsule as it may cause increased side effects.",
          "Discontinue Cephoral 400 mg Capsule and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:04:54.362Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9ba1",
    "original_record": {
      "input_index": 4376,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9ba1"
        },
        "name": "Cephoral",
        "strength": "400 mg",
        "generic": "Cefixime Trihydrate",
        "company": "Labaid Pharma Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/7534/cephoral-400-mg-capsule",
        "_page": 141,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6851/cephran-1-gm-injection",
    "name": "Cephran",
    "dosage_form": "IM/IV Injection",
    "generic": "Cephradine",
    "strength": "1 gm/vial",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 80.30",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "1 gm vial",
          "price": "৳ 80.30",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      },
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/6846/cephran-500-mg-capsule?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/6847/cephran-125-mg-suspension?ref=1"
      },
      {
        "text": "250 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/6848/cephran-ds-250-mg-suspension?ref=1"
      },
      {
        "text": "125 mg/1.25 ml (Drops)",
        "href": "https://medex.com.bd/brands/6849/cephran-125-mg-pediatric-drop?ref=1"
      },
      {
        "text": "500 mg/vial (Injection)",
        "href": "https://medex.com.bd/brands/6850/cephran-500-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cephran is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Cephran is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Cephran:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Cephran which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Cephran should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Cephran may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Cephran contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Cephran therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Cephran therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Cephran Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Cephran Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:55.709Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9baa",
    "original_record": {
      "input_index": 4377,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9baa"
        },
        "name": "Cephran",
        "strength": "1 gm/vial",
        "generic": "Cephradine",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "IM/IV Injection",
        "source_url": "https://medex.com.bd/brands/6851/cephran-1-gm-injection",
        "_page": 141,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37794/cephrasic-500-mg-capsule",
    "name": "Cephrasic",
    "dosage_form": "Capsule",
    "generic": "Cephradine",
    "strength": "500 mg",
    "company": "Physic pharmaceuticals ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 14.00",
      "strip_price": "৳ 98.00",
      "pack_size_info": "(4 x 7: ৳ 392.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 14.00",
          "pack_size_info": "(4 x 7: ৳ 392.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 98.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/37795/cephrasic-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cephrasic is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Cephrasic is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Cephrasic:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Cephrasic which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Cephrasic should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Cephrasic may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Cephrasic contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Cephrasic therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Cephrasic therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Cephrasic Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Cephrasic Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:56.944Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bae",
    "original_record": {
      "input_index": 4378,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bae"
        },
        "name": "Cephrasic",
        "strength": "500 mg",
        "generic": "Cephradine",
        "company": "Physic pharmaceuticals ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/37794/cephrasic-500-mg-capsule",
        "_page": 141,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/18706/cepime-1-gm-injection",
    "name": "Cepime",
    "dosage_form": "IM/IV Injection",
    "generic": "Cefepime Hydrochloride",
    "strength": "1 gm/vial",
    "company": "Rephco Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 550.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "1 gm vial",
          "price": "৳ 550.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg/vial (Injection)",
        "href": "https://medex.com.bd/brands/18707/cepime-500-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/215/cefepime-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cepime is indicated for the treatment of the following infections caused by susceptible strains of the microorganisms: Cepime is indicated for the treatment of the following infections caused by susceptible strains of the microorganisms:",
        "items": [
          "Pneumonia (moderate to severe): caused by Streptococcus pneumoniae, including cases associated with concurrent bacteremia, Pseudomonas aeruginosa, Klebsiella pneumoniae, or Enterobacter species.",
          "Pneumonia (moderate to severe): caused by Streptococcus pneumoniae, including cases associated with concurrent bacteremia, Pseudomonas aeruginosa, Klebsiella pneumoniae, or Enterobacter species.",
          "Febrile Neutropenia: Cepime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. In patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. Insufficient data exist to support the efficacy of cefepime monotherapy in such patients.",
          "Uncomplicated and Complicated Urinary Tract Infections (including pyelonephritis): caused by Escherichia coli or Klebsiella pneumoniae, when the infection is severe, or caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis, when the infection is mild to moderate, including cases associated with concurrent bacteremia with these microorganisms.",
          "Uncomplicated Skin and Skin Structure Infections: caused by Staphylococcus aureus (methicillin- susceptible strains only) or Streptococcus pyogenes.",
          "Complicated Intra-abdominal Infections (used in combination with metronidazole): caused by Escherichia coli, viridians group streptococci, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, or Bacteroides fragilis."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephalosporins are bactericidal and have the same mode of action as other beta-lactam antibiotics (such as penicillins). Cephalosporins disrupt the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The final transpeptidation step in the synthesis of the peptidoglycan is facilitated by transpeptidases known as penicillin binding proteins (PBPs).",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Renal function should be monitored carefully if high doses of aminoglycosides are to be administered with Cepime because of the increased potential of nephrotoxicity and ototoxicity of aminoglycoside antibiotics. Nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefepime is contraindicated in patients who have shown immediate hypersensitivity reactions to cefepime or the cephalosporin class of antibiotics, penicillin, or other betalactum antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cepime is contraindicated in patients who have shown immediate hypersensitivity reactions to cefepime or the cephalosporin class of antibiotics, penicillin, or other betalactum antibiotics.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category B. There are, however, no adequate and well-controlled studies of cefepime use in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefepime is excreted in human breast milk in very low concentrations (0.5 pg/ml). Caution should be exercised when cefepime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prescribing Cepime in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.",
          "As with other antimicrobials, prolonged use of Cepime may result in overgrowth of non susceptible microorganisms. Repeated evaluation of the patient's condition is essential.",
          "Many cephalosporins, including cefepime, have been associated with a fall in prothrombin activity. Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy. Prothrombin time should be monitored in patients at risk.",
          "Cepime should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis.",
          "Arginine has been shown to alter glucose metabolism and elevate serum potassium transiently when administered at 33 times the amount provided by the maximum recommended human dose of Cepime. The effect of lower doses is not presently known."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use (2 months up to 16 years)",
        "information": ": The maximum dose for pediatric patients should not exceed the recommended adult dose. The usual recommended dosage in pediatric patients up to 40 kg in weight for uncomplicated and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin structure infections, and pneumonia is 50 mg/kg/dose, administered every 12 hours (50 mg/kg/dose, every 8 hours for febrile neutropenic patients), for durations as given above.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Serious adverse events have occurred in geriatric patients with renal insufficiency given unadjusted doses of cefepime, including life-threatening or fatal occurrences of the following: encephalopathy, myoclonus, and seizures. Cepime is known to be substantially excreted by the kidney, and the risk of toxic reactions to Cepime may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and renal function should be monitored.",
        "items": []
      },
      {
        "title": "Impaired Hepatic Function",
        "information": ": No adjustment is necessary for patients with impaired hepatic function.",
        "items": []
      },
      {
        "title": "Impaired Renal Function",
        "information": ": In patients with impaired renal function (creatinine clearance<60 ml/min), the dose of Cepime should be adjusted to compensate for the slower rate of renal elimination.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Patients who receive an overdose should be carefully observed and given supportive treatment. In the presence of renal insufficiency, hemodialysis, not peritoneal dialysis, is recommended to aid the removal of cefepime from the body. Accidental overdosing has occurred when large doses were given to patients with impaired renal function. Symptoms of overdose include encephalopathy (disturbance of consciousness including confusion, hallucinations, stupor, and coma), myoclonus, seizures, and neuromuscular excitability.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Fourth generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cefepime should be administered intravenously over approximately 30 minutes.",
        "instructions": [
          "Moderate to Severe Pneumonia due to S. pneumoniae, *P. aeruginosa, K. pneumoniae, or Enterobacter species: 1-2 gm IV 12 hourly for 10 days.",
          "Empiric therapy for febrile neutropenic patients: 2 gm IV 8 hourly for 7** days.",
          "Mild to Moderate Uncomplicated or Complicated Urinary Tract Infections, including pyelonephritis, due to E. coli, K. pneumoniae, or P. mirabilis*: 0.5-1 gm IV/IM*** 12 hourly for 7-10 days.",
          "Severe Uncomplicated or Complicated Urinary Tract Infections, including pyelonephritis, due to E. coli or K. pneumoniae*: 2 gm IV 12 hourly for 10 days.",
          "Moderate to Severe Uncomplicated Skin and Skin Structure Infections due to S. aureus or S. pyogenes: 2 gm IV 12 hourly for 10 days.",
          "Complicated Intra-abdominal Infections (used in combination with metronidazole) caused by E. coli, viridans group streptococci, P. aeruginosa, K. pneumoniae, Enterobacter species, or B. fragilis: 2 gm IV 12 hourly for 7-10 days."
        ]
      },
      {
        "medication_type": "Note:",
        "information": "*including cases associated with concurrent bacteremia. **or until resolution of neutropenia. In patients whose fever resolves but who remain neutropenic for more than 7 days, the need for continued antimicrobial therapy should be re evaluated frequently. *** IM route of administration is indicated only for mild to moderate, uncomplicated or complicated UTls due to E. coli when the IM route is considered to be a more appropriate route of drug administration.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:58.012Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bb1",
    "original_record": {
      "input_index": 4379,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bb1"
        },
        "name": "Cepime",
        "strength": "1 gm/vial",
        "generic": "Cefepime Hydrochloride",
        "company": "Rephco Pharmaceuticals Ltd.",
        "medicine_type": "IM/IV Injection",
        "source_url": "https://medex.com.bd/brands/18706/cepime-1-gm-injection",
        "_page": 141,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6853/ceproval-125-mg-suspension",
    "name": "Ceproval",
    "dosage_form": "Powder for Suspension",
    "generic": "Cephradine",
    "strength": "125 mg/5 ml",
    "company": "Peoples Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 70.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/6852/ceproval-500-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ceproval is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Ceproval is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Ceproval:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Ceproval which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Ceproval should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Ceproval may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Ceproval contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Ceproval therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Ceproval therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Ceproval Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Ceproval Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:04:59.057Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bb9",
    "original_record": {
      "input_index": 4380,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bb9"
        },
        "name": "Ceproval",
        "strength": "125 mg/5 ml",
        "generic": "Cephradine",
        "company": "Peoples Pharma Ltd.",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/6853/ceproval-125-mg-suspension",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26339/ceptiva-003-mg-tablet",
    "name": "Ceptiva",
    "dosage_form": "Tablet",
    "generic": "Ethinyl Estradiol + Desogestrel",
    "strength": "0.03 mg+0.15 mg",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 105.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "21 tablet pack",
          "price": "৳ 105.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/332/ethinyl-estradiol-desogestrel-003-mg/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ceptiva tablet is indicated to prevent pregnancy. Oral contraceptives are a very effective method of birth control. When taken correctly (without missing tablets), the chance of becoming pregnant is very low.",
        "items": []
      }
    ],
    "mode_of_action": [],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "Do not use the combined Pill if you have any of the conditions listed below. If any of these apply to you, tell your doctor before starting to use this tablet. Your doctor may advise you to use a different type of Pill or an entirely different (non-hormonal) method of birth control. If any of these conditions appear for the first time while using the Pill, stop taking it at once and consult your doctor. In the meantime, use non-hormonal contraceptive measures.",
        "items": [
          "If you have, or have ever had a disorder affecting the blood circulation. In particular, those conditions relating to thrombosis. Thrombosis is the formation of a blood clot. This may occur in the blood vessels of the legs (deep vein thrombosis), the lungs (pulmonary embolism), the heart (heart attack), the brain (stroke), or other parts of the body.",
          "If you have or have ever had a condition that may be a first sign of a heart attack (such as angina pectoris or chest pain) or stroke (such as transient ischaemic attack or small reversible stroke).",
          "If you have diabetes mellitus with blood vessel damage.",
          "If you have jaundice (yellowing of the skin) or severe liver disease.",
          "If you have or have had cancer of the breast or the genital organs.",
          "If you have or have had a benign or malignant tumour in the liver.",
          "If you have any unexplained vaginal bleeding.",
          "If you are pregnant or think you might be pregnant.",
          "If you are allergic to any of the ingredients of this tablet."
        ]
      }
    ],
    "side_effects": [
      {
        "title": "Possible side effects",
        "information": ": The following side effects have been reported by users of the Pill, although they need not be caused by the Pill. These side effects may occur in the first few months that you are using the Pill and usually lessen with time.",
        "items": [
          "breast tenderness, pain and secretion;",
          "headache;",
          "changes in sexual drive; depressive moods;",
          "contact lens intolerance;",
          "nausea, vomiting and feeling sick;",
          "changes in vaginal secretion;",
          "various skin reactions;",
          "fluid retention;",
          "changes in body weight;",
          "hypersensitivity reactions."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The Pill and Breastfeeding: This tablet is generally not recommended for use during breast feeding. If you wish to take the Pill while breastfeeding, please seek the advice of your doctor. The Pill and Pregnancy: This tablet must not be used by women who are pregnant, or who think they may be pregnant.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Before you start to use this tablet: If the combined Pill is used in the presence of any of the conditions listed below you may need to be kept under close observation. Your doctor can explain this to you. Therefore, if any of these apply to you, tell your doctor before starting to use this tablet If any of the above conditions appear for the first time, recur or worsen while using the Pill, you should contact your doctor.",
        "items": [
          "you smoke;",
          "you have diabetes;",
          "you are overweight;",
          "you have high blood pressure;",
          "you have a heart valve disorder or a certain heart rhythm disorder;",
          "you have an inflammation of your veins (superficial phlebitis);",
          "you have varicose veins;",
          "anyone in your immediate family has had a thrombosis, a heart attack or a stroke;",
          "you suffer from migraine;",
          "you suffer from epilepsy;",
          "you or someone in your immediate family have or had high blood levels of cholesterol or triglycerides (fatty substances);",
          "anyone in your immediate family has had breast cancer;",
          "you have liver or gallbladder disease;",
          "you have Crohn's disease or ulcerative colitis (chronic inflammatory bowel disease);",
          "you have systemic lupus eryhematosus (SLE; a disease affecting the skin all over the body);",
          "you have haemolytic uraemic syndrome (HUS; a disorder of blood coagulation causing failure of the kidneys);",
          "you have sickle cell disease;",
          "you have or have had chloasma (yellowish-brown pigmentation patches on the skin, particularly of the face): if so, avoid too much exposure to the sun or ultraviolet radiation."
        ]
      },
      {
        "title": "The Pill and Thrombosis",
        "information": ": A thrombosis is the formation of a blood clot, which may block a blood vessel. A thrombosis sometimes occurs in the deep veins of the legs (deep venous thrombosis). If this blood clot breaks away from the veins where it is formed, it may reach and block the arteries of the lungs, causing a so-called \"Pulmonary embolism.\" Deep venous thrombosis is a rare occurrence. It can develop whether or not you are taking the Pill. It can also happen if you become pregnant. The risk is higher in Pill-users than in non-users, but it is not as high as the risk during pregnancy. Blood clots can also occur very rarely in the blood vessels of the heart (causing a heart attack) or the brain (causing a stroke). Extremely rarely blood clots can occur in the liver, gut, kidney or eye. Very occasionally a thrombosis may cause serious permanent disabilities or may even be fatal. The risk of having a heart attack or stroke increases, as you get older. It also increases the more you smoke. When using the Pill you should stop smoking, especially if you are older than about 35 years of age. If you develop high blood pressure while using the Pill, you may be told to stop using it. The risk of having a deep venous thrombosis is temporarily increased as a result of an operation or immobilisation (for example, when you have your leg or legs in plaster or splints). In women who use the Pill, the risk may be yet higher. Tell your doctor you are using the Pill well in advance of any expected hospitalisation or surgery. Your doctor may tell you to stop taking the Pill several weeks before surgery or at the time of immobilisation. Your doctor will also tell you when you can start taking the Pill again after you are back on your feet. If you notice possible signs of a thrombosis, stop taking the Pill and consult your doctor immediately.",
        "items": []
      },
      {
        "title": "The Pill and cancer",
        "information": ": Breast cancer has been diagnosed, slightly more often in women who use the Pill than in women of the same age who do not use the Pill. This slight increase in the numbers of breast cancer diagnoses gradually disappears during the course of the 10 years after stopping use of the Pill. It is not known whether the difference is caused by the Pill. It may be that the women were examined more often, so that the breast cancer was noticed earlier. In rare cases benign liver tumours and even more rarely, malignant liver tumours have been reported in users of the Pill. These tumours may lead to internal bleeding. Contact your doctor immediately if you have severe pain in your stomach. Cervical cancer has been reported to occur more often in women using the Pill for a long time. This finding may not be caused by the Pill but may be related to sexual behaviour and other factors.",
        "items": []
      },
      {
        "title": "The Pill and other Medicines",
        "information": ": Some medicines may stop the Pill from working properly. These include medicines used for the treatment of epilepsy (eg. primidone, phenytoin, barbiturates) and tuberculosis (eg. rifampicin); and antibiotics (eg. ampcillin, tetracyclines, griseofulvin) for some other infectious diseases. Always tell the doctor, who prescribes the Pill, which medicines you are already using. Also tell any other doctor or dentist who prescribes another medicine (or the dispensing pharmacist) that you use this tablet. They can tell you if you need to take additional contraceptive precautions and if so, for how long.",
        "items": []
      },
      {
        "title": "The Pill and Ability to Drive",
        "information": ": There are no observed effects.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool & dry place in between 2-25° C, protect from light. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "This is a combined oral contraceptive pill ('the combined Pill'). Each tablet contains a small amount of two different female hormones. These are desogestrel (a progestogen) and ethinylestradiol (an estrogen). Because of the small amounts of hormones, this is considered a low-dose oral contraceptive. As all tablets in the pack combine the same hormones in the same dose, it is considered a monophasic combined oral contraceptive.",
        "items": []
      }
    ],
    "administration": [
      {
        "title": null,
        "information": "If you forget tablets: More than one tablet forgotten in a pack: Ask your doctor for advice.",
        "items": [
          "If you are less than 12 hours late in taking a tablet, the reliability of the Pill is maintained. Take the tablet as soon as you remember and take the next tablets at the usual times.",
          "If you are more than 12 hours late in taking any tablet, the reliability of the Pill may be reduced. The more consecutive tablets you have missed, the higher the risk that the contraceptive efficacy is decreased. There is a particularly high risk of becoming pregnant if you miss tablets at the beginning or at the end of the pack. Therefore you should follow the rules given below."
        ]
      },
      {
        "title": "1 tablet missed in week 1",
        "information": ": Take the missed tablet as soon as you remember (even if this means taking two tablets at the same time) and take the next tablets at the usual time. Use extra contraceptive precautions (barrier method) for the next 7 days. If you had sexual intercourse in the week before missing the tablets, there is a possibility of becoming pregnant. So tell your doctor immediately.",
        "items": []
      },
      {
        "title": "1 tablet missed in week 2",
        "information": ": Take the missed tablet as soon as you remember (even if this means taking two tablets at the same time) and take the next tablets at the usual time. The reliability of the Pill is maintained. You need not use extra contraceptive precautions.",
        "items": []
      },
      {
        "title": "1 tablet missed in week 3",
        "information": ": You may choose either of the following options, without the need for extra contraceptive precautions. Take the missed tablet as soon as you remember (even if this means taking two tablets at the same time) and take the next tablets at the usual time. Start the next pack as soon as the current pack is finished so that no gap is left between packs. You may not have a withdrawal bleed until the end of the second pack but you may have spotting or breakthrough bleeding on tablet-taking days. Or Stop taking tablets from your current pack, have a tabletfree break of 7 days or less (also count the day you missed your tablet) and continue with the next pack. When following this method, you can always start your next pack on the same day of the week as you usually do. If you have forgotten tablets in a pack and you do not have the expected period in the first normal tablet-free break, you may be pregnant. Consult your doctor before you start with the next pack.",
        "items": []
      },
      {
        "title": "you vomit",
        "information": ": If you vomit within 3 to 4 hours after taking your this tablet, the active ingredients may not have been completely absorbed. This is like missing a tablet. Therefore, follow the advice for missed tablets.",
        "items": []
      },
      {
        "title": "you want to delay your period",
        "information": ": you can delay your period if you start with your next pack of this tablet immediately after finishing your current pack. You can continue with this pack for as long as you wish, until this pack is empty. When you wish your period to begin, just stop tablet taking. While using the second pack you may have some breakthrough bleeding or spotting on tablet-taking days. Start with your next pack after the usual 7 day tablet-free break.",
        "items": []
      },
      {
        "title": "you want to change the starting day of your period",
        "information": ": If you take your tablets as directed, you will have your period on about the same day every 4 weeks. If you want to change this, just shorten, (never lengthen) the next tablet-free break. For example, if your period usually starts on a Friday and in future you want it to start on Tuesday (3 days earlier) you should now start your next pack 3 days sooner than you usually do. If you make your tablet-free break very short (e.g. 3 days or less) you may not have a bleeding during the break. You may have some breakthrough bleeding or spotting during the use of the next pack.",
        "items": []
      },
      {
        "title": "You have unexpected bleeding",
        "information": ": With all Pills, for the first few months, you can have irregular vaginal bleeding (spotting or breakthrough bleeding) between your periods. You may need to use sanitary protection, but continue to take your tablets as normal. Irregular vaginal bleeding usually stops once your body has adjusted to the pill (usually after about 3 tablet-taking cycles). If it continues, becomes heavy or starts again, tell your doctor.",
        "items": []
      },
      {
        "title": "you have missed a period",
        "information": ": If you have taken all of your tablets at the right time, and you have not vomited, or used other medicines then you are very unlikely to be pregnant. Continue to take this tablet as usual. If you miss your period twice in a row, you may be pregnant. Tell your doctor immediately. Do not start the next pack of this tablet until your doctor has checked you are not pregnant.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Oral Contraceptive preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "This pack contains 21 tablets. On the pack, each tablet is marked with the day of the week on which it is to be taken. Take your tablet at about the same time each day, with some water if necessary. Follow the direction of the arrows until all 21 tablets have been taken. During the next 7 days you take no tablets. A period should begin during these 7 days (the withdrawal bleed). Usually, it will start on day 2-3 after the last tablet. Start taking your next pack on the 8th day even if your period continues. This means that you will always start new packs on the same day of the week, and also that you have your withdrawal bleed on about the same days, each month. Starting your first pack of this tablet-",
        "instructions": []
      },
      {
        "medication_type": "When no hormonal contraceptive has been used in the past month",
        "information": ": Start taking this tablet on the first day of your cycle, i.e. the first day of menstrual bleeding. Take a tablet marked with that day of the week. For example, if your period starts on a Friday, take a tablet marked Friday. Then follow the day's in order. You may also start on days 2-5 of your cycle, but in that case make sure you also use an additional contraceptive method (barrier method) for the first 7 days of tablet taking in the first cycle.",
        "instructions": []
      },
      {
        "medication_type": "When changing from another combined Pill",
        "information": ": You can start taking this tablet the day after you take the last tablet from your present Pill pack (this means no tablet free break). If your present Pill pack also contains inactive tablets you can start this tablet on the day after taking the last active tablet (if you are not sure which this is, ask your doctor or pharmacist). You can also start later, but never later than the day following the tablet-free break of your present Pill (or the day after the last inactive tablet of your present Pill).",
        "instructions": []
      },
      {
        "medication_type": "When changing from a progestagen-only Pill (minipill)",
        "information": ": You can stop taking the minipill any day and start taking this tablet the next day, at the same time. But make sure you also use an additional contraceptive method (a barrier method) for the first 7 days of tablet taking when having intercourse.",
        "instructions": []
      },
      {
        "medication_type": "When changing from an injectable or implant",
        "information": ": Start using this tablet when your next injection is due or on the day that your implant is removed. But make sure you also use an additional contraceptive method (a barrier method) for the first 7 days of tablet-taking when having intercourse.",
        "instructions": []
      },
      {
        "medication_type": "After having a baby",
        "information": ": If you have just had a baby, your doctor may tell you to wait until after your first normal period before you start taking this tablet. Sometimes it is possible to start sooner. Your doctor will advise you. If you are breast-feeding and want to take this tablet, you should discuss this first with your doctor.",
        "instructions": []
      },
      {
        "medication_type": "After a miscarriage or an abortion",
        "information": ": Your doctor will advise you.",
        "instructions": []
      },
      {
        "medication_type": "If too many this tablet are taken (overdose)",
        "information": ": There have been no reports of serious harmful effects from taking too many this tablets at one time. If you have taken several tablets at a time, you may have nausea, vomiting or vaginal bleeding. If you discover that a child has taken this tablet, ask your doctor for advice.",
        "instructions": []
      },
      {
        "medication_type": "When you want to stop taking this tablet",
        "information": ": You can stop taking this tablet at any time you want. If you do not want to become pregnant, ask your doctor about other methods of birth control. If you stop taking this tablet because you want to get pregnant, it is generally recommended that you wait until you have had a natural period before trying to conceive. This helps you to work out when the baby will be due.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:00.417Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bbb",
    "original_record": {
      "input_index": 4381,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bbb"
        },
        "name": "Ceptiva",
        "strength": "0.03 mg+0.15 mg",
        "generic": "Ethinyl Estradiol + Desogestrel (0.03 mg)",
        "company": "ACI Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/26339/ceptiva-003-mg-tablet",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3151/cerenin-5-mg-tablet",
    "name": "Cerenin",
    "dosage_form": "Tablet",
    "generic": "Vinpocetine",
    "strength": "5 mg",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.55",
      "strip_price": "৳ 35.50",
      "pack_size_info": "(5 x 10: ৳ 177.50)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.55",
          "pack_size_info": "(5 x 10: ৳ 177.50)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 35.50",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1128/vinpocetine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Acute Cerebro-Vascular Accidents (Strokes): Ischaemic strokes due to cerebral thrombosis, cerebral embolism, acute circulatory disorder, hypertensive crisis; the acute cardiovascular disorders, ischaemic neurological defcit, complete stroke (CS), multiinfarct dementia, cerebral arteriosclerosis ... Read moreAcute Cerebro-Vascular Accidents (Strokes): Ischaemic strokes due to cerebral thrombosis, cerebral embolism, acute circulatory disorder, hypertensive crisis; the acute cardiovascular disorders, ischaemic neurological defcit, complete stroke (CS), multiinfarct dementia, cerebral arteriosclerosis, hypertensive encephalopathy, post-apoplectic conditions with the background of haemorrhagic strokes etc.Senile Disorder: For relief of psychosomatic symptoms in the elderly due to cerebral insufciency eg. forgetfulness, memory disturbances, slow thinking, lack of concentration, dizziness, mood instability, aphasia, sleep disturbances, vasovegetative symptoms of menopausal syndrome etc.Visual Disorder: Vascular disorders of the choroid and retina due to arteriosclerosis. Vasospasm, macula degenerations, arterial or venous thrombosis or embolism and glaucoma secondary to the above mentioned disorders.Hearing Disorder: For the treatment of impaired hearing of vascular or toxic (iatrogenic) origin presbyacusis, meniere's disease, cochleovestibular neuritis, tinnitus and dizziness of labirynth origin.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Vinpocetine increases cerebral metabolism; it increases glucose and O2 consumption; improves cerebral hypoxia tolerance; shifts glucose metabolism to the energetically more favourable aerobic pathway, but it increases the anaerobic pathway as well; it elevates the ATP concentration and the ATP/AMP ratio in the brain, and elevates the cerebral norepinephrine, dopamine and serotonin levels. Vinpocetine considerably improves cerebral microcirculation by inhibiting platelet aggregation, reducing the pathologically increased blood viscosity, and increases erythrocyte deformability. It also promotes O 2 transport into the tissues by reducing the O 2 affinity of erythrocytes. It selectively and intensely increases cerebral blood flow and the share of the brain in cardiac output, it reduces cerebral vascular resistance without affecting systemic circulation (blood pressure, heart rate, cardiac output, total peripheral resistance). It does not elicit steal phenomenon; on the contrary, it primarily improves the blood supply of the injured and ischaemic area while it remains unchanged in the intact areas (inverse steal effect). It further increases blood flow which is already increased as a result of hypoxia.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The injection is chemically incompatible with heparin, therefore, it should not be injected in the same syringe.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Parenteral treatment- Severe ischaemic heart disease, severe rhythm disorders and pregnancy.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Transient hypotension, tachycardia may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "In Pregnancy and Lactation the drug is contraindicated.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In the acute stage until the improvement of symptoms parenteral treatment is recommended followed by oral treatment. In chronic cases oral therapy should be applied.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light and moisture.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cerebral vasodilator & Neurosensory oxygenator drugs",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ": 1-2 tablets thrice daily, the maintenance dose is 1 tablet thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "IM Injection",
        "information": ": Daily dose of 20-40 mg are to be given until improvement of symptoms is reached (for not longer than 10 days) then oral treatment should be applied. If this regimen fails, infusion treatment should be started.",
        "instructions": []
      },
      {
        "medication_type": "IV Infusion",
        "information": ": The daily starting dose is 20 mg in slow drip infusion (2 ampoules in 500-1000 ml infusion solution). This dose can be increased to 1 mg/kg body weight during 3 to 4 days. Treatment should be continued for 10-14 days depending on the tolerance of the patients and the dose should be gradually reduced before discontinuation of treatment.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:01.595Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bbc",
    "original_record": {
      "input_index": 4382,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bbc"
        },
        "name": "Cerenin",
        "strength": "5 mg",
        "generic": "Vinpocetine",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/3151/cerenin-5-mg-tablet",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3152/cereton-5-mg-tablet",
    "name": "Cereton",
    "dosage_form": "Tablet",
    "generic": "Vinpocetine",
    "strength": "5 mg",
    "company": "General Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 4.04",
      "strip_price": "৳ 40.40",
      "pack_size_info": "(5 x 10: ৳ 202.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.04",
          "pack_size_info": "(5 x 10: ৳ 202.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 40.40",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg/2 ml (Injection)",
        "href": "https://medex.com.bd/brands/3153/cereton-10-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1128/vinpocetine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Acute Cerebro-Vascular Accidents (Strokes): Ischaemic strokes due to cerebral thrombosis, cerebral embolism, acute circulatory disorder, hypertensive crisis; the acute cardiovascular disorders, ischaemic neurological defcit, complete stroke (CS), multiinfarct dementia, cerebral arteriosclerosis ... Read moreAcute Cerebro-Vascular Accidents (Strokes): Ischaemic strokes due to cerebral thrombosis, cerebral embolism, acute circulatory disorder, hypertensive crisis; the acute cardiovascular disorders, ischaemic neurological defcit, complete stroke (CS), multiinfarct dementia, cerebral arteriosclerosis, hypertensive encephalopathy, post-apoplectic conditions with the background of haemorrhagic strokes etc.Senile Disorder: For relief of psychosomatic symptoms in the elderly due to cerebral insufciency eg. forgetfulness, memory disturbances, slow thinking, lack of concentration, dizziness, mood instability, aphasia, sleep disturbances, vasovegetative symptoms of menopausal syndrome etc.Visual Disorder: Vascular disorders of the choroid and retina due to arteriosclerosis. Vasospasm, macula degenerations, arterial or venous thrombosis or embolism and glaucoma secondary to the above mentioned disorders.Hearing Disorder: For the treatment of impaired hearing of vascular or toxic (iatrogenic) origin presbyacusis, meniere's disease, cochleovestibular neuritis, tinnitus and dizziness of labirynth origin.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Vinpocetine increases cerebral metabolism; it increases glucose and O2 consumption; improves cerebral hypoxia tolerance; shifts glucose metabolism to the energetically more favourable aerobic pathway, but it increases the anaerobic pathway as well; it elevates the ATP concentration and the ATP/AMP ratio in the brain, and elevates the cerebral norepinephrine, dopamine and serotonin levels. Vinpocetine considerably improves cerebral microcirculation by inhibiting platelet aggregation, reducing the pathologically increased blood viscosity, and increases erythrocyte deformability. It also promotes O 2 transport into the tissues by reducing the O 2 affinity of erythrocytes. It selectively and intensely increases cerebral blood flow and the share of the brain in cardiac output, it reduces cerebral vascular resistance without affecting systemic circulation (blood pressure, heart rate, cardiac output, total peripheral resistance). It does not elicit steal phenomenon; on the contrary, it primarily improves the blood supply of the injured and ischaemic area while it remains unchanged in the intact areas (inverse steal effect). It further increases blood flow which is already increased as a result of hypoxia.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The injection is chemically incompatible with heparin, therefore, it should not be injected in the same syringe.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Parenteral treatment- Severe ischaemic heart disease, severe rhythm disorders and pregnancy.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Transient hypotension, tachycardia may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "In Pregnancy and Lactation the drug is contraindicated.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In the acute stage until the improvement of symptoms parenteral treatment is recommended followed by oral treatment. In chronic cases oral therapy should be applied.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light and moisture.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cerebral vasodilator & Neurosensory oxygenator drugs",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ": 1-2 tablets thrice daily, the maintenance dose is 1 tablet thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "IM Injection",
        "information": ": Daily dose of 20-40 mg are to be given until improvement of symptoms is reached (for not longer than 10 days) then oral treatment should be applied. If this regimen fails, infusion treatment should be started.",
        "instructions": []
      },
      {
        "medication_type": "IV Infusion",
        "information": ": The daily starting dose is 20 mg in slow drip infusion (2 ampoules in 500-1000 ml infusion solution). This dose can be increased to 1 mg/kg body weight during 3 to 4 days. Treatment should be continued for 10-14 days depending on the tolerance of the patients and the dose should be gradually reduced before discontinuation of treatment.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:02.698Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bbd",
    "original_record": {
      "input_index": 4383,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bbd"
        },
        "name": "Cereton",
        "strength": "5 mg",
        "generic": "Vinpocetine",
        "company": "General Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/3152/cereton-5-mg-tablet",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3153/cereton-10-mg-injection",
    "name": "Cereton",
    "dosage_form": "Injection",
    "generic": "Vinpocetine",
    "strength": "10 mg/2 ml",
    "company": "General Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 40.12",
      "strip_price": null,
      "pack_size_info": "(1 x 5: ৳ 200.60)",
      "packages": [
        {
          "label": "2 ml ampoule",
          "price": "৳ 40.12",
          "pack_size_info": "(1 x 5: ৳ 200.60)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/3152/cereton-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1128/vinpocetine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Acute Cerebro-Vascular Accidents (Strokes): Ischaemic strokes due to cerebral thrombosis, cerebral embolism, acute circulatory disorder, hypertensive crisis; the acute cardiovascular disorders, ischaemic neurological defcit, complete stroke (CS), multiinfarct dementia, cerebral arteriosclerosis ... Read moreAcute Cerebro-Vascular Accidents (Strokes): Ischaemic strokes due to cerebral thrombosis, cerebral embolism, acute circulatory disorder, hypertensive crisis; the acute cardiovascular disorders, ischaemic neurological defcit, complete stroke (CS), multiinfarct dementia, cerebral arteriosclerosis, hypertensive encephalopathy, post-apoplectic conditions with the background of haemorrhagic strokes etc.Senile Disorder: For relief of psychosomatic symptoms in the elderly due to cerebral insufciency eg. forgetfulness, memory disturbances, slow thinking, lack of concentration, dizziness, mood instability, aphasia, sleep disturbances, vasovegetative symptoms of menopausal syndrome etc.Visual Disorder: Vascular disorders of the choroid and retina due to arteriosclerosis. Vasospasm, macula degenerations, arterial or venous thrombosis or embolism and glaucoma secondary to the above mentioned disorders.Hearing Disorder: For the treatment of impaired hearing of vascular or toxic (iatrogenic) origin presbyacusis, meniere's disease, cochleovestibular neuritis, tinnitus and dizziness of labirynth origin.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Vinpocetine increases cerebral metabolism; it increases glucose and O2 consumption; improves cerebral hypoxia tolerance; shifts glucose metabolism to the energetically more favourable aerobic pathway, but it increases the anaerobic pathway as well; it elevates the ATP concentration and the ATP/AMP ratio in the brain, and elevates the cerebral norepinephrine, dopamine and serotonin levels. Vinpocetine considerably improves cerebral microcirculation by inhibiting platelet aggregation, reducing the pathologically increased blood viscosity, and increases erythrocyte deformability. It also promotes O 2 transport into the tissues by reducing the O 2 affinity of erythrocytes. It selectively and intensely increases cerebral blood flow and the share of the brain in cardiac output, it reduces cerebral vascular resistance without affecting systemic circulation (blood pressure, heart rate, cardiac output, total peripheral resistance). It does not elicit steal phenomenon; on the contrary, it primarily improves the blood supply of the injured and ischaemic area while it remains unchanged in the intact areas (inverse steal effect). It further increases blood flow which is already increased as a result of hypoxia.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The injection is chemically incompatible with heparin, therefore, it should not be injected in the same syringe.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Parenteral treatment- Severe ischaemic heart disease, severe rhythm disorders and pregnancy.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Transient hypotension, tachycardia may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "In Pregnancy and Lactation the drug is contraindicated.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In the acute stage until the improvement of symptoms parenteral treatment is recommended followed by oral treatment. In chronic cases oral therapy should be applied.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light and moisture.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cerebral vasodilator & Neurosensory oxygenator drugs",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ": 1-2 tablets thrice daily, the maintenance dose is 1 tablet thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "IM Injection",
        "information": ": Daily dose of 20-40 mg are to be given until improvement of symptoms is reached (for not longer than 10 days) then oral treatment should be applied. If this regimen fails, infusion treatment should be started.",
        "instructions": []
      },
      {
        "medication_type": "IV Infusion",
        "information": ": The daily starting dose is 20 mg in slow drip infusion (2 ampoules in 500-1000 ml infusion solution). This dose can be increased to 1 mg/kg body weight during 3 to 4 days. Treatment should be continued for 10-14 days depending on the tolerance of the patients and the dose should be gradually reduced before discontinuation of treatment.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:03.858Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bbe",
    "original_record": {
      "input_index": 4384,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bbe"
        },
        "name": "Cereton",
        "strength": "10 mg/2 ml",
        "generic": "Vinpocetine",
        "company": "General Pharmaceuticals Ltd.",
        "medicine_type": "Injection",
        "source_url": "https://medex.com.bd/brands/3153/cereton-10-mg-injection",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/9108/cero-03-eye-drop",
    "name": "Cero",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Ciprofloxacin",
    "strength": "0.3%",
    "company": "Gaco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 40.12",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 40.12",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.3% (Eye Ointment)",
        "href": "https://medex.com.bd/brands/9109/cero-03-eye-ointment?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/266/ciprofloxacin-ophthalmic/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cero 0.3% ophthalmic solution is indicated for the treatment of corneal ulcers, conjunctivitis, and blepharitis, which are caused by susceptible strains of bacteria.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ciprofloxacin has in vitro activity against a wide range of Gram-negative and Gram-positive organisms. Ciprofloxacin is bactericidal and acts by inhibiting the A subunits of DNA gyrase (topoisomerase) which is essential in the reproduction of bacterial DNA.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Specific drug interaction studies have not been conducted with ophthalmic Cero. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant warfarin and its derivatives and have been associated with transient elevations in serum creatinine in patients receiving cyclosporin concomitantly.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "A history of hypersensitivity to Ciprofloxacin or any other component of the product. A history of hypersensitivity to other quinolones, including Nalidixic acid, may also contraindicate the use of Ciprofloxacin.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most frequently reported drug related adverse reaction was local burning or discomfort. In corneal ulcer studies with frequent administration of the drug, white crystalline precipitates were seen in approximately 17% of patients. Other reactions occurring in less than 10% of patients included lid margin crusting, crystals/scales, foreign body sensation, itching, conjunctival hyperemia and a bad taste following instillation. Additional events occurring in less than 1% of patients included corneal staining, keratopathy/keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, nausea and decreased vision.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. Ciprofloxacin ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "General: As with other anti-infective, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super-infection occurs, discontinue use and initiate alternative therapy. Cero should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity reaction.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "A topical overdose of Cero eye drops may be flushed from the eye(s) with warm tap water.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature, protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Aural Anti-bacterial preparations, Ophthalmic antibacterial drugs",
    "dosage": [
      {
        "medication_type": "For Corneal Ulcers",
        "information": ": Instill 2 drops into the affected eye every 15 minutes for the first six hours and then 2 drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill 2 drops into the affected eye hourly. On the third through the fourteenth day, place 2 drops into the affected eye every four hours. Treatment may be continued after 14 days if corneal re-epithelialization has not occurred.",
        "instructions": []
      },
      {
        "medication_type": "Bacterial Conjunctivitis/Blepharitis",
        "information": ": Instill 1 drop to the conjunctival sac(s) every two hours for two days and 1 drop every four hours for the next five days.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric use",
        "information": ": Safety and effectiveness in children under 1 year of age have not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:04.992Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bc3",
    "original_record": {
      "input_index": 4385,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bc3"
        },
        "name": "Cero",
        "strength": "0.3%",
        "generic": "Ciprofloxacin (Ophthalmic)",
        "company": "Gaco Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/9108/cero-03-eye-drop",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15832/cerodex-03-01-eye-drop",
    "name": "Cerodex",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Ciprofloxacin + Dexamethasone",
    "strength": "0.3%+0.1%",
    "company": "Gaco Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 75.23",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 75.23",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/264/ciprofloxacin-dexamethasone/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Eye: This is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection ... Read moreEye: This is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.Ear: This is also indicated in the treatment of ear infections accompanied by inflammation such as otitis externa, acute and chronic otitis media etc. The combination may also be used post-operatively in the ear.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": "Dexamethasone",
        "information": "is glucocorticoid. It has an anti-inflammatory and anti-allergic action. It is used topically in the treatment of inflammatory conditions of the anterior segment of the eye. It reduces prostaglandin synthesis by inhibiting the enzyme phospholipase A2. Also, Dexamethasone inhibits the chemotactic infiltration of neutrophils into the site of inflammation.",
        "items": []
      },
      {
        "title": "Ciprofloxacin",
        "information": "has in vitro activity against a wide range of gram-negative and gram-positive organisms, possessing the greatest antibacterial activity of all quinolones. The bactericidal action of Ciprofloxacin results from interference with the enzyme DNA gyrase which is needed for the synthesis of bacterial DNA.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Specific drug interaction studies have not been conducted with ophthalmic Ciprofloxacin and Dexamethasone. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant warfarin and its derivatives and have been associated with transient elevations in serum creatinine in patients receiving cyclosporin concomitantly.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to any ingredient of the product. Herpes simplex and other viral conditions, mycosis, glaucoma, newborn babies, fungal diseases of ocular or auricular structures.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Eye",
        "information": ": The most frequently reported drug-related adverse reactions seen with Ciprofloxacin are transient ocular burning or discomfort. Other reported reactions include stinging, redness, itching, conjunctivitis/keratitis, periocular/facial edema, foreign body sensation, photophobia, blurred vision, tearing, dryness, and eye pain. Rare reports of dizziness have been received. The reactions due to the steroid component are elevation of intraocular pressure (IOP) with possible development of glaucoma, and infrequent optic nerve damage; posterior subcapsular cataract formation; and delayed wound healing.",
        "items": []
      },
      {
        "title": "Ear",
        "information": ": The most common adverse effects are discomfort and ear pain. Others reported reactions are irritability, dizziness, erythema etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy: There are no adequate and well controlled studies in pregnant women. This Sterile Eye & Ear Drops should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus. Nursing Mothers: It is not known whether this drug is excreted in human milk. So, caution should be exercised when using this Sterile Eye & Ear Drops to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The possibility of fungal infections of the cornea should be considered after long-term steroid dosing and in patients with persistent corneal ulceration. Prolonged use of antibiotic may result in overgrowth of non-susceptible organisms. Prolonged use of topical ophthalmic steroids may result in glaucoma, with damage to the optic nerve, defects in visual acuity and fields of vision and posterior subcapsular cataract formation. Intraocular pressure should be routinely monitored.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, away from light. Keep out of reach of children. Shake well before each use. The drug is to be used within 30 days after first opening. The bottle is to be closed strongly immediately after use.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Aural steroid & antibiotic combined preparations",
    "dosage": [
      {
        "medication_type": "For Eye",
        "information": ": 1 drop to be instilled into conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to 1 drop every two hours.",
        "instructions": []
      },
      {
        "medication_type": "For Ear",
        "information": ":",
        "instructions": [
          "Acute otitis media in pediatric patients with typanastomy tube: 4 drops instilled into the affected ear 2 times daily for 7 days.",
          "Acute otitis externa: 4 drops instilled into the affected ear 2 times daily for 7 days."
        ]
      },
      {
        "medication_type": "Pediatric Use",
        "information": ": Safety and effectiveness in pediatric patients below 1 year have not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:05.967Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bca",
    "original_record": {
      "input_index": 4386,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bca"
        },
        "name": "Cerodex",
        "strength": "0.3%+0.1%",
        "generic": "Ciprofloxacin + Dexamethasone",
        "company": "Gaco Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15832/cerodex-03-01-eye-drop",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7215/cerox-a-125-mg-suspension",
    "name": "Cerox-A",
    "dosage_form": "Powder for Suspension",
    "generic": "Cefuroxime Axetil",
    "strength": "125 mg/5 ml",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 300.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "70 ml bottle",
          "price": "৳ 300.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7213/cerox-a-250-mg-tablet?ref=1"
      },
      {
        "text": "500 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7214/cerox-a-500-mg-tablet?ref=1"
      },
      {
        "text": "750 mg/vial (Injection)",
        "href": "https://medex.com.bd/brands/7217/cerox-a-750-mg-injection?ref=1"
      },
      {
        "text": "1.5 gm/vial (Injection)",
        "href": "https://medex.com.bd/brands/7218/cerox-a-15-gm-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/226/cefuroxime-axetil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "It is indicated for the treatment of infections caused by sensitive bacteria. It is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli",
          "Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No potentially hazardous interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse effects to Cerox-A have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cerox-A should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cerox-A has shown, that is not likely to be a problem at the recommended to dose levels.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5 o C",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Second generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet or Suspension- Adolescents and adults (13 years and older)- Paediatric Patients (3 months to 12 years)- Parenteral-",
        "instructions": [
          "Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days",
          "Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days",
          "Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days",
          "Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days",
          "Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days",
          "Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days",
          "Uncomplicated Gonorrhoea: 1000 mg Single dose",
          "Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days",
          "MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days",
          "Early Lyme disease: 500 mg b.i.d. for 20 days",
          "Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days",
          "Acute otitis media: 30 mg/kg/day b.i.d for 10 days",
          "Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days",
          "Impetigo: 30 mg/kg/day b.i.d for 10 days"
        ]
      },
      {
        "medication_type": "Adult",
        "information": ": 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 30 - 100 mg/kg/day given in 2 or 3 equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Surgical prophylaxis",
        "information": ": 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days.",
        "instructions": []
      },
      {
        "medication_type": "Acute exacerbations of chronic bronchitis",
        "information": ": 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.)",
        "instructions": []
      },
      {
        "medication_type": "In Gonorrhoea",
        "information": ": Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In Meningitis:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 3 gm IV injection three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In bone and joint infections:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1.5 gm IV injection four times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:07.050Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bd1",
    "original_record": {
      "input_index": 4387,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bd1"
        },
        "name": "Cerox-A",
        "strength": "125 mg/5 ml",
        "generic": "Cefuroxime Axetil",
        "company": "ACI Limited",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/7215/cerox-a-125-mg-suspension",
        "_page": 143,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7217/cerox-a-750-mg-injection",
    "name": "Cerox-A",
    "dosage_form": "IM/IV Injection",
    "generic": "Cefuroxime Axetil",
    "strength": "750 mg/vial",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 175.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "750 mg vial",
          "price": "৳ 175.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7213/cerox-a-250-mg-tablet?ref=1"
      },
      {
        "text": "500 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7214/cerox-a-500-mg-tablet?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/7215/cerox-a-125-mg-suspension?ref=1"
      },
      {
        "text": "1.5 gm/vial (Injection)",
        "href": "https://medex.com.bd/brands/7218/cerox-a-15-gm-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/226/cefuroxime-axetil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "It is indicated for the treatment of infections caused by sensitive bacteria. It is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli",
          "Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No potentially hazardous interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse effects to Cerox-A have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cerox-A should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cerox-A has shown, that is not likely to be a problem at the recommended to dose levels.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5 o C",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Second generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet or Suspension- Adolescents and adults (13 years and older)- Paediatric Patients (3 months to 12 years)- Parenteral-",
        "instructions": [
          "Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days",
          "Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days",
          "Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days",
          "Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days",
          "Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days",
          "Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days",
          "Uncomplicated Gonorrhoea: 1000 mg Single dose",
          "Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days",
          "MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days",
          "Early Lyme disease: 500 mg b.i.d. for 20 days",
          "Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days",
          "Acute otitis media: 30 mg/kg/day b.i.d for 10 days",
          "Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days",
          "Impetigo: 30 mg/kg/day b.i.d for 10 days"
        ]
      },
      {
        "medication_type": "Adult",
        "information": ": 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 30 - 100 mg/kg/day given in 2 or 3 equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Surgical prophylaxis",
        "information": ": 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days.",
        "instructions": []
      },
      {
        "medication_type": "Acute exacerbations of chronic bronchitis",
        "information": ": 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.)",
        "instructions": []
      },
      {
        "medication_type": "In Gonorrhoea",
        "information": ": Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In Meningitis:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 3 gm IV injection three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In bone and joint infections:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1.5 gm IV injection four times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:08.104Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bd2",
    "original_record": {
      "input_index": 4388,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bd2"
        },
        "name": "Cerox-A",
        "strength": "750 mg/vial",
        "generic": "Cefuroxime Axetil",
        "company": "ACI Limited",
        "medicine_type": "IM/IV Injection",
        "source_url": "https://medex.com.bd/brands/7217/cerox-a-750-mg-injection",
        "_page": 143,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7406/cerox-cv-250-mg-tablet",
    "name": "Cerox CV",
    "dosage_form": "Tablet",
    "generic": "Cefuroxime Axetil + Clavulanic Acid",
    "strength": "250 mg+62.5 mg",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": "৳ 245.00",
      "pack_size_info": "(2 x 7: ৳ 490.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 35.00",
          "pack_size_info": "(2 x 7: ৳ 490.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 245.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(125 mg+31.25 mg)/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/7404/cerox-cv-125-mg-suspension?ref=1"
      },
      {
        "text": "125 mg+31.25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7405/cerox-cv-125-mg-tablet?ref=1"
      },
      {
        "text": "500 mg+125 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7407/cerox-cv-500-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/227/cefuroxime-axetil-clavulanic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cerox CV is indicated for the treatment of infections caused by sensitive bacteria. Cerox CV is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli.",
          "Acute bacterial exacerbation of chronic bronchitis and secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Uncomplicated skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Uncomplicated urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Uncomplicated Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.",
          "Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Haemophilus influenzae (including ampicillin-resistant strains) & Klebsiella spp.",
          "Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis & Staphylococcus aureus (penicillinase and non-penicillinase producing strains)",
          "Switch therapy (Injectable to oral)"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a bactericidal second generation cephalosporin antibiotic which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process. Clavulanic acid is a naturally derived beta lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta lactam antibiotics which binds irreversibly to beta-lactamase enzymes and inactivates them. Clavulanic acid gives protection of Cefuroxime from degradation by beta lactamase enzymes and provides a solution for the treatment of bacterial infections caused by beta lactam resistant bacteria.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the area under the serum concentration versus time curve by 50%. Drug that reduces gastric acidity may result in a lower bioavailability of Cefuroxime and tend to cancel the effect of postprandial absorption.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime-Clavulanic Acid is contraindicated in patients with known allergy to cephalosporin & in patients with Pseudomembranous Colitis.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally Cefuroxime-Clavulanic Acid is well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth of nonsusceptible microorganisms. Rarely (<0.2%) renal dysfunction, anaphylaxis, angioedema, pruritis, rash and serum sickness like urticaria may appear.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "While all antibiotics should be avoided in the first trimester if possible. However, Cefuroxime-Clavulanic Acid can be safely used in later pregnancy to treat urinary and other infections. Cefuroxime-Clavulanic Acid is excreted into the breast milk in small quantities. However, the possibility of sensitizing the infant should be kept in mind.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light and moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Adolescents and adults (13 years and older)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/tonsillitis",
        "information": ": 250 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 250 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial exacerbation of chronic bronchitis",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Secondary bacterial infections of acute bronchitis",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated skin and skin structure infections",
        "information": ": 250-500 mg b.i.d. for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated urinary tract infections",
        "information": ": 250 mg b.i.d. for 7-10 days",
        "instructions": []
      },
      {
        "medication_type": "Uncomplicated Gonorrhoea",
        "information": ": 1000 mg b.i.d. Single dose",
        "instructions": []
      },
      {
        "medication_type": "Community acquired pneumonia",
        "information": ": 250-500 mg b.i.d. for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "MDR Typhoid Fever",
        "information": ": 500 mg b.i.d. for 10-14 days",
        "instructions": []
      },
      {
        "medication_type": "Early Lyme disease",
        "information": ": 500 mg b.i.d. for 20 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Paediatric Patients (3 months to 12 years)-",
        "instructions": []
      },
      {
        "medication_type": "Pharyngitis/Tonsillitis",
        "information": ": 20 mg/kg/day b.i.d for 5-10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute otitis media",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Acute bacterial maxillary sinusitis",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Impetigo",
        "information": ": 30 mg/kg/day b.i.d for 10 days",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cefuroxime-Clavulanic Acid tablet may be taken without regard of food.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cerox CV 250 mg+62.5 mg Tablet?",
        "answer": [
          "Cefuroxime is the cephalosporin antibiotic and Clavulanic acid is a beta-lactamase inhibitor. Cerox CV 250 mg+62.5 mg Tablet is indicated for the treatment of infections caused by sensitive bacteria."
        ]
      },
      {
        "question": "What is Cerox CV 250 mg+62.5 mg Tablet used for?",
        "answer": [
          "Cerox CV 250 mg+62.5 mg Tablet is used to treat pharyngitis, tonsillitis, sinusitis, bronchitis, SSTI, UTI, gonorrhoea, pneumonia, typhoid fever."
        ]
      },
      {
        "question": "How long does it take for Cerox CV 250 mg+62.5 mg Tablet to take effect?",
        "answer": [
          "Cerox CV 250 mg+62.5 mg Tablet starts working within 2-3 hours after taking it."
        ]
      },
      {
        "question": "How long do the effects of this medicine last?",
        "answer": [
          "The effect of Cerox CV 250 mg+62.5 mg Tablet lasts for an average duration of 4-8 hours."
        ]
      },
      {
        "question": "Cerox CV 250 mg+62.5 mg Tablet it safe to consume alcohol while taking this medicine?",
        "answer": [
          "Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption."
        ]
      },
      {
        "question": "Is Cerox CV 250 mg+62.5 mg Tablet a habit forming medicine?",
        "answer": [
          "No habit-forming tendencies were reported for Cerox CV 250 mg+62.5 mg Tablet."
        ]
      },
      {
        "question": "Can this medicine be taken during pregnancy?",
        "answer": [
          "Cerox CV 250 mg+62.5 mg Tablet is safe to use in pregnancy to treat bacterial infections. However, it is recommended to use this medicine only after consulting your doctor."
        ]
      },
      {
        "question": "Can Cerox CV 250 mg+62.5 mg Tablet be taken while breast-feeding?",
        "answer": [
          "Cerox CV 250 mg+62.5 mg Tablet is safe to use during breastfeeding. It enters into breast milk at low levels."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "You have been prescribed Cerox CV 250 mg+62.5 mg Tablet medicine to treat bacterial infections, even if they have developed resistance.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect. Taking probiotics may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.",
          "Stop taking Cerox CV 250 mg+62.5 mg Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.",
          "Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:05:09.277Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bcd",
    "original_record": {
      "input_index": 4389,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bcd"
        },
        "name": "Cerox CV",
        "strength": "250 mg+62.5 mg",
        "generic": "Cefuroxime Axetil + Clavulanic Acid",
        "company": "ACI Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/7406/cerox-cv-250-mg-tablet",
        "_page": 142,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7218/cerox-a-15-gm-injection",
    "name": "Cerox-A",
    "dosage_form": "IV Injection",
    "generic": "Cefuroxime Axetil",
    "strength": "1.5 gm/vial",
    "company": "ACI Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 275.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "1.5 gm vial",
          "price": "৳ 275.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7213/cerox-a-250-mg-tablet?ref=1"
      },
      {
        "text": "500 mg (Tablet)",
        "href": "https://medex.com.bd/brands/7214/cerox-a-500-mg-tablet?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/7215/cerox-a-125-mg-suspension?ref=1"
      },
      {
        "text": "750 mg/vial (Injection)",
        "href": "https://medex.com.bd/brands/7217/cerox-a-750-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/226/cefuroxime-axetil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "It is indicated for the treatment of infections caused by sensitive bacteria. It is indicated for the treatment of infections caused by sensitive bacteria.",
        "items": [
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.",
          "Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)",
          "Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli",
          "Acute bacterial exacerbation of chronic bronchitis and Secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).",
          "Skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.",
          "Urinary tract infections caused by E.coli or Klebsiella pneumoniae.",
          "Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).",
          "Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.",
          "Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefuroxime is a well-characterized and effective antibacterial agent, which has broad-spectrum bactericidal activity against a wide range of common pathogens, including β-lactamase producing strains. Cefuroxime has good stability to bacterial β-lactamase and consequently, is active against many ampicillin-resistant and amoxycillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No potentially hazardous interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefuroxime is contraindicated in patients with known allergy to Cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse effects to Cerox-A have occurred infrequently and have been generally mild and transient in nature. Effects reported include rashes and gastrointestinal disturbances. As with other antibiotics, prolonged use may result in the overgrowth of non susceptible organisms e.g. Candida.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Cefuroxime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cefuroxime have been shown to be excreted in human milk. So, caution should be exercised when Cefuroxime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cerox-A should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis. Cephalosporin antibiotics may in general be given safely to patients who are hypersensitive to penicillin although cross reactions have reported. Cerox-A has shown, that is not likely to be a problem at the recommended to dose levels.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool, dry place (below 30 o C), away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "The use of freshly reconstituted solution is recommended. However, it maintains potency for at least 24 hours at room temperature or 48 hours at 5 o C",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Second generation Cephalosporins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet or Suspension- Adolescents and adults (13 years and older)- Paediatric Patients (3 months to 12 years)- Parenteral-",
        "instructions": [
          "Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days",
          "Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days",
          "Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days",
          "Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days",
          "Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days",
          "Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days",
          "Uncomplicated Gonorrhoea: 1000 mg Single dose",
          "Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days",
          "MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days",
          "Early Lyme disease: 500 mg b.i.d. for 20 days",
          "Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days",
          "Acute otitis media: 30 mg/kg/day b.i.d for 10 days",
          "Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days",
          "Impetigo: 30 mg/kg/day b.i.d for 10 days"
        ]
      },
      {
        "medication_type": "Adult",
        "information": ": 750 mg three times daily by IM or IV injection. In severe infections, dose can be increased upto 1.5 gm three times daily by IV injection. The frequency may be increased to four times daily, if necessary, giving total daily doses of 3 to 6 gms.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 30 - 100 mg/kg/day given in 3 or 4 equally divided doses. A dose of 60 mg/kg/day is appropriate for most infections.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 30 - 100 mg/kg/day given in 2 or 3 equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Surgical prophylaxis",
        "information": ": 1.5 gm by IV injection at induction of anaesthesia; up to 3 further doses of 750 mg may be given by IV/IM injection every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": 1.5 gm IV injection twice daily for 2-3 days, followed by 500 mg twice daily (oral) for 7-10 days.",
        "instructions": []
      },
      {
        "medication_type": "Acute exacerbations of chronic bronchitis",
        "information": ": 750 mg twice daily (IM or IV injection) for 2-3 days, followed by 500 mg twice daily (oral) for 5-10 days. (Duration of both parenteral and oral therapy is determined by the severity of the infection and the clinical status of the patient.)",
        "instructions": []
      },
      {
        "medication_type": "In Gonorrhoea",
        "information": ": Adult: 1.5 gm as a single dose (as 2 x 750mg injections intramuscularly with different sites, e.g. each buttock).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In Meningitis:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 3 gm IV injection three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 200-240 mg/kg/day by IV injection in 3 or 4 divided doses reduced to 100 mg/kg/day after 3 days or on clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Neonate",
        "information": ": 100 mg/kg/day by IV injection at initial dose, reduced to 50 mg/kg/day, When clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In bone and joint infections:",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1.5 gm IV injection four times daily.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(above 3 months of age): 150 mg/kg/day (not to exceed the maximum adult dose) in equally divided doses every 8 hours.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:10.580Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bd3",
    "original_record": {
      "input_index": 4391,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bd3"
        },
        "name": "Cerox-A",
        "strength": "1.5 gm/vial",
        "generic": "Cefuroxime Axetil",
        "company": "ACI Limited",
        "medicine_type": "IV Injection",
        "source_url": "https://medex.com.bd/brands/7218/cerox-a-15-gm-injection",
        "_page": 143,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19145/cerzin-10-mg-tablet",
    "name": "Cerzin",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "FnF Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(100's pack: ৳ 250.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cerzin is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Cerzin is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Cerzin is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Cerzin has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Cerzin is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:11.979Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bdd",
    "original_record": {
      "input_index": 4392,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bdd"
        },
        "name": "Cerzin",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "FnF Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/19145/cerzin-10-mg-tablet",
        "_page": 143,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30405/cesonide-80-mcg-solution-for-inhalation",
    "name": "Cesonide",
    "dosage_form": "Solution for Inhalation",
    "generic": "Ciclesonide",
    "strength": "80 mcg/actuation",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 275.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "120 metered doses",
          "price": "৳ 275.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "160 mcg/actuation (Inhaler)",
        "href": "https://medex.com.bd/brands/30404/cesonide-160-mcg-solution-for-inhalation?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1840/ciclesonide-inhalation-aerosol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cesonide inhalation aerosol is indicated for treatment to control persistent asthma in adults (18 years and older).",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ciclesonide, which is a new once daily inhaled corticosteroid, is an ester prodrug that requires hydrolyzation by endogenous esterases in the lung to form its active metabolite (B-9207-021). The activated ciclesonide has an approximately 100-fold greater affinity for glucocorticoid receptors compared with the parent compound and produces high local anti-inflammatory activity.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Co-administration with a potent inhibitor of the cytochrome P450 3A4 system (e.g. ketoconazole, itraconazole and ritonavir or nelfinavir) should be considered with caution. The risk of clinical adverse effect (eg cushingoid syndrome) cannot be excluded.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to Ciclesonide or any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common (1-10%): Paradoxical bronchospasm; uncommon (0.1-1%): Bad taste, application site reactions, application site dryness, hoarseness, cough after inhalation, rash and eczema. Systemic effects of inhaled corticosteroids may occur, particularly at high doses prescribed for prolonged periods. These effects are much less likely to occur than with oral corticosteroids. Possible systemic effects include adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma. Patients with severe hepatic impairment should be monitored for potential systemic effects.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "As with other inhaled glucocorticoids, Ciclesonide should only be used during pregnancy or lactation if the potential benefit to the mother justifies the potential risk to the mother, foetus or child. The lowest effective dose of Ciclesonide needed to maintain adequate asthma control should be used.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with all inhaled corticosteroids, Cesonide should be administered with caution in patients with active or quiescent pulmonary tuberculosis, fungal, viral, or bacterial infections, and only if these patients are adequately treated. As with all inhaled corticosteroids, Cesonide is not indicated in the treatment of status asthmaticus where intensive measures are required, or to relieve acute asthma symptoms for which an inhaled short-acting bronchodilator is required. Patients should be advised to have such rescue medication available. Patients transferred from oral steroids should be monitored regularly and their dose of systemic steroid reduced cautiously. Treatment with Cesonide should not be stopped abruptly.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "The inhaler should be stored below 30°C, protected from direct sunlight and heat. The canister should not be broken, punctured or burnt, even when apparently empty. Keep away from eyes. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Before using your inhaler for the first time, or if it has not been used for a week or more, \"test fire\" it, i.e. release one puff into the air.",
        "items": []
      },
      {
        "title": "How to use your inhaler correctly",
        "information": ":",
        "items": [
          "Remove the mouthpiece cover, and check the mouthpiece thoroughly to see that it is clean. Shake the inhaler vigorously.",
          "Hold the inhaler as shown between index finger and thumb. Breathe out gently through your mouth and immediately place the mouthpiece in your mouth between your teeth (Do not bite it).",
          "Grip the mouthpiece firmly with your lips. Tilt your head slightly backwards. Start breathing in slowly through your mouth. At the same time press the canister as shown, to release one dose while continuing to breathe in steadily and deeply.",
          "Remove the inhaler from your mouth. Hold the breath at least for 10 seconds, or as long as it is comfortable. Breathe out slowly.",
          "If another dose is required, wait for at least 1 minute and repeat the whole process. After use, place the cover to close the mouthpiece.",
          "Shake well before each use."
        ]
      },
      {
        "title": "How to clean your inhaler",
        "information": ":",
        "items": [
          "Gently pull the metal canister out of the plastic body of the inhaler, remove the mouthpiece cover.",
          "Rinse the plastic body and the mouthpiece cover in warm water but do not put the metal canister into water.",
          "Leave to dry in warm place, avoid excessive heat.",
          "Replace the canister and the mouthpiece cover correctly.",
          "Clean your inhaler at least once a week."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Respiratory corticosteroids",
    "dosage": [
      {
        "medication_type": null,
        "information": "Ciclesonide is for inhalation use only. The recommended starting dose of Ciclesonide is 160 micrograms once daily which is usually also the maximum dose. Dose reduction to 80 micrograms once daily may be an effective maintenance dose for some patients. Ciclesonide should preferably be administered in the evening although morning dosing of Ciclesonide has also been shown to be effective. There is no need to adjust the dose in elderly patients or those with hepatic or renal impairment. Patients with severe asthma are at risk of acute attacks and should have regular assessments of their asthma control including pulmonary function tests. Increasing use of short-acting bronchodilators to relieve asthma symptoms indicates deterioration of asthma control. If patients find that short-acting relief bronchodilator treatment becomes less effective, or they need more inhalations than usual, medical attention must be sought. In this situation, patients should be reassessed and consideration given to the need for increased anti-inflammatory treatment therapy (e.g. higher doses of Ciclesonide or a course of oral corticosteroids). Severe asthma exacerbations should be managed in the usual way.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:13.125Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9be1",
    "original_record": {
      "input_index": 4393,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9be1"
        },
        "name": "Cesonide",
        "strength": "80 mcg/actuation",
        "generic": "Ciclesonide (Inhalation Aerosol)",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Solution for Inhalation",
        "source_url": "https://medex.com.bd/brands/30405/cesonide-80-mcg-solution-for-inhalation",
        "_page": 143,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/10573/cetal-plus-500-mg-tablet",
    "name": "Cetal Plus",
    "dosage_form": "Tablet",
    "generic": "Paracetamol + Caffeine",
    "strength": "500 mg+65 mg",
    "company": "Supreme Pharmaceutical Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 1.90",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 190.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.90",
          "pack_size_info": "(100's pack: ৳ 190.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/861/paracetamol-caffeine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetal Plus is indicated in the following conditions-",
        "items": [
          "Headache",
          "Migraine",
          "Toothache",
          "Neuralgia",
          "Feverishness",
          "Period pain",
          "Sore throat",
          "Backache",
          "Help to reduce the temperature",
          "Aches and pain of colds and flu"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a combination of Paracetamol and Caffeine. Paracetamol has analgesic and antipyretic properties with weak anti-inflammatory activity. Caffeine is an alkaloid which is a theophylline-like xanthine derivative. By intermolecular association with Paracetamol, Caffeine increases the solubility and transmembrane permeation of Paracetamol. In addition, Caffeine increases the pain threshold and tolerance of pain. Caffeine has also an intrinsic power to raise vessel tone in the brain, which provides another benefit to treat migraine and headache.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "May reduce serum levels with anticonvulsants (e.g. phenytoin, barbiturates, carbamazepine). May enhance the anticoagulant effect of warfarin and other coumarins with prolonged use. Accelerated absorption with metoclopramide and domperidone. May increase serum levels with probenecid. May increase serum levels of chloramphenicol. May reduce absorption with colestyramine within 1 hr of admin. May cause severe hypothermia with phenothiazine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Paracetamol is contraindicated in patients with severe renal function impairment and hepatic disease (Viral Hepatitis). Known hypersensitivity to paracetamol or caffeine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects of paracetamol are usually mild, though haematological reactions including thrombocytopenia, leukopenia, pancytopenia, neutropenia, and agranulocytosis have been reported. Pancreatitis, skin rashes, and other allergic reactions occur occasionally.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnant mothers should consult with doctors before taking Paracetamol & Caffeine. Paracetamol & Caffeine can be taken whilst breast feeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Paracetamol & Caffeine should be given cautiously in the following cases: In patients with hepatic or renal failure, in patients taking other hepatotoxic medication. Prolonged use of the drug without consulting a physician should be avoided.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Symptoms of Paracetamol overdose in the first 24 hours are pallor, nausea, vomiting, anorexia and abdominal pain. Liver damage may become apparent 12 to 40 hours after ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protect from light and moisture.Keep all medicines out of the reach of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-Opioid Analgesics",
    "dosage": [
      {
        "medication_type": "Adult dose",
        "information": ": 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.",
        "instructions": []
      },
      {
        "medication_type": "Child dose",
        "information": ": Not recommended for children below 12 years.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:14.548Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9be6",
    "original_record": {
      "input_index": 4394,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9be6"
        },
        "name": "Cetal Plus",
        "strength": "500 mg+65 mg",
        "generic": "Paracetamol + Caffeine",
        "company": "Supreme Pharmaceutical Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/10573/cetal-plus-500-mg-tablet",
        "_page": 143,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/14020/cetox-plus-200-mg-tablet",
    "name": "Cetox Plus",
    "dosage_form": "Tablet",
    "generic": "Vitamin C + Vitamin E",
    "strength": "200 mg+50 mg",
    "company": "Chemist Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 16.00",
      "pack_size_info": "(5 x 4: ৳ 80.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(5 x 4: ৳ 80.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 16.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1162/vitamin-c-vitamin-e/brand-names",
    "indications": [
      {
        "title": null,
        "information": "The active ingredients of Vitamin C and Vitamin E have been linked with reduced risks of cardiovascular diseases in human. Concurrent intake of Vitamin E and Vitamin C suggests that their action may be synergistic.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": "Vitamin C",
        "information": ": Necessary for collagen formation and tissue repair; plays a role in oxidation/reduction reactions as well as other metabolic pathways including synthesis of catecholamines, carnitine, and steroids; also plays a role in conversion of folic acid to folinic acid.",
        "items": []
      },
      {
        "title": "Vitamin E",
        "information": "plays a role in protecting red blood cells against hemolysis; has protective effects against free radicals on polyunsaturated fatty acids found in cell membranes; plays a role in preventing oxidation of vitamin A and C.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Vitamin C is incompatible in solution with Aminophylline, Bleomycin, Erythromycin, Lactobionate, Nafcillin, Nitrofurantoin Sodium, Conjugated oestrogens, Sodium bicarbonate, Salphafurazole diethanolamine, Chloramphenicol sodium succinate, Chlorthiazide sodium and Hydrocortisone sodium succinate. It increases the apparent half life of Paracetamol and enhances iron absorption from the gastrointestinal tract. No potentially useful drug Interaction with Vitamin E has been described. However, high doses of Vitamin E can impair intestinal absorption of Vitamin A and K.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Vitamin C in megadoses has been contra-indicated for patients with hyperoxaluria. A pregnant woman taking more than 5 gm daily ascorbate may suffer from fetal abortion. Higher doses of Vitamin C have reported to cause failure of conception. In case of Vitamin E, there is no absolute contra-indication.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Vitamin C is usually well tolerated. Large doses are reported to cause diarrhea and other gastrointestinal disturbances. Vitamin E is usually well tolerated. Large doses may cause diarrhea, abdominal discomfort, and other gastrointestinal disturbances, and have also been reported to cause fatigue and weakness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category A. Adequate and well-controlled human studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Vitamin C should be given with care to patient with hyperoxaluria. In patients taking oral anticoagulants or oestrogens Vitamin E should be given carefully because it has been found to antagonize the effects of Vitamin K leading to an increase in blood clotting time in these patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-oxidant Multivitamin preparations, Specific combined vitamin preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Vitamin C & E capsule is administered orally. The adult dose is 1 capsule daily or as directed by the registered physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:15.662Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bfa",
    "original_record": {
      "input_index": 4395,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bfa"
        },
        "name": "Cetox Plus",
        "strength": "200 mg+50 mg",
        "generic": "Vitamin C + Vitamin E",
        "company": "Chemist Laboratories  Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/14020/cetox-plus-200-mg-tablet",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12015/cetriben-10-mg-tablet",
    "name": "Cetriben",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Benham Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.00",
      "strip_price": "৳ 30.00",
      "pack_size_info": "(10 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.00",
          "pack_size_info": "(10 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/19134/cetriben-5-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetriben is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Cetriben is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Cetriben is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Cetriben has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Cetriben is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:16.629Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bfc",
    "original_record": {
      "input_index": 4396,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bfc"
        },
        "name": "Cetriben",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Benham Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12015/cetriben-10-mg-tablet",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19134/cetriben-5-mg-syrup",
    "name": "Cetriben",
    "dosage_form": "Syrup",
    "generic": "Cetirizine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Benham Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12015/cetriben-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetriben is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Cetriben is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Cetriben is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Cetriben has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Cetriben is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:18.083Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bfd",
    "original_record": {
      "input_index": 4397,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bfd"
        },
        "name": "Cetriben",
        "strength": "5 mg/5 ml",
        "generic": "Cetirizine Hydrochloride",
        "company": "Benham Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/19134/cetriben-5-mg-syrup",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19137/cetril-5-mg-syrup",
    "name": "Cetril",
    "dosage_form": "Syrup",
    "generic": "Cetirizine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Chemist Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/11938/cetril-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetril is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Cetril is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Cetril is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Cetril has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Cetril is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:19.233Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9bff",
    "original_record": {
      "input_index": 4398,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9bff"
        },
        "name": "Cetril",
        "strength": "5 mg/5 ml",
        "generic": "Cetirizine Hydrochloride",
        "company": "Chemist Laboratories  Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/19137/cetril-5-mg-syrup",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33329/cetrilon-03-3-solution",
    "name": "Cetrilon",
    "dosage_form": "Solution",
    "generic": "Chlorhexidine Gluconate + Cetrimide",
    "strength": "0.3%+3%",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 44.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "112 ml bottle",
          "price": "৳ 44.00",
          "pack_size_info": null
        },
        {
          "label": "500 ml bottle",
          "price": "৳ 125.00",
          "pack_size_info": null
        },
        {
          "label": "1 liter pack",
          "price": "৳ 220.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/241/chlorhexidine-gluconate-cetrimide/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetrilon solution is used for cleansing and irrigating the skin and dirty wounds where an added surfactant effect is required.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": "Chlorhexidine",
        "information": ": Chlorhexidine is an antiseptic and disinfectant which is effective against a wide range of vegetative Gram-positive and Gram-negative organisms, some viruses and some fungi. It is ineffective against bacterial spores at room temperature, and acid-fast bacteria are inhibited but not killed. It is more active against Gram-positive than Gram-negative bacteria and some species of Pseudomonas and Proteus are relatively less susceptible. Chlorhexidine is most active at a neutral or slightly acid pH and its activity may be reduced by blood and other organic matter.",
        "items": []
      },
      {
        "title": "Cetrimide",
        "information": ": Cetrimide is a quaternary ammonium disinfectant with properties typical of cationic surfactants. Solutions of these surfactants have emulsifying and detergent properties and bactericidal activity against both Gram-positive and Gram-negative organisms but higher concentrations are necessary to kill the latter. The combined detergent and antibacterial properties of cetrimide make it useful in cleansing dirty or infected wounds. It is however, relatively ineffective against bacterial spores, acid-fast bacteria, viruses and fungi.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "Known hypersensitivity to either chlorhexidine or cetrimide. Do not use to irrigate the brain, meninges, eyes or perforated eardrum.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Irritative skin reactions and hypersensitivity reactions to chlorhexidine have been reported. In the event that these reactions occur, discontinue use. Cetrimide may have a prolonging effect on the wound healing process.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": There are no adequate data from the use of chlorhexidine and cetrimide in pregnant women. The potential risk for humans is unknown but is most likely very low since chlorhexidine and cetrimide are poorly absorbed following topical application.",
        "items": []
      },
      {
        "title": "Breastfeeding",
        "information": ": It is not known whether chlorhexidine and cetrimide are excreted in breast milk. There are no adequate data from the use of chlorhexidine and cetrimide in breast-feeding women. However, it is unlikely that the products are excreted in breast milk, since the products are poorly absorbed. After topical usage of the product, as a general precaution, rinse nipples thoroughly with water before breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "For external use only. Not for injection, for irrigation only. Not isotonic and is haemolytic. Cetrimide may have a prolonging effect on the wound healing process. Use of this antiseptic should be restricted to infection control and cleansing of wounds rather than general wound management.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "While accidental ingestion is unlikely to cause any systemic effects due to poor absorption of chlorhexidine and cetrimide, ingestion of high concentrations could cause irritation of the gastrointestinal mucosa/gastritis. Gastric lavage might be needed. Symptomatic treatment should be employed. If swallowed, wash out mouth, drink plenty of milk or water and seek medical advice. In case of overdose, seek medical attention or contact a poison control centre.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 25°C. Protect from light. Single use only. Discard unused portion.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Chlorhexidine & Chloroxylenol preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Rinse the area to be cleaned with water, apply the minimum amount of irrigation necessary to cover the wound area and wash gently. Rinse again thoroughly. Apply to wound as necessary. Discard remaining solution after use. Paediatric Use: Use with care in neonates, particularly in premature infants. Chlorhexidine may cause irritation or chemical burns.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:20.620Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c01",
    "original_record": {
      "input_index": 4399,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c01"
        },
        "name": "Cetrilon",
        "strength": "0.3%+3%",
        "generic": "Chlorhexidine Gluconate + Cetrimide",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Solution",
        "source_url": "https://medex.com.bd/brands/33329/cetrilon-03-3-solution",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19132/cetriz-5-mg-syrup",
    "name": "Cetriz",
    "dosage_form": "Syrup",
    "generic": "Cetirizine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Astra Biopharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/11941/cetriz-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetriz is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Cetriz is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Cetriz is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Cetriz has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Cetriz is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:21.760Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c05",
    "original_record": {
      "input_index": 4400,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c05"
        },
        "name": "Cetriz",
        "strength": "5 mg/5 ml",
        "generic": "Cetirizine Hydrochloride",
        "company": "Astra Biopharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/19132/cetriz-5-mg-syrup",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/36634/cetrolix-250-mcg-injection",
    "name": "Cetrolix",
    "dosage_form": "SC Injection",
    "generic": "Cetrorelix Acetate",
    "strength": "250 mcg/vial",
    "company": "Eskayef Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 2,500.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "250 mcg vial",
          "price": "৳ 2,500.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/235/cetrorelix-acetate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetrolix is indicated for the treatment of infertility in females. It restricts eggs to release directly and prevents premature ovulation. In Female infertility, Cetrolix prevents release of premature eggs during a process called ovulation in females. This helps in normal development ... Read moreCetrolix is indicated for the treatment of infertility in females. It restricts eggs to release directly and prevents premature ovulation. In Female infertility, Cetrolix prevents release of premature eggs during a process called ovulation in females. This helps in normal development of an egg in a woman's ovary (female reproductive organ), and stimulates the release of a healthy, matured egg. This helps to treat infertility in women and increases the chance of a successful pregnancy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetrorelix Acetate is a synthetic decapeptide with gonadotropin-releasing hormone (GnRH) antagonistic activity. Cetrorelix Acetate blocks the effects of GnRH. GnRH controls the secretion of luteinizing hormone (LH), which induces ovulation during the menstrual cycle. During hormone treatment for ovarian stimulation, premature ovulation may lead to eggs that are not suitable for fertilization. Cetrorelix Acetate blocks such undesirable premature ovulation. GnRH induces the production and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the gonadotropic cells of the anterior pituitary. Due to a positive estradiol (E2) feedback at midcycle, GnRH liberation is enhanced resulting in an LH-surge. This LH-surge induces the ovulation of the dominant follicle, resumption of oocyte meiosis and subsequently luteinization as indicated by rising progesterone levels. Cetrorelix Acetate competes with natural GnRH for binding to membrane receptors on pituitary cells and thus controls the release of LH and FSH in a dose-dependent manner. The onset of LH suppression is approximately two hours with the 0.25 mg dose. This suppression is maintained by continuous treatment and there is a more pronounced effect on LH than on FSH. An initial release of endogenous gonadotropins has not been detected with Cetrorelix injection, which is consistent with an antagonist effect. The effects of Cetrorelix Acetate on LH and FSH are reversible after discontinuation of treatment. In women, Cetrorelix Acetate delays the LH-surge, and consequently ovulation, in a dose dependent fashion. FSH levels are not affected at the doses used during controlled ovarian stimulation. A dose of Cetrorelix Acetate 0.25 mg every 24 hours has been shown to maintain the effect.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No formal drug-drug interaction studies have been performed with Cetrolix. In vitro investigations have shown that interactions are unlikely with medicinal products that are metabolized by cytochrome P450 or glucuronised or conjugated in some other way. However, the possibility of interactions with gonadotropins or medicinal products that may induce histamine release in susceptible individuals, cannot be totally excluded.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol.",
          "Pregnancy and lactation.",
          "Postmenopausal women.",
          "Patients with moderate and severe renal and hepatic impairment"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most commonly reported adverse effects are local injection site reactions such as erythema, swelling and pruritus that are usually transient in nature and mild in intensity. Mild to moderate ovarian hyperstimulation syndrome (OHSS) (WHO grade I or II) have been commonly reported and should be considered as an intrinsic risk of the stimulation procedure.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Cetrorelix Acetate is not intended to be used during pregnancy and lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "This medicinal product must be allowed to reach room temperature prior to injection. It should be removed from the refrigerator approximately 30 minutes before use.",
          "Do not use if the reconstituted solution contains particles or if the solution is not clear.",
          "The solution should be used immediately after reconstitution."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "If you think you have taken too much Cetrolix, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "To be used immediately after reconstitution. Store in a refrigerator (2°C to 8°C temperature). Do not freeze. Keep away from light & wet place. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Choose an injection site on your lower abdominal area. It should be preferably around, but at least one inch away, from your belly button. Choose a different injection site each day to minimize local irritation. Take the second alcohol wipe, clean the skin at the injection site and allow the alcohol to dry. Keep the alcohol wipe nearby. Pick up the syringe. Invert the syringe and hold it as if 'throwing a dart'. With your other hand, gently squeeze the skin together to make a little elevation at the injection site. Using a 'dart like motion', slowly insert the needle at an angle of about 45° to 90° (you need very little force but quick action). Once the needle is inserted into the tissue all the way, inject the solution. Do this by pushing gently on the plunger with your thumb of the hand holding the syringe. Take as much time as you need to inject all the solution. Immediately withdraw the needle. Clean the injection site with the clean side of the alcohol pad using a circular motion. If there is minor oozing, you may need to apply a small amount of pressure for a minute. Use the syringe and needles only once. Dispose of the syringe and needles immediately after use. Discard into a disposal container or puncture-proof container with a lid that fits firmly.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs affecting (inhibiting) gonadotrophin",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cetrorelix Acetate administered subcutaneously once daily (0.25 mg dose) at 24 hour intervals, either in the morning or in the evening as part of the multiple dose protocol during the early-to mid-follicular phase (Day 5/6 to Day11). It is for subcutaneous injection into the lower abdominal wall. The first administration of Cetrorelix Acetate 0.25 mg should be performed under the supervision of a physician. The reconstituted product is to be administered subcutaneously. Use immediately after reconstitution.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:23.138Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c08",
    "original_record": {
      "input_index": 4401,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c08"
        },
        "name": "Cetrolix",
        "strength": "250 mcg/vial",
        "generic": "Cetrorelix Acetate",
        "company": "Eskayef Pharmaceuticals Ltd.",
        "medicine_type": "SC Injection",
        "source_url": "https://medex.com.bd/brands/36634/cetrolix-250-mcg-injection",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/5980/cetrotide-250-mcg-injection",
    "name": "Cetrotide",
    "dosage_form": "SC Injection",
    "generic": "Cetrorelix Acetate",
    "strength": "250 mcg/vial",
    "company": "Merck",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5,450.00",
      "strip_price": null,
      "pack_size_info": "(7's pack: ৳ 38,150.00)",
      "packages": [
        {
          "label": "250 mcg vial",
          "price": "৳ 5,450.00",
          "pack_size_info": "(7's pack: ৳ 38,150.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/235/cetrorelix-acetate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cetrotide is indicated for the treatment of infertility in females. It restricts eggs to release directly and prevents premature ovulation. In Female infertility, Cetrotide prevents release of premature eggs during a process called ovulation in females. This helps in normal development ... Read moreCetrotide is indicated for the treatment of infertility in females. It restricts eggs to release directly and prevents premature ovulation. In Female infertility, Cetrotide prevents release of premature eggs during a process called ovulation in females. This helps in normal development of an egg in a woman's ovary (female reproductive organ), and stimulates the release of a healthy, matured egg. This helps to treat infertility in women and increases the chance of a successful pregnancy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetrorelix Acetate is a synthetic decapeptide with gonadotropin-releasing hormone (GnRH) antagonistic activity. Cetrorelix Acetate blocks the effects of GnRH. GnRH controls the secretion of luteinizing hormone (LH), which induces ovulation during the menstrual cycle. During hormone treatment for ovarian stimulation, premature ovulation may lead to eggs that are not suitable for fertilization. Cetrorelix Acetate blocks such undesirable premature ovulation. GnRH induces the production and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the gonadotropic cells of the anterior pituitary. Due to a positive estradiol (E2) feedback at midcycle, GnRH liberation is enhanced resulting in an LH-surge. This LH-surge induces the ovulation of the dominant follicle, resumption of oocyte meiosis and subsequently luteinization as indicated by rising progesterone levels. Cetrorelix Acetate competes with natural GnRH for binding to membrane receptors on pituitary cells and thus controls the release of LH and FSH in a dose-dependent manner. The onset of LH suppression is approximately two hours with the 0.25 mg dose. This suppression is maintained by continuous treatment and there is a more pronounced effect on LH than on FSH. An initial release of endogenous gonadotropins has not been detected with Cetrorelix injection, which is consistent with an antagonist effect. The effects of Cetrorelix Acetate on LH and FSH are reversible after discontinuation of treatment. In women, Cetrorelix Acetate delays the LH-surge, and consequently ovulation, in a dose dependent fashion. FSH levels are not affected at the doses used during controlled ovarian stimulation. A dose of Cetrorelix Acetate 0.25 mg every 24 hours has been shown to maintain the effect.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No formal drug-drug interaction studies have been performed with Cetrotide. In vitro investigations have shown that interactions are unlikely with medicinal products that are metabolized by cytochrome P450 or glucuronised or conjugated in some other way. However, the possibility of interactions with gonadotropins or medicinal products that may induce histamine release in susceptible individuals, cannot be totally excluded.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol.",
          "Pregnancy and lactation.",
          "Postmenopausal women.",
          "Patients with moderate and severe renal and hepatic impairment"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most commonly reported adverse effects are local injection site reactions such as erythema, swelling and pruritus that are usually transient in nature and mild in intensity. Mild to moderate ovarian hyperstimulation syndrome (OHSS) (WHO grade I or II) have been commonly reported and should be considered as an intrinsic risk of the stimulation procedure.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Cetrorelix Acetate is not intended to be used during pregnancy and lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "This medicinal product must be allowed to reach room temperature prior to injection. It should be removed from the refrigerator approximately 30 minutes before use.",
          "Do not use if the reconstituted solution contains particles or if the solution is not clear.",
          "The solution should be used immediately after reconstitution."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "If you think you have taken too much Cetrotide, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "To be used immediately after reconstitution. Store in a refrigerator (2°C to 8°C temperature). Do not freeze. Keep away from light & wet place. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Choose an injection site on your lower abdominal area. It should be preferably around, but at least one inch away, from your belly button. Choose a different injection site each day to minimize local irritation. Take the second alcohol wipe, clean the skin at the injection site and allow the alcohol to dry. Keep the alcohol wipe nearby. Pick up the syringe. Invert the syringe and hold it as if 'throwing a dart'. With your other hand, gently squeeze the skin together to make a little elevation at the injection site. Using a 'dart like motion', slowly insert the needle at an angle of about 45° to 90° (you need very little force but quick action). Once the needle is inserted into the tissue all the way, inject the solution. Do this by pushing gently on the plunger with your thumb of the hand holding the syringe. Take as much time as you need to inject all the solution. Immediately withdraw the needle. Clean the injection site with the clean side of the alcohol pad using a circular motion. If there is minor oozing, you may need to apply a small amount of pressure for a minute. Use the syringe and needles only once. Dispose of the syringe and needles immediately after use. Discard into a disposal container or puncture-proof container with a lid that fits firmly.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs affecting (inhibiting) gonadotrophin",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cetrorelix Acetate administered subcutaneously once daily (0.25 mg dose) at 24 hour intervals, either in the morning or in the evening as part of the multiple dose protocol during the early-to mid-follicular phase (Day 5/6 to Day11). It is for subcutaneous injection into the lower abdominal wall. The first administration of Cetrorelix Acetate 0.25 mg should be performed under the supervision of a physician. The reconstituted product is to be administered subcutaneously. Use immediately after reconstitution.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:24.318Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c09",
    "original_record": {
      "input_index": 4402,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c09"
        },
        "name": "Cetrotide",
        "strength": "250 mcg/vial",
        "generic": "Cetrorelix Acetate",
        "company": "Janata Traders",
        "medicine_type": "SC Injection",
        "source_url": "https://medex.com.bd/brands/5980/cetrotide-250-mcg-injection",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/17247/cetuxim-5-mg-injection",
    "name": "Cetuxim",
    "dosage_form": "IV Infusion",
    "generic": "Cetuximab",
    "strength": "5 mg/ml",
    "company": "Beacon Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 20,885.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 mg vial",
          "price": "৳ 20,885.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1290/cetuximab/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Squamous Cell Carcinoma Of The Head And Neck (SCCHN): Cetuxim is indicated in combination with radiation therapy for the initial treatment of locally or regionally advanced squamous cell carcinoma of the head and neck.Cetuxim is indicated in ... Read moreSquamous Cell Carcinoma Of The Head And Neck (SCCHN): Cetuxim is indicated in combination with radiation therapy for the initial treatment of locally or regionally advanced squamous cell carcinoma of the head and neck.Cetuxim is indicated in combination with platinum-based therapy with 5-FU for the first-line treatment of patients with recurrent locoregional disease or metastatic squamous cell carcinomaof the head and neck.Cetuxim, as a single agent, is indicated for the treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck for whom prior platinum-based therapy has failed.K-Ras Wild-Type, EGFR-Expressing Colorectal Cancer: Cetuxim is indicated for the treatment of K-Ras wild-type, epidermal growth factor receptor (EGFR)- expressing, metastatic colorectal cancer (mCRC) as determined by FDA-approved tests for this use",
        "items": [
          "In combination with FOLFIRI (irinotecan, 5-fluorouracil, leucovorin) for first-line treatment",
          "In combination with irinotecan in patients who are refractory to irinotecan-based chemotherapy",
          "As a single agent in patients who have failed oxaliplatin- and irinotecan-based chemotherapy or who are intolerant to irinotecan."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetuximab is a recombinant human/mouse chimeric monoclonal antibody. It binds specifically to the epidermal growth factor receptor (EGFR), thus competitively inhibiting the binding of epidermal growth factor (EGF) and other ligands. This blocks phosphorylation and activation of receptor-associated kinases, thus inhibiting cell growth, inducing apoptosis and decreases matrix metalloproteinase and vascular EGF production.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Fatigue, pain, headache, fever, confusion, anxiety, insomnia, chills, rigors, depression. Acneiform rash, rash, dry skin, pruritus, nail changes, hypomagnesaemia, abdominal pain, constipation, diarrhoea, vomiting, nausea, wt loss, weakness, bone pain.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": category C. Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the fetus.",
        "items": []
      },
      {
        "title": "Nursing Mothers",
        "information": ": It is not known whether Cetuximab is secreted in human milk. IgG antibodies, such as Cetuximab, can be excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Cetuximab, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. If nursing is interrupted, based on the mean half-life of cetuximab, nursing should not be resumed earlier than 60 days following the last dose of Cetuximab.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Infusion rate should be reduced if patient exhibits signs of toxicity. Discontinue treatment if there is severe infusion reactions. Caution when used in patients with history of coronary artery disease, heart failure and arrhythmias. Monitor serum electrolytes during and after (for at least 8 wk) Cetuxim therapy. Exposure to sunlight may worsen skin reactions. Risk of interstitial lung disease in patients with preexisting lung disease. Dose should be modified if there is occurrence of severe acneiform rash, refer to product insert/SPG for dosing guidelines.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Dose modification in cases of severe acneiform rash (grade 3 or 4):",
        "items": [
          "1st occurrence: Delay infusion by 1-2 wk. If improvement, continue at 250 mg/m2; discontinue if no improvement.",
          "2nd occurrence: Delay infusion by1-2 wk. If improvement, continue at reduced dose of 200 mg/m2; discontinue if no improvement.",
          "3rd occurrence: Delay infusion by 1-2 wk. If improvement, continue at reduced dose of 150 mg/m2; discontinue if no improvement. 4th occurrence: Discontinue therapy."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The maximum single dose of Cetuxim administered is 1000 mg/m 2 in one patient. No adverse events were reported for this patient.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store vials under refrigeration at 2° to 8° C. Do not freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Do not administer cetuximab as an intravenous push or bolus. Administer via infusion pump or syringe pump. Do not exceed an infusion rate of 10 mg/min. Administer through a low protein binding 0.22-micrometer in-line filter. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. The solution should be clear and colorless and may contain a small amount of easily visible, white, amorphous, cetuximab particulates. Do not s hake or dilute.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Targeted Cancer Therapy",
    "dosage": [
      {
        "medication_type": null,
        "information": "Squamous Cell Carcinoma Of The Head And Neck:",
        "instructions": []
      },
      {
        "medication_type": "Cetuximab in combination with radiation therapy or in combination with platinum-based therapy with 5-FU",
        "information": ":",
        "instructions": [
          "The recommended initial dose is 400 mg/m2 administered one week prior to initiation of a course of radiation therapy or on the day of initiation of platinum-based therapy with 5-FU as a 120-minute intravenous infusion (maximum infusion rate 10 mg/min). Complete Cetuximab administration 1 hour prior to platinum-based therapy with 5-FU.",
          "The recommended subsequent weekly dose (all other infusions) is 250 mg/m2 infused over 60 minutes (maximum infusion rate 10 mg/min) for the duration of radiation therapy (6–7 weeks) or until disease progression or unacceptable toxicity when administered in combination with platinum-based therapy with 5-FU. Complete Cetuximab administration 1 hour prior to radiation therapy or platinumbased therapy with 5-FU."
        ]
      },
      {
        "medication_type": "Cetuximab monotherapy",
        "information": ": Colorectal Cancer:",
        "instructions": [
          "The recommended initial dose is 400 mg/m2 administered as a 120-minute intravenous infusion (maximum infusion rate 10 mg/min).",
          "The recommended subsequent weekly dose (all other infusions) is 250 mg/m2 infused over 60 minutes (maximum infusion rate 10 mg/min) until disease progression or unacceptable toxicity.",
          "Determine EGFR-expression status using FDA-approved tests prior to initiating treatment. Also confirm the absence of a Ras mutation prior to initiation of treatment with Cetuximab.",
          "The recommended initial dose, either as monotherapy or in combination with irinotecan or FOLFIRI (irinotecan, 5-fluorouracil, leucovorin), is 400 mg/m2 administered as a 120-minute intravenous infusion (maximum infusion rate 10 mg/min). Complete Cetuximab administration 1 hour prior to FOLFIRI.",
          "The recommended subsequent weekly dose, either as monotherapy or in combination with irinotecan or FOLFIRI, is 250 mg/m2 infused over 60 minutes (maximum infusion rate 10 mg/min) until disease progression or unacceptable toxicity. Complete Cetuximab administration 1 hour prior to FOLFIRI."
        ]
      },
      {
        "medication_type": "Recommended Premedication",
        "information": ": Premedicate with an H1 antagonist (eg, 50 mg of diphenhydramine) intravenously 30–60 minutes prior to the first dose; premedication should be administered for subsequent Cetuximab doses based upon clinical judgment and presence/severity of prior infusion reactions.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:25.443Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c0a",
    "original_record": {
      "input_index": 4403,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c0a"
        },
        "name": "Cetuxim",
        "strength": "5 mg/ml",
        "generic": "Cetuximab",
        "company": "Beacon Pharmaceuticals PLC",
        "medicine_type": "IV Infusion",
        "source_url": "https://medex.com.bd/brands/17247/cetuxim-5-mg-injection",
        "_page": 144,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/13917/cevion-1000-mg-tablet",
    "name": "Cevion",
    "dosage_form": "Effervescent Tablet",
    "generic": "Vitamin C [Ascorbic acid]",
    "strength": "1000 mg",
    "company": "Healthcare Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.08",
      "strip_price": "৳ 80.82",
      "pack_size_info": "(1 x 10: ৳ 80.82)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.08",
          "pack_size_info": "(1 x 10: ৳ 80.82)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.82",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1137/vitamin-c-ascorbic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ascorbic Acid (Cevion) is indicated in- Ascorbic Acid (Cevion) is indicated in-",
        "items": [
          "Prevents & treats scurvy",
          "Helps in healing wounds & broken bones",
          "Helps to form collagen in connective tissues",
          "Aids in iron absorption & helps to treat anemia",
          "Contributes in production of hemoglobin & red blood cell in bone marrow",
          "Prevents & treats scurvy",
          "Helps in healing wounds & broken bones",
          "Helps to form collagen in connective tissues",
          "Aids in iron absorption & helps to treat anemia",
          "Contributes in production of hemoglobin & red blood cell in bone marrow",
          "Aids in preventing many types of viral and bacterial infections and potentiates the immune system",
          "Aids in the treatment & prevention of the common cold",
          "Promotes healthy capillaries, gums & teeth"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a preparation of Ascorbic Acid (Vitamin C). Ascorbic Acid is an essential nutrient, which means it cannot be produced by the body and therefore must be obtained from diet or supplements. Ascorbic Acid has many important functions. It is required for tissue growth & repair, Adrenal gland function, enhanced immunity & healthy gums. As an antioxidant, it gives protection against harmful pollution, infection & reduces cellular damage. As a coenzyme, it is a necessary factor for wound healing, drug metabolism & metabolism of cholesterol & folic acid. As an essential nutrient, vitamin C supports healthy hair & skin, strengthens the immune system and maintain overall good health.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Potentially hazardous interactions",
        "information": ": Ascorbic acid is incompatible in solution with aminophylline, bleomycin, erythromycin, lactobionate, nafcillin, nitrofurantoin sodium, conjugated oestrogen, sodium bicarbonate, sulphafurazole diethanolamine, chloramphenicol sodium succinate, chlorthiazide sodium and hydrocortisone sodium succinate.",
        "items": []
      },
      {
        "title": "Useful interactions",
        "information": ": Ascorbic acid increases the apparent half-life of paracetamol and enhances iron absorption from the gastrointestinal tract.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Cevion has little toxicity and only mega-doses of Cevion may cause diarrhoea, abdominal bloating, iron over-absorption that is harmful in patients with thalassaemia, sideroblastic anemia, and haemochromatosis; hyperoxaluria, hyperuricosuria, and hemolysis in patients with glucose-6 phosphate dehydrogenase deficiency. A pregnant woman taking more than 5 gm/day may suffer fetal abortion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The drug is safe in normal doses in pregnant women, but a daily intake of 5 gm or more is reported to have caused abortion. The drug may be taken safely during lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ingestion of megadose (more than 1000 mg daily) of Cevion during pregnancy has resulted in scurvy in neonates. Cevion in mega-doses has been contraindicated for patients with hyperoxaluria. Cevion itself is a reactive substance in the redox system and can give rise to false positive reactions in certain analytical tests for glucose, uric acid, creatine and occult blood.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Should be stored in a dry place below 30˚C.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Vitamin-C Preparations",
    "dosage": [
      {
        "medication_type": "Oral tablet administration",
        "information": ":",
        "instructions": [
          "For the prevention of scurvy: 1 tablet daily",
          "For the treatment of scurvy: 1-2 tablets daily; but dose may be increased depending on the severity of the condition.",
          "For the reduction of risk of stroke in the elderly: 1-2 tablets daily.",
          "In other cases: 1 tablet daily or as directed by the physician.",
          "Maximum safe dose is 2000 mg daily in divided doses."
        ]
      },
      {
        "medication_type": "Oral sachet administration",
        "information": ": 1 sachet daily or as directed by registered physician. Maximum Dose: 2000 mg/day (4 sachets/day).",
        "instructions": []
      },
      {
        "medication_type": "Parenteral administration",
        "information": ":",
        "instructions": [
          "Vitamin C is usually administered orally. When oral administration is not feasible or when malabsorption is suspected, the drug may be administered IM, IV, or subcutaneously. When given parenterally, utilization of the vitamin reportedly is best after IM administration and that is the preferred parenteral route.",
          "For intravenous injection, dilution into a large volume parenteral such as Normal Saline, Water for Injection, or Glucose is recommended to minimize the adverse reactions associated with intravenous injection.",
          "The average protective dose of vitamin C for adults is 70 to 150 mg daily. In the presence of scurvy, doses of 300 mg to 1 g daily are recommended. However, as much as 6 g has been administered parenterally to normal adults without evidence of toxicity.",
          "To enhance wound healing, doses of 300 to 500 mg daily for a week or ten days both preoperatively and postoperatively are generally considered adequate, although considerably larger amounts have been recommended. In the treatment of burns, doses are governed by the extent of tissue injury. For severe burns, daily doses of 1 to 2 g are recommended. In other conditions in which the need for vitamin C is increased, three to five times the daily optimum allowances appear to be adequate.",
          "Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:26.631Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c0e",
    "original_record": {
      "input_index": 4404,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c0e"
        },
        "name": "Cevion",
        "strength": "1000 mg",
        "generic": "Vitamin C [Ascorbic acid]",
        "company": "Healthcare Pharmaceuticals Ltd.",
        "medicine_type": "Effervescent Tablet",
        "source_url": "https://medex.com.bd/brands/13917/cevion-1000-mg-tablet",
        "_page": 145,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/36458/cfb-100-mg-tablet",
    "name": "CFB",
    "dosage_form": "Tablet",
    "generic": "Ciprofibrate",
    "strength": "100 mg",
    "company": "Delta Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(3 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(3 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1884/ciprofibrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following:",
        "items": [
          "Treatment of severe hypertriglyceridemia with or without low HDL cholesterol.",
          "Mixed hyperlipidemia when a statin is contraindicated or not tolerated."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ciprofbrate reduces both LDL & VLDL and hence the levels of triglyceride and cholesterol associated with these lipoprotein fractions. It also increases levels of HDL cholesterol. Ciprofbrate is effective in the treatment of hyperlipidemia associated with high plasma concentrations of LDL and VLDL. There is evidence that treatment with fibrates may reduce coronary heart disease events.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Other fibrates & HMG CoA reductase inhibitors",
        "information": ": As Risk of myopathy, rhabdomyolysis and myoglobinuria may be increased if Ciprofbrate is used in combination with other fibrates and HMG CoA reductase inhibitors.",
        "items": []
      },
      {
        "title": "Oral anticoagulant therapy",
        "information": ": Caution should be exercised when Ciprofbrate is taken with oral anticoagulants. Concomitant oral anticoagulant therapy should be given at a reduced dosage and adjusted according to INR.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to the active substance or to any of the excipients",
          "Severe hepatic impairment",
          "Severe renal impairment (creatinine clearance <30 ml/min/1.73 m2)",
          "Pregnancy and lactation or when pregnancy is suspected",
          "Concurrent use with another fibrate"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Headache, Dizziness, Somnolence, Vertigo, Nausea, Vomiting, Diarrhoea, Dyspepsia, Abdominal pain, Rash, Alopecia, Myalgia, Fatigue.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is no evidence that Ciprofbrate is teratogenic but signs of toxicity at high doses were observed in teratogenicity tests in animals. As there are no data on its use in human pregnancy, Ciprofbrate is contraindicated during pregnancy. As there are no data on its use in lactation, Ciprofbrate is contraindicated in nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Special warnings",
        "information": ": Patients with rare hereditary problems of galactose intolerance, lactose deficiency or glucose-galactose malabsorption should not take this medicine.",
        "items": []
      },
      {
        "title": "Myalgia/myopathy",
        "information": ": Patients should be advised to report unexplained muscle pain, tenderness or weakness immediately.",
        "items": []
      },
      {
        "title": "Patients with impaired hepatic function",
        "information": ": Periodic hepatic function tests are recommended (every 3 months for the first 12 months of treatment). Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Protect from light and moisture. Keep the medicine out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-hypertensive, Other Anti-anginal & Anti-ischaemic drugs",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": The recommended dose is Ciprofbrate 100 mg per day. This dose should not be exceeded.",
        "instructions": []
      },
      {
        "medication_type": "Patients with renal insufficiency",
        "information": ": In moderate renal impairment (creatinine clearance 30-80 ml/min/1.73 m 2 ) it is recommended that dosage be reduced to one tablet every other day. Patients should be carefully monitored. Ciprofbrate should not be used in severe renal impairment (creatinine clearance <30 ml/min/1.73 m 2 ).",
        "instructions": []
      },
      {
        "medication_type": "Patients with hepatic insufficiency",
        "information": ": Use with caution in patients with impaired hepatic function. Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": As for adults but precautions should be taken for Age more than 70 years.",
        "instructions": []
      },
      {
        "medication_type": "Paediatric population",
        "information": ": Not recommended since safety and efficacy in children has not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:27.854Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c13",
    "original_record": {
      "input_index": 4405,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c13"
        },
        "name": "CFB",
        "strength": "100 mg",
        "generic": "Ciprofibrate",
        "company": "Delta Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/36458/cfb-100-mg-tablet",
        "_page": 145,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/18582/cfresh-liquigel-1-eye-drop",
    "name": "Cfresh Liquigel",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Carboxymethylcellulose Sodium",
    "strength": "1%",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 275.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "10 ml drop",
          "price": "৳ 275.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/205/carboxymethylcellulose-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cfresh Liquigel ophthalmic solution is used as a lubricant to relieve irritation and discomfort due to dryness of the eye or due to exposure to wind or sun.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Carboxymethylcellulose Sodium is an ocular lubricant, contributing to an alleviation of subjected symptoms seen in moderate to severe dry eye syndromes (DES) and long lasting protection against dryness and irritation of the affected eyes. This is a lubricating formulation similar to normal tears. The pharmacological effect of the active substance, Carboxymethylcellulose Sodium is not receptor-mediated, but is due to its property as viscosity enhancer resulting in increasing the retention time of this eye drop.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "If several medicines are to be administered to the eye, there should be an interval of at least 5 minutes between each application.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This eye drop is contraindicated in patients with known hypersensitivity to any ingredient of the product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Burning, Eye Irritation or Pruritus, Visual disturbance, Ocular discharge were reported with this eye drop.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Safe use during pregnancy and lactation has not been established. If pregnant or breast-feeding, ask your doctor before use.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Concomitant ocular medication should be administered 15 minutes prior to the instillation of this eye drop. Remove contact lenses before using Cfresh Liquigel. Do not use if this solution changes color & becomes cloudy. Don't touch tip of container to any surface to avoid contamination and replace cap after each use.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at temperature not exceeding 30°C in a dry place. Protect from light. The bottle is to be closed strongly immediately after use. Keep away from the reach of children. Generally all products are to be used within 30 days after the first opening. Only the preservative free liquigel of popular pharma (Aquafresh PF Liquigel) can be used up to 60 days after opening.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Instructions for Drop Instillation-",
        "items": []
      },
      {
        "title": "Step-1",
        "information": ": Hold the bottle directly below the cap and turn the cap to open the bottle.",
        "items": []
      },
      {
        "title": "Step-2",
        "information": ": Tilt your head backwards and hold the bottle above your eye. Pull the lower eyelid down and look up the blue tip. Squeeze the bottle gently in the middle and let a drop fall into your eye. Do not squeeze too hard.",
        "items": []
      },
      {
        "title": "Step-3",
        "information": ": Close your eye and press the inner corner of the eye with your finger for about two minutes. This helps to stop the medicine from getting into the rest of the body.",
        "items": []
      },
      {
        "title": "Step-4",
        "information": ": After each use you may shake the bottle once in a downwards direction or recap.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": "Adult use",
        "information": ": Instill 1 drop in the affected eye(s) 4 times a day or as needed.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric use",
        "information": ": This eye drop should not be used in infants and small children under 3 years.",
        "instructions": []
      },
      {
        "medication_type": "Geriatric use",
        "information": ": No overall differences in safety or effectiveness have been observed between elderly and other adult patients.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:28.884Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c16",
    "original_record": {
      "input_index": 4406,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c16"
        },
        "name": "Cfresh Liquigel",
        "strength": "1%",
        "generic": "Carboxymethylcellulose Sodium",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/18582/cfresh-liquigel-1-eye-drop",
        "_page": 145,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/4525/chear-50-mg-tablet",
    "name": "Chear",
    "dosage_form": "Tablet",
    "generic": "Sertraline Hydrochloride",
    "strength": "50 mg",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": "৳ 70.00",
      "pack_size_info": "(5 x 10: ৳ 350.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(5 x 10: ৳ 350.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/4524/chear-25-mg-tablet?ref=1"
      },
      {
        "text": "100 mg (Tablet)",
        "href": "https://medex.com.bd/brands/4526/chear-100-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/981/sertraline-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Chear tablet is indicated for the treatment of-",
        "items": [
          "Major depressive disorder (MDD)",
          "Obsessive-compulsive disorder (OCD)",
          "Panic disorder (PD)",
          "Post-traumatic stress disorder (PTSD)",
          "Social anxiety disorder (SAD)",
          "Premenstrual dysphoric disorder (PMDD)."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Sertraline has potent and selective inhibitory action on CNS neuronal reuptake of 5-HT resulting in increased 5-HT concentrations at the synaptic clefts, leading to facilitation of its sustained activity at the postsynaptic receptor sites. It ultimately results in an improvement of depression. Reduction of Serotonin turnover in brain by Sertraline is also another contributing fact implicated in its action. Its prolonged elimination half-life offers a benefit of once daily administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Potential effects of co-administration of drugs that are highly bound to plasma proteins- As Chear is tightly bound to plasma protein, the administration of Chear to a patient taking another drug which is tightly bound to protein, (e.g. warfarin, digitoxin) may cause a shift in plasma concentrations potentially resulting in an adverse effect. Conversely adverse effects may result from displacement of protein bound Chear by other tightly bound drugs. Chear may interact with other drugs such as Cimetidine, CNS active drugs like Diazepam, Hypoglycemic drugs, Atenolol etc.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Sertraline is contraindicated in patients with a known hypersensitivity to Sertraline or any of the excipients of drug. In patients with moderate to severe hepatic impairment is not recommended.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Chear may cause side effects like upset stomach, diarrhoea, constipation, vomiting, dry mouth, loss of appetite, weight changes, drowsiness, dizziness, headache, pain, burning or tingling in the hands or feet, excitement, sore throat etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies did not provide any evidence of teratogenicity, the safety of Sertraline during human pregnancy has not been established. Sertraline is known to be excreted in breast milk. Its effects on the nursing infant have not yet been established. If treatment with Sertraline is considered necessary, discontinuation of breast-feeding should be considered.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Precaution should be taken in case of liver problems, kidney diseases, seizures, heart problems and any allergies. Chear may cause dizziness or drowsiness. Caution should be taken in activities requiring alertness such as driving or using machinery. Caution is advised while using Chear in the elderly because they may be more sensitive to the effects of the drug. Do not take Chear if you have taken monoamine oxidase inhibitor in the last five weeks. Risk of suicidal thinking and change of behavior may occur (close monitoring of the patient after 2 to 3 weeks of use is required).",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Do not store above 30°C. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "SSRIs & related anti-depressant drugs",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": "- Major depressive disorder: Obsessive-compulsive disorder: Panic disorder, Post-traumatic stress disorder, Social anxiety disorder:",
        "instructions": [
          "Starting Dose: 50 mg",
          "Therapeutic Range: 50-200 mg",
          "Starting Dose: 50 mg",
          "Therapeutic Range: 50-200 mg",
          "Starting Dose: 25 mg",
          "Therapeutic Range: 50-200 mg"
        ]
      },
      {
        "medication_type": "Pediatric Patients (ages 6-12 years old)",
        "information": "- Obsessive-compulsive disorder: The recommended interval between dose changes is one week.",
        "instructions": [
          "Starting Dose: 25 mg",
          "Therapeutic Range: 50-200 mg"
        ]
      },
      {
        "medication_type": "Premenstrual dysphoric disorder (PMDD)",
        "information": ": Starting dosage for PMDD is 50 mg/day. Sertraline may be administered either continuously (every day throughout the menstrual cycle) or intermittently (starting the daily dosage 14 days prior to the anticipated onset of menstruation and continuing through the onset of menses). Intermittent dosing would be repeated with each new cycle.",
        "instructions": []
      },
      {
        "medication_type": "Continuous",
        "information": ": Patients not responding to a 50 mg dosage may benefit from dosage increases at 50 mg increments per menstrual cycle up to 150 mg per day.",
        "instructions": []
      },
      {
        "medication_type": "Intermittent",
        "information": ": Patients not responding to a 50 mg dosage may benefit from increasing the dosage up to a maximum of 100 mg per day during the next menstrual cycle (and subsequent cycles).",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:29.959Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c1f",
    "original_record": {
      "input_index": 4407,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c1f"
        },
        "name": "Chear",
        "strength": "50 mg",
        "generic": "Sertraline Hydrochloride",
        "company": "ACI Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/4525/chear-50-mg-tablet",
        "_page": 145,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/21687/chemocain-2-injection",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c24",
    "error": "Cannot read properties of null (reading 'length')",
    "fetched_at": "2025-09-20T02:05:31.042Z",
    "original_record": {
      "_id": {
        "$oid": "68c3c0d7ef5b8f2b163a9c24"
      },
      "name": "Chemocain",
      "strength": "2%",
      "generic": "Lidocaine Hydrochloride (Injection)",
      "company": "Chemist Laboratories  Ltd.",
      "medicine_type": "Injection",
      "source_url": "https://medex.com.bd/brands/21687/chemocain-2-injection",
      "_page": 145,
      "image_uri": null,
      "createdAt": {
        "$date": "2025-09-12T06:45:33.175Z"
      },
      "updatedAt": {
        "$date": "2025-09-12T06:45:33.175Z"
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/13919/chewce-250-mg-chewable-tablet",
    "name": "Chewce",
    "dosage_form": "Chewable Tablet",
    "generic": "Vitamin C [Ascorbic acid]",
    "strength": "250 mg",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 1.90",
      "strip_price": "৳ 19.00",
      "pack_size_info": "(20 x 10: ৳ 380.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.90",
          "pack_size_info": "(20 x 10: ৳ 380.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 19.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1137/vitamin-c-ascorbic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ascorbic Acid (Chewce) is indicated in- Ascorbic Acid (Chewce) is indicated in-",
        "items": [
          "Prevents & treats scurvy",
          "Helps in healing wounds & broken bones",
          "Helps to form collagen in connective tissues",
          "Aids in iron absorption & helps to treat anemia",
          "Contributes in production of hemoglobin & red blood cell in bone marrow",
          "Prevents & treats scurvy",
          "Helps in healing wounds & broken bones",
          "Helps to form collagen in connective tissues",
          "Aids in iron absorption & helps to treat anemia",
          "Contributes in production of hemoglobin & red blood cell in bone marrow",
          "Aids in preventing many types of viral and bacterial infections and potentiates the immune system",
          "Aids in the treatment & prevention of the common cold",
          "Promotes healthy capillaries, gums & teeth"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a preparation of Ascorbic Acid (Vitamin C). Ascorbic Acid is an essential nutrient, which means it cannot be produced by the body and therefore must be obtained from diet or supplements. Ascorbic Acid has many important functions. It is required for tissue growth & repair, Adrenal gland function, enhanced immunity & healthy gums. As an antioxidant, it gives protection against harmful pollution, infection & reduces cellular damage. As a coenzyme, it is a necessary factor for wound healing, drug metabolism & metabolism of cholesterol & folic acid. As an essential nutrient, vitamin C supports healthy hair & skin, strengthens the immune system and maintain overall good health.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Potentially hazardous interactions",
        "information": ": Ascorbic acid is incompatible in solution with aminophylline, bleomycin, erythromycin, lactobionate, nafcillin, nitrofurantoin sodium, conjugated oestrogen, sodium bicarbonate, sulphafurazole diethanolamine, chloramphenicol sodium succinate, chlorthiazide sodium and hydrocortisone sodium succinate.",
        "items": []
      },
      {
        "title": "Useful interactions",
        "information": ": Ascorbic acid increases the apparent half-life of paracetamol and enhances iron absorption from the gastrointestinal tract.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Chewce has little toxicity and only mega-doses of Chewce may cause diarrhoea, abdominal bloating, iron over-absorption that is harmful in patients with thalassaemia, sideroblastic anemia, and haemochromatosis; hyperoxaluria, hyperuricosuria, and hemolysis in patients with glucose-6 phosphate dehydrogenase deficiency. A pregnant woman taking more than 5 gm/day may suffer fetal abortion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The drug is safe in normal doses in pregnant women, but a daily intake of 5 gm or more is reported to have caused abortion. The drug may be taken safely during lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ingestion of megadose (more than 1000 mg daily) of Chewce during pregnancy has resulted in scurvy in neonates. Chewce in mega-doses has been contraindicated for patients with hyperoxaluria. Chewce itself is a reactive substance in the redox system and can give rise to false positive reactions in certain analytical tests for glucose, uric acid, creatine and occult blood.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Should be stored in a dry place below 30˚C.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Vitamin-C Preparations",
    "dosage": [
      {
        "medication_type": "Oral tablet administration",
        "information": ":",
        "instructions": [
          "For the prevention of scurvy: 1 tablet daily",
          "For the treatment of scurvy: 1-2 tablets daily; but dose may be increased depending on the severity of the condition.",
          "For the reduction of risk of stroke in the elderly: 1-2 tablets daily.",
          "In other cases: 1 tablet daily or as directed by the physician.",
          "Maximum safe dose is 2000 mg daily in divided doses."
        ]
      },
      {
        "medication_type": "Oral sachet administration",
        "information": ": 1 sachet daily or as directed by registered physician. Maximum Dose: 2000 mg/day (4 sachets/day).",
        "instructions": []
      },
      {
        "medication_type": "Parenteral administration",
        "information": ":",
        "instructions": [
          "Vitamin C is usually administered orally. When oral administration is not feasible or when malabsorption is suspected, the drug may be administered IM, IV, or subcutaneously. When given parenterally, utilization of the vitamin reportedly is best after IM administration and that is the preferred parenteral route.",
          "For intravenous injection, dilution into a large volume parenteral such as Normal Saline, Water for Injection, or Glucose is recommended to minimize the adverse reactions associated with intravenous injection.",
          "The average protective dose of vitamin C for adults is 70 to 150 mg daily. In the presence of scurvy, doses of 300 mg to 1 g daily are recommended. However, as much as 6 g has been administered parenterally to normal adults without evidence of toxicity.",
          "To enhance wound healing, doses of 300 to 500 mg daily for a week or ten days both preoperatively and postoperatively are generally considered adequate, although considerably larger amounts have been recommended. In the treatment of burns, doses are governed by the extent of tissue injury. For severe burns, daily doses of 1 to 2 g are recommended. In other conditions in which the need for vitamin C is increased, three to five times the daily optimum allowances appear to be adequate.",
          "Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:32.121Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c28",
    "original_record": {
      "input_index": 4409,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c28"
        },
        "name": "Chewce",
        "strength": "250 mg",
        "generic": "Vitamin C [Ascorbic acid]",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/13919/chewce-250-mg-chewable-tablet",
        "_page": 145,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/302/chir-ds-400-mg-chewable-tablet",
    "name": "Chir DS",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Reliance Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 5.14",
      "strip_price": null,
      "pack_size_info": "(10's pack: ৳ 51.40)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.14",
          "pack_size_info": "(10's pack: ৳ 51.40)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Chir DS is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Chir DS, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Chir DS should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Chir DS is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Chir DS exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Chir DS is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:33.199Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c29",
    "original_record": {
      "input_index": 4410,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c29"
        },
        "name": "Chir DS",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Reliance Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/302/chir-ds-400-mg-chewable-tablet",
        "_page": 145,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19185/chlorovis-05-eye-drop",
    "name": "Chlorovis",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Chloramphenicol",
    "strength": "0.5%",
    "company": "Biopharma Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 34.40",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "10 ml drop",
          "price": "৳ 34.40",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/237/chloramphenicol-ophthalmic/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Chlorovis is indicated for the treatment of ocular infections involving the conjunctiva and/or cornea caused by Chlorovis-susceptible organisms. Such as Staphylococcus aureus, Streptococcus pneumoniae, E.coli, H. influenzae, Klebsiella/Enterobacter spp, Moraxella lacunata, and Neisseria species.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Chloramphenicol is a broad-spectrum bacteriostatic antibiotic which acts through the inhibition of bacterial protein synthesis by interfering with the transfer of activated amino acids from soluble RNA to ribosomes.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Chymotrypsin may be inhibited if given simultaneously with Chlorovis.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in individuals with a history of hypersensitivity to Chloramphenicol or any ingredients of the preparation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The systemic adverse reaction has not been observed within short-term topical use of Chlorovis. The most frequently reported adverse reactions have been burning, stinging, conjunctival hyperemia, blood dyscrasia, allergic or inflammatory reactions, vesicular and maculopapular dermatitis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Safety for use in pregnancy and lactation has not been established. Therefore, use only when considered essential by the physicians.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Chlorovis ophthalmic solution should never be given for minor infections or for prophylaxis. Repeated course and prolonged treatment should be avoided. Blood dyscrasias (granulocytopenia, thrombocytopenia and moderate anaemia) may occur after prolonged ophthalmic use.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental ingestion of the medicine is unlikely to cause any toxicity due to low content of antibiotic.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (between 2°C-8°C) and dry place, protect from light, keep out of reach of children. Do not touch the dropper tip to the surface since this may contaminate the solution. Do not use after 30 days of the first opening.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ear Anti-Infectives & Antiseptics, Eye Anti-Infectives & Antiseptics, Macrolides",
    "dosage": [
      {
        "medication_type": "Adult and Children",
        "information": ": Instill 1 or 2 drops in the conjunctival sac 4-6 times per day for the first 72 hours and then every 4 hours thereafter. Treatment should be continued for approximately 7 days, but should not be continued for more than 3 weeks without re-evaluation by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:34.375Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c30",
    "original_record": {
      "input_index": 4411,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c30"
        },
        "name": "Chlorovis",
        "strength": "0.5%",
        "generic": "Chloramphenicol (Ophthalmic)",
        "company": "Biopharma Limited",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/19185/chlorovis-05-eye-drop",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31059/cholcut-20-mg-tablet",
    "name": "Cholcut",
    "dosage_form": "Tablet",
    "generic": "Rosuvastatin Calcium",
    "strength": "20 mg",
    "company": "Ziska Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": "৳ 300.00",
      "pack_size_info": "(2 x 10: ৳ 600.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 30.00",
          "pack_size_info": "(2 x 10: ৳ 600.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 300.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/24368/cholcut-10-mg-tablet?ref=1"
      },
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/24369/cholcut-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/970/rosuvastatin-calcium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cholcut tablet is indicated for: Cholcut tablet is indicated for:",
        "items": [
          "Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.",
          "Patients with hypertriglyceredemia as an adjunct to diet.",
          "Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.",
          "Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.",
          "Patients with hypertriglyceredemia as an adjunct to diet.",
          "Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.",
          "Patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.",
          "Slowing the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C as an adjunct to diet.",
          "Pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total-C, LDL-C and ApoB after failing an adequate trial of diet therapy.",
          "Risk reduction of Myocardial Infarction (MI), stroke and arterial revascularization procedures in patients without clinically evident CHD, but with multiple risk factors."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methyl glutaryl coenzyme A to mevalonate, a precursor of cholesterol. Rosuvastatin produces its lipid-modifying effects in two ways. First, it increases the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL. Second, Rosuvastatin inhibits hepatic synthesis of VLDL, which reduces the total number of VLDL and LDL particles.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Remarkable drug interactions of Cholcut are-",
        "items": [
          "Cyclosporine: Combination increases Cholcut exposure. Cholcut dose should be limited to 5 mg once daily.",
          "Gemfibrosil: Combination should be avoided. If used together, Cholcut dose should be limited to 10 mg once daily.",
          "Lopinavir/Ritonavir or atazanavir/ritonavir: Combination increases Cholcut exposure. Cholcut dose should be to 10 mg once daily.",
          "Coumarin anticoagulants: Combination prolongs international normalized ratio (INR). Stable INR should be achieved prior to starting Cholcut. INR should be monitored frequently until stable upon initiation or alteration of Cholcut therapy.",
          "Concomitant lipid-lowering therapies: Use with fibrates and niacin products may increase the risk of skeletal muscle effects."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Rosuvastatin is contraindicated if-",
        "items": [
          "Known hypersensitivity to product components",
          "Liver disease, which may include unexplained persistent elevations in hepatic transaminase levels",
          "Pregnant women and women who may become pregnant",
          "Nursing mothers"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cholcut is generally well tolerated. The most frequent adverse events thought to be related to Cholcut were headache, myalgia, constipation, asthenia, abdominal pain and nausea.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Rosuvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards. If the patient becomes pregnant while taking this drug, therapy should be discontinued immediately. It is not known whether Rosuvastatin is excreted in human milk, but a small amount of another drug in this class does pass into breast milk.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cholcut should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age >65 years, inadequately treated hypothyroidism, renal impairment). The risk of myopathy during treatment with Cholcut may be increased with concurrent administration of some other lipid-lowering therapies (Fibrates or Niacin), Gemfibrozil, Cyclosporine, Lopinavir/Ritonavir, or Atazanavir/Ritonavir. Cholcut therapy should be discontinued if markedly elevated creatinine kinase levels occur or myopathy is diagnosed or suspected. Cholcut therapy should also be temporarily withheld in any patient with an acute, serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., sepsis, hypotension, dehydration, major surgery, trauma, severe metabolic, endocrine, and electrolyte disorders, or uncontrolled seizures). It is recommended that liver enzyme tests be performed before and at 12 weeks following both the initiation of therapy and any elevation of dose, and periodically (e.g., semiannually) thereafter.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no specific treatment in the event of overdose. In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. Hemodialysis does not significantly enhance clearance of Cholcut.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30 o C temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C22H28FN3O6S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-970-rosuvastatin-calcium-chemical-structure-UjXgzBvpDHiLnIP3gZua.svg"
    },
    "therapeutic_class": "Other Anti-anginal & Anti-ischaemic drugs, Statins",
    "dosage": [
      {
        "medication_type": "Heterozygous Familial Hypercholesterolemia in Pediatric Patients (10 to 17 years of age)",
        "information": ": The usual dose range of Rosuvastatin is 5-20 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made at intervals of 4 weeks or more.",
        "instructions": []
      },
      {
        "medication_type": "Very High Cholesterol and High Risk of Ml or Stroke",
        "information": ": 40 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Homozygous Familial Hypercholesterolemia",
        "information": ": The recommended starting dose of Rosuvastatin is 20 mg once daily. Response to therapy should be estimated from preapheresis LDL-C levels.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Asian Patients",
        "information": ": Initiation of Rosuvastatin therapy with 5 mg once daily should be considered for Asian patients",
        "instructions": []
      },
      {
        "medication_type": "Use with Cyclosporine, Lopinavir/Ritonavir or Atazanavir/Ritonavir",
        "information": ": In patients taking Cyclosporine, the dose of Rosuvastatin should be limited to 5 mg once daily. In patients taking a combination of Lopinavir and Ritonavir or Atazanavir and Ritonavir, the dose of Rosuvastatin should be limited to 10 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Concomitant Lipid-Lowering Therapy",
        "information": ": The risk of skeletal muscle effects may be enhanced when Rosuvastatin is used in combination with Niacin or Fenofibrate; a reduction in Rosuvastatin dosage should be considered in this setting. Combination therapy with Gemfibrozil should be avoided because of an increase in Rosuvastatin exposure with concomitant use; if Rosuvastatin is used in combination with Gemfibrozil, the dose of Rosuvastatin should be limited to 10 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Patients with Severe Renal Impairment",
        "information": ": For patients with severe renal impairment (ClCr<30 mL/min/1.73 m²) not on hemodialysis, dosing of Rosuvastatin should be started at 5 mg once daily and not exceed 10 mg once daily.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cholcut 20 mg Tablet?",
        "answer": [
          "Cholcut 20 mg Tablet is a HMG-CoA reductase inhibitor drug which is helpful in lowering the cholesterol level and triglycerides in the body."
        ]
      },
      {
        "question": "What are the uses of Cholcut 20 mg Tablet?",
        "answer": [
          "Cholcut 20 mg Tablet is useful against the conditions like Hyperlipidemia, Hypertriglyceridemia, Type 3 Hyperlipoproteinemia and Stroke."
        ]
      },
      {
        "question": "What are the side effects of Cholcut 20 mg Tablet?",
        "answer": [
          "Side effects of Cholcut 20 mg Tablet include Muscle pain, Weakness, Headache and Abdominal pain."
        ]
      },
      {
        "question": "For how long should I take Cholcut 20 mg Tablet?",
        "answer": [
          "Cholcut 20 mg Tablet should be taken till you see improvement in your medical condition. Follow your doctor’s instructions to know the duration for Cholcut 20 mg Tablet."
        ]
      },
      {
        "question": "Does Cholcut 20 mg Tablet cause weight gain?",
        "answer": [
          "Weight gain is a very rare side effect of Cholcut 20 mg Tablet. This medication does not lead to weight gain and in case you are observing this symptom, please consult a doctor for diagnosis."
        ]
      },
      {
        "question": "Does Cholcut 20 mg Tablet make you tired?",
        "answer": [
          "Tiredness and fatigue is a common side effect of Cholcut 20 mg Tablet however, the exact reason behind it is still not known. Consult a doctor if it persists for a longer duration of time."
        ]
      },
      {
        "question": "Should Cholcut 20 mg Tablet be taken at night?",
        "answer": [
          "Cholcut 20 mg Tablet is not mandatory to take Cholcut 20 mg Tablet at night. You can take it in the morning too, however, it should be consumed once a day only. Ideally, you must follow your doctor’s instructions regarding the dosage."
        ]
      },
      {
        "question": "What foods should be avoided when taking Cholcut 20 mg Tablet?",
        "answer": [
          "Avoid eating junk food and foods that are high in calories as they can increase the cholesterol levels. You must eat only a low-cholesterol diet during the course of Cholcut 20 mg Tablet treatment."
        ]
      },
      {
        "question": "How do I know whether Cholcut 20 mg Tablet is beneficial for me or not?",
        "answer": [
          "If you start noticing improvement in your condition, then Cholcut 20 mg Tablet is beneficial for you. In case, you do not see any positive effects of Cholcut 20 mg Tablet or experience adverse side effects after consuming this medicine, then consult a doctor to know a safer substitute of Cholcut 20 mg Tablet."
        ]
      },
      {
        "question": "Can Cholcut 20 mg Tablet cause memory loss?",
        "answer": [
          "Memory loss is a very unusual side effect that can occur. If this symptom occurs, stop taking this medicine and consult a doctor immediately."
        ]
      },
      {
        "question": "Is it true that Cholcut 20 mg Tablet can cause diabetes?",
        "answer": [
          "This medicine does not cause diabetes, however, if you already are at higher risk of having this disorder, then this medicine can enhance the risk factor by increasing the blood sugar levels. In such a case, regular monitoring of blood sugar level is mandatory."
        ]
      },
      {
        "question": "Can I take alcohol with Cholcut 20 mg Tablet?",
        "answer": [
          "Do not take alcohol during the course of treatment with this medicine as it can increase the risk of having liver problems. Also, alcohol can increase the levels of triglyceride levels in the body."
        ]
      },
      {
        "question": "Can Cholcut 20 mg Tablet cause muscle problems or muscle injury?",
        "answer": [
          "Muscle pain or any other problem associated with muscles is the most common side effect of this medicine. Consult your doctor if this side effect is causing discomfort in doing day to day activities."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Cholcut 20 mg Tablet treats high cholesterol by lowering \"bad\" cholesterol (LDL) and triglycerides (fats). It should be taken in addition to regular exercise and low-fat diet.",
          "In general, Cholcut 20 mg Tablet is safe. It may cause diarrhea, gas or an upset stomach. If any of these happen to you, take it with food.",
          "Inform your doctor if you experience fatigue, muscle weakness or muscle pain.",
          "Your doctor may check your liver function before starting the treatment and regularly thereafter. Inform your doctor if you notice signs of liver problems such as stomach pains, unusually dark urine or yellowing of skin or eyes.",
          "Inform your doctor if you have kidney disease, liver disease or diabetes before starting treatment with this medicine. If you are diabetic, monitor your blood sugar level regularly as Cholcut 20 mg Tablet may cause an increase in your blood sugar level.",
          "Do not take Cholcut 20 mg Tablet if you are pregnant, planning a pregnancy or breastfeeding."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:05:35.578Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c36",
    "original_record": {
      "input_index": 4412,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c36"
        },
        "name": "Cholcut",
        "strength": "20 mg",
        "generic": "Rosuvastatin Calcium",
        "company": "Ziska Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/31059/cholcut-20-mg-tablet",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/24368/cholcut-10-mg-tablet",
    "name": "Cholcut",
    "dosage_form": "Tablet",
    "generic": "Rosuvastatin Calcium",
    "strength": "10 mg",
    "company": "Ziska Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": "৳ 200.00",
      "pack_size_info": "(3 x 10: ৳ 600.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 20.00",
          "pack_size_info": "(3 x 10: ৳ 600.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/24369/cholcut-5-mg-tablet?ref=1"
      },
      {
        "text": "20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/31059/cholcut-20-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/970/rosuvastatin-calcium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cholcut tablet is indicated for: Cholcut tablet is indicated for:",
        "items": [
          "Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.",
          "Patients with hypertriglyceredemia as an adjunct to diet.",
          "Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.",
          "Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.",
          "Patients with hypertriglyceredemia as an adjunct to diet.",
          "Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.",
          "Patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.",
          "Slowing the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C as an adjunct to diet.",
          "Pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total-C, LDL-C and ApoB after failing an adequate trial of diet therapy.",
          "Risk reduction of Myocardial Infarction (MI), stroke and arterial revascularization procedures in patients without clinically evident CHD, but with multiple risk factors."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methyl glutaryl coenzyme A to mevalonate, a precursor of cholesterol. Rosuvastatin produces its lipid-modifying effects in two ways. First, it increases the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL. Second, Rosuvastatin inhibits hepatic synthesis of VLDL, which reduces the total number of VLDL and LDL particles.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Remarkable drug interactions of Cholcut are-",
        "items": [
          "Cyclosporine: Combination increases Cholcut exposure. Cholcut dose should be limited to 5 mg once daily.",
          "Gemfibrosil: Combination should be avoided. If used together, Cholcut dose should be limited to 10 mg once daily.",
          "Lopinavir/Ritonavir or atazanavir/ritonavir: Combination increases Cholcut exposure. Cholcut dose should be to 10 mg once daily.",
          "Coumarin anticoagulants: Combination prolongs international normalized ratio (INR). Stable INR should be achieved prior to starting Cholcut. INR should be monitored frequently until stable upon initiation or alteration of Cholcut therapy.",
          "Concomitant lipid-lowering therapies: Use with fibrates and niacin products may increase the risk of skeletal muscle effects."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Rosuvastatin is contraindicated if-",
        "items": [
          "Known hypersensitivity to product components",
          "Liver disease, which may include unexplained persistent elevations in hepatic transaminase levels",
          "Pregnant women and women who may become pregnant",
          "Nursing mothers"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cholcut is generally well tolerated. The most frequent adverse events thought to be related to Cholcut were headache, myalgia, constipation, asthenia, abdominal pain and nausea.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Rosuvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards. If the patient becomes pregnant while taking this drug, therapy should be discontinued immediately. It is not known whether Rosuvastatin is excreted in human milk, but a small amount of another drug in this class does pass into breast milk.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cholcut should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age >65 years, inadequately treated hypothyroidism, renal impairment). The risk of myopathy during treatment with Cholcut may be increased with concurrent administration of some other lipid-lowering therapies (Fibrates or Niacin), Gemfibrozil, Cyclosporine, Lopinavir/Ritonavir, or Atazanavir/Ritonavir. Cholcut therapy should be discontinued if markedly elevated creatinine kinase levels occur or myopathy is diagnosed or suspected. Cholcut therapy should also be temporarily withheld in any patient with an acute, serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., sepsis, hypotension, dehydration, major surgery, trauma, severe metabolic, endocrine, and electrolyte disorders, or uncontrolled seizures). It is recommended that liver enzyme tests be performed before and at 12 weeks following both the initiation of therapy and any elevation of dose, and periodically (e.g., semiannually) thereafter.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no specific treatment in the event of overdose. In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. Hemodialysis does not significantly enhance clearance of Cholcut.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30 o C temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C22H28FN3O6S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-970-rosuvastatin-calcium-chemical-structure-UjXgzBvpDHiLnIP3gZua.svg"
    },
    "therapeutic_class": "Other Anti-anginal & Anti-ischaemic drugs, Statins",
    "dosage": [
      {
        "medication_type": "Heterozygous Familial Hypercholesterolemia in Pediatric Patients (10 to 17 years of age)",
        "information": ": The usual dose range of Rosuvastatin is 5-20 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made at intervals of 4 weeks or more.",
        "instructions": []
      },
      {
        "medication_type": "Very High Cholesterol and High Risk of Ml or Stroke",
        "information": ": 40 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Homozygous Familial Hypercholesterolemia",
        "information": ": The recommended starting dose of Rosuvastatin is 20 mg once daily. Response to therapy should be estimated from preapheresis LDL-C levels.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Asian Patients",
        "information": ": Initiation of Rosuvastatin therapy with 5 mg once daily should be considered for Asian patients",
        "instructions": []
      },
      {
        "medication_type": "Use with Cyclosporine, Lopinavir/Ritonavir or Atazanavir/Ritonavir",
        "information": ": In patients taking Cyclosporine, the dose of Rosuvastatin should be limited to 5 mg once daily. In patients taking a combination of Lopinavir and Ritonavir or Atazanavir and Ritonavir, the dose of Rosuvastatin should be limited to 10 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Concomitant Lipid-Lowering Therapy",
        "information": ": The risk of skeletal muscle effects may be enhanced when Rosuvastatin is used in combination with Niacin or Fenofibrate; a reduction in Rosuvastatin dosage should be considered in this setting. Combination therapy with Gemfibrozil should be avoided because of an increase in Rosuvastatin exposure with concomitant use; if Rosuvastatin is used in combination with Gemfibrozil, the dose of Rosuvastatin should be limited to 10 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Patients with Severe Renal Impairment",
        "information": ": For patients with severe renal impairment (ClCr<30 mL/min/1.73 m²) not on hemodialysis, dosing of Rosuvastatin should be started at 5 mg once daily and not exceed 10 mg once daily.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cholcut 10 mg Tablet?",
        "answer": [
          "Cholcut 10 mg Tablet is a HMG-CoA reductase inhibitor drug which is helpful in lowering the cholesterol level and triglycerides in the body."
        ]
      },
      {
        "question": "What are the uses of Cholcut 10 mg Tablet?",
        "answer": [
          "Cholcut 10 mg Tablet is useful against the conditions like Hyperlipidemia, Hypertriglyceridemia, Type 3 Hyperlipoproteinemia and Stroke."
        ]
      },
      {
        "question": "What are the side effects of Cholcut 10 mg Tablet?",
        "answer": [
          "Side effects of Cholcut 10 mg Tablet include Muscle pain, Weakness, Headache and Abdominal pain."
        ]
      },
      {
        "question": "For how long should I take Cholcut 10 mg Tablet?",
        "answer": [
          "Cholcut 10 mg Tablet should be taken till you see improvement in your medical condition. Follow your doctor’s instructions to know the duration for Cholcut 10 mg Tablet."
        ]
      },
      {
        "question": "Does Cholcut 10 mg Tablet cause weight gain?",
        "answer": [
          "Weight gain is a very rare side effect of Cholcut 10 mg Tablet. This medication does not lead to weight gain and in case you are observing this symptom, please consult a doctor for diagnosis."
        ]
      },
      {
        "question": "Does Cholcut 10 mg Tablet make you tired?",
        "answer": [
          "Tiredness and fatigue is a common side effect of Cholcut 10 mg Tablet however, the exact reason behind it is still not known. Consult a doctor if it persists for a longer duration of time."
        ]
      },
      {
        "question": "Should Cholcut 10 mg Tablet be taken at night?",
        "answer": [
          "Cholcut 10 mg Tablet is not mandatory to take Cholcut 10 mg Tablet at night. You can take it in the morning too, however, it should be consumed once a day only. Ideally, you must follow your doctor’s instructions regarding the dosage."
        ]
      },
      {
        "question": "What foods should be avoided when taking Cholcut 10 mg Tablet?",
        "answer": [
          "Avoid eating junk food and foods that are high in calories as they can increase the cholesterol levels. You must eat only a low-cholesterol diet during the course of Cholcut 10 mg Tablet treatment."
        ]
      },
      {
        "question": "How do I know whether Cholcut 10 mg Tablet is beneficial for me or not?",
        "answer": [
          "If you start noticing improvement in your condition, then Cholcut 10 mg Tablet is beneficial for you. In case, you do not see any positive effects of Cholcut 10 mg Tablet or experience adverse side effects after consuming this medicine, then consult a doctor to know a safer substitute of Cholcut 10 mg Tablet."
        ]
      },
      {
        "question": "Can Cholcut 10 mg Tablet cause memory loss?",
        "answer": [
          "Memory loss is a very unusual side effect that can occur. If this symptom occurs, stop taking this medicine and consult a doctor immediately."
        ]
      },
      {
        "question": "Is it true that Cholcut 10 mg Tablet can cause diabetes?",
        "answer": [
          "This medicine does not cause diabetes, however, if you already are at higher risk of having this disorder, then this medicine can enhance the risk factor by increasing the blood sugar levels. In such a case, regular monitoring of blood sugar level is mandatory."
        ]
      },
      {
        "question": "Can I take alcohol with Cholcut 10 mg Tablet?",
        "answer": [
          "Do not take alcohol during the course of treatment with this medicine as it can increase the risk of having liver problems. Also, alcohol can increase the levels of triglyceride levels in the body."
        ]
      },
      {
        "question": "Can Cholcut 10 mg Tablet cause muscle problems or muscle injury?",
        "answer": [
          "Muscle pain or any other problem associated with muscles is the most common side effect of this medicine. Consult your doctor if this side effect is causing discomfort in doing day to day activities."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Cholcut 10 mg Tablet treats high cholesterol by lowering \"bad\" cholesterol (LDL) and triglycerides (fats). It should be taken in addition to regular exercise and low-fat diet.",
          "In general, Cholcut 10 mg Tablet is safe. It may cause diarrhea, gas or an upset stomach. If any of these happen to you, take it with food.",
          "Inform your doctor if you experience fatigue, muscle weakness or muscle pain.",
          "Your doctor may check your liver function before starting the treatment and regularly thereafter. Inform your doctor if you notice signs of liver problems such as stomach pains, unusually dark urine or yellowing of skin or eyes.",
          "Inform your doctor if you have kidney disease, liver disease or diabetes before starting treatment with this medicine. If you are diabetic, monitor your blood sugar level regularly as Cholcut 10 mg Tablet may cause an increase in your blood sugar level.",
          "Do not take Cholcut 10 mg Tablet if you are pregnant, planning a pregnancy or breastfeeding."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:05:37.283Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c38",
    "original_record": {
      "input_index": 4413,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c38"
        },
        "name": "Cholcut",
        "strength": "10 mg",
        "generic": "Rosuvastatin Calcium",
        "company": "Ziska Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/24368/cholcut-10-mg-tablet",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/14890/cholera-saline-injection",
    "name": "Cholera Saline",
    "dosage_form": "IV Infusion",
    "generic": "Cholera Saline",
    "strength": null,
    "company": "ACME Laboratories Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 70.14",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "500 ml bag",
          "price": "৳ 70.14",
          "pack_size_info": null
        },
        {
          "label": "1000 ml bag",
          "price": "৳ 91.99",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/905/cholera-saline/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cholera Saline Saline contains different electrolytes which are usually depleted in various conditions e.g. diarrhoea, vomiting, profuse sweating etc. So, this saline is indicated in cholera, also in diarrhoea, vomiting, fluid loss, to replenish and restore the normal electrolyte balance of the body.",
        "items": []
      }
    ],
    "mode_of_action": [],
    "interaction": [],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": null,
        "items": [
          "Severe burning, pain, or swelling around the IV needle;",
          "Warmth, redness, oozing, or bleeding where the IV was placed;",
          "fever, ongoing cough."
        ]
      }
    ],
    "pregnancy_cat": [],
    "precautions": [
      {
        "title": null,
        "information": "Since Cholera Saline Saline contains different electrolytes, it should be infused with caution in patients where electrolyte imbalance may cause detrimental effects, e.g. in pregnancy, renal impairment, heart failure, pulmonary congestion, head injury etc. or in patients receiving potassium sparing diuretics.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Should be stored at controlled room temperature.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Administration Procedure:",
        "items": [
          "Check infusion set and infusion solution prior to use",
          "Pull moderately to tear off the protective cover of the Eurohead",
          "Hold lightly the Eurohead but not the bag",
          "Open the flow regulator fully and hold the giving set on the top white area, but not the membrane venting region",
          "Insert the spike of the administration set to the Eurohead and fit the connector of the administration set firmly to the needle",
          "Gradually allow the fluid to flow down to the needle tip and close",
          "Remove the protective cover of the needle",
          "Locate the venipuncture site and clean the site with an antiseptic solution, and then insert the needle",
          "Securely tape the puncture site",
          "Securely tape the wings and tubing",
          "Start infusion while adjusting drip speed"
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Intravenous fluid preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "The volume and rate of infusion of Cholera Saline depends upon the requirements of the patient and the judgement of the physician. It usually varies with age, weight and clinical condition of the patient.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:38.801Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c3b",
    "original_record": {
      "input_index": 4414,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c3b"
        },
        "name": "Cholera Saline",
        "strength": null,
        "generic": "Cholera Saline",
        "company": "ACME Laboratories Ltd.",
        "medicine_type": "IV Infusion",
        "source_url": "https://medex.com.bd/brands/14890/cholera-saline-injection",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33787/cholevit-200000-iu-injectable-solution-oral-im",
    "name": "Cholevit",
    "dosage_form": "Injectable Solution (Oral & IM)",
    "generic": "Cholecalciferol [Vitamin D3]",
    "strength": "200000 IU/ml",
    "company": "Globe Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 120.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "1 ml ampoule",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/252/cholecalciferol-vitamin-d3/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Vitamin D3 deficiency can occur in people whose exposure to sunlight is limited and in those whose diet is deficient in vitamin D3.",
        "items": [
          "Cholevit is essential for the effective calcium and phosphate absorption required for healthy bones and teeth, preventing rickets, osteomalacia and osteoporosis.",
          "Cholevit is also essential to prevent pre-eclampsia during pregnancy and breast feeding as it is an essential nutrient for a growing infant.",
          "Cholevit has vital role on immunity boost up."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The active form of Vitamin D3, Calcitriol, exerts its effect by binding to the Vitamin D receptors (VDRs) which are widely distributed through many body tissues.Vitamin D3 has a half life of about 50 days as it is fat soluble.Vitamin D3 is absorbed in the small intestine and bound to specific a-globulins and transported to the liver where it is metabolised to 25-hydroxy Vitamin D3 (Calcidiol). A second hydroxylation to 1,25-dihydroxy Vitamin D3 (Calcitriol) occurs in the kidney. This metabolite is responsible for the vitamin's ability to increase the absorption of calcium. Non-metabolised Vitamin D3 is stored in tissues such as fat and muscle.Vitamin D3 is eliminated via faeces and urine.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Drug interaction with medication",
        "information": ": Concomitant treatment with phenytoin or barbiturates can decrease the effect of vitamin D because of metabolic activation. Concomitant use of glucocorticoids can decrease the effect of vitamin D. The effectsof digitalis and other cardiac glycosides may be accentuated with the oral administration of calcium combined with vitamin D. Strict medical supervision is needed and, if necessary monitoring of ECG and calcium. Simultaneous treatment with ion exchange resins such as cholestyramine or laxatives such as paraffin oil may reduce the gastrointestinal absorption of vitamin D. The cytotoxic agent actinomycin and imidazole antifungal agents interfere with vitamin D activity by inhibiting the conversion of 25-hydroxyvitamin D to 1, 25-dihydroxyvitamin D by the kidney enzyme, 25-hydroxyvitamin D-1-hydroxylase.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Vitamin D3 is contraindicated in all diseases associated with hypercalcaemia. It is also contraindicated in patients with known hypersensitivity to Vitamin D3 (or medicines of the same class) and any of the excipients. It is contraindicated if there is evidence of Vitamin D3 toxicity.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally all nutritional supplements are considered to be safe and well tolerable. However, few most common side effects can generally occur including hypocalcaemia syndrome or calcium intoxication (depending on the severity and duration of hypocalcaemia), occasional acute symptoms include anorexia, headache, nausea, vomiting, abdominal pain or stomach ache and constipation with the administration of colecalciferol.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Studies have shown safe use of doses up to 4000 IU during pregnancy. The recommended daily intake for pregnant women is 400 IU, however, in women who are considered to be Vitamin D3 deficient a higher dose may be required. During pregnancy women should follow the advice of their medical practitioner as their requirements may vary depending on the severity of their disease and their response to treatment Vitamin D3 and its metabolites are excreted in breast milk. Overdose in infants induced by nursing mothers has not been observed; however, when prescribing additional vitamin D3 to a breast-fed child the practitioner should consider the dose of any additional vitamin D3 given to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Plasma-calcium concentration should be monitored at intervals in patients receiving high doses of Vitamin D3, in renal impairment, and during pregnancy & lactation. People using Digoxin and Thiazide Diuretics should consult a health care practitioner before supplementing with Vitamin D3. People with liver or kidney disease, primary hyperthyroidism, lymphoma, tuberculosis and granulomatous disease should consult a health care practitioner before supplementing with Vitamin D3.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The most serious consequence of acute or chronic overdose is hypercalcaemia due to vitamin D toxicity. Symptoms may include nausea, vomiting, polyuria, anorexia, weakness, apathy, thirst and constipation. Chronic overdoses can lead to vascular and organ calcification as a result of hypercalcaemia. Treatment should consist of stopping all intakes of vitamin D and rehydration.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 25°C) and dry place protected from light. Keep away from the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Vitamin in bone formation, Vitamin-D preparations",
    "dosage": [
      {
        "medication_type": "For capsule",
        "information": ": Adults:",
        "instructions": [
          "Treatment of Vitamin D3 deficiency: 40000 IU once weekly for 7 weeks. Doses for maintenance therapy is 1400-2000 IU/day. To confirm the target level of 25 hydroxyvitamin D, measurement of it should be determined 3-4 months after initiating the maintenance therapy.",
          "Prevention of Vitamin D3 deficiency: 20000 IU every 4 weeks. Higher doses may be required in certain situations.",
          "Addition to specific therapy for osteoporosis: 20000 IU once a month."
        ]
      },
      {
        "medication_type": "For capsule",
        "information": ": Children (12-18 years):",
        "instructions": [
          "Treatment of Vitamin D3 deficiency: 20000 IU once every 2 weeks for 6 weeks.",
          "Prevention of Vitamin D3 deficiency: 20000 IU every 6 weeks."
        ]
      },
      {
        "medication_type": "For film-coated tablet",
        "information": ": 1000 IU (1-2 tablets) daily, or as directed by physician. Take the medicine with food or within 1 hour after a meal.",
        "instructions": []
      },
      {
        "medication_type": "For oroflash or chewable tablets",
        "information": ": 1000 IU to 2000 IU daily, or as directed by physician. Take the medicine with food or within 1 hour after a meal. Place the tablet in mouth swallow after chewing.",
        "instructions": []
      },
      {
        "medication_type": "For Oral Solution",
        "information": ":",
        "instructions": [
          "Up to one year: 400 IU once a day or as directed by the physician.",
          "1 year to 18 years: 600 IU once a day or as directed by the physician."
        ]
      },
      {
        "medication_type": "Injection",
        "information": ": For treatment-",
        "instructions": [
          "Rickets: 1 ampoule every 2 weeks for one month then 1 ampoule for every 4 months",
          "Osteoporosis: 1 ampoule every 2 weeks for 3 months",
          "Osteomalacia: 1 ampoule every 2 weeks for 3 months",
          "Tetany caused by hypocalcaemia: 1 ampoule for every 4 months which may be increased to 2 ampoules",
          "Menopause: 1 ampoule for every 6 months",
          "Vitamin 03 deficiency: 1 ampoule can be repeated 1 to 6 months later"
        ]
      },
      {
        "medication_type": "Injection",
        "information": ": For prevention- Direction of use of Injection-",
        "instructions": [
          "Pregnancy: 1/2 ampoule at 6th or 7th months",
          "During breastfeeding: 1/2 ampoule for every 6 months",
          "Children up to 5 years: 1 ampoule for every 6 months",
          "Adolescent: 1 ampoule for every 6 months",
          "Elderly Dosages: 1/2 ampoule for every 3 months."
        ]
      },
      {
        "medication_type": "For oral use",
        "information": "-",
        "instructions": [
          "Step-1: Place the thumb on ampoule and break the upper narrow part of the ampoule.",
          "Step-2: Pour out the solution of the ampoule in a spoon.",
          "Step-3: Mix the solution with water or milk before oral use."
        ]
      },
      {
        "medication_type": "For lM use",
        "information": "-",
        "instructions": [
          "Step-1: Place the thumb on ampoule and break the upper narrow part of the ampoule.",
          "Step-2: Then use as IM injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:39.843Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c3d",
    "original_record": {
      "input_index": 4415,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c3d"
        },
        "name": "Cholevit",
        "strength": "200000 IU/ml",
        "generic": "Cholecalciferol [Vitamin D3]",
        "company": "Globe Pharmaceuticals Ltd.",
        "medicine_type": "Injectable Solution (Oral & IM)",
        "source_url": "https://medex.com.bd/brands/33787/cholevit-200000-iu-injectable-solution-oral-im",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34077/choliva-10-mg-tablet",
    "name": "Choliva",
    "dosage_form": "Tablet",
    "generic": "Obeticholic Acid",
    "strength": "10 mg",
    "company": "UniMed UniHealth Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 55.00",
      "strip_price": "৳ 550.00",
      "pack_size_info": "(1 x 10: ৳ 550.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 55.00",
          "pack_size_info": "(1 x 10: ৳ 550.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 550.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/34076/choliva-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1458/obeticholic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Choliva tablet is indicated for the treatment of adult patients with primary biliary cholangitis (PBC) Either in combination with ursodeoxycholic acid (UDCA) with an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA.",
        "items": [
          "without cirrhosis or",
          "with compensated cirrhosis who do not have evidence of portal hypertension"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": "Mechanism of Action",
        "information": ": Obeticholic acid is an agonist for Farnesoid X Receptor (FXR), a nuclear receptor expressed in the liver and intestine. FXR is a key regulator of bile acid, inflammatory, fibrotic and metabolic pathways. FXR activation decreases the intracellular hepatocyte concentrations of bile acids by suppressing de novo synthesis from cholesterol as well as by increased transport of bile acids out of the hepatocytes. These mechanisms limit the overall size of the circulating bile acid pool while promoting choleresis, thus reducing hepatic exposure to bile acids.",
        "items": []
      },
      {
        "title": "Pharmacodynamics",
        "information": ": Pharmacodynamic Markers: In the trial, administration of Obeticholic acid 10 mg once daily was associated with a 173% increase in concentrations of FGF-19 an FXR-inducible enterokine involved in bile acid homeostasis from baseline to Month 12. Concentrations of cholic acid and chenodeoxycholic acid were reduced 2.7 micromolar and 1.4 micromolar respectively from baseline to Month 12. The clinical relevance of these findings is unknown.",
        "items": []
      },
      {
        "title": "Cardiac Electrophysiology",
        "information": ": At a dose of 10 times the maximum recommended dose Obeticholic acid does not prolong the QT interval to any clinically relevant extent.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Bile Acid Binding Resins",
        "information": ": Bile acid binding resins such as cholestyramine, colestipol or colesevelam adsorb and reduce bile acid absorption and may reduce the absorption, systemic exposure and efficacy of Choliva. If taking a bile acid binding resin, take Choliva at least 4 hours before or 4 hours after taking the bile acid binding resin or at as great an interval as possible.",
        "items": []
      },
      {
        "title": "Warfarin",
        "information": ": The International Normalized Ratio (INR) decreased following the coadministration of warfarin and Choliva. Monitor INR and adjust the dosage of warfarin as needed to maintain the target INR range when co-administering Choliva and warfarin.",
        "items": []
      },
      {
        "title": "CYP1A2 Substrates with Narrow Therapeutic Index",
        "information": ": Choliva may increase the exposure to concomitant drugs that are CYP1A2 substrates. Therapeutic monitoring of CYP1A2 substrates with a narrow therapeutic index (e.g., theophylline and tizanidine) is recommended when co-administered with Choliva.",
        "items": []
      },
      {
        "title": "Inhibitors of Bile Salt Efflux Pump",
        "information": ": Avoid concomitant use of inhibitors of the bile salt efflux pump (BSEP) such as cyclosporine. Concomitant medications that inhibit canalicular membrane bile acid transporters such as the BSEP may exacerbate accumulation of conjugated bile salts including taurine conjugate of Choliva in the liver and result in clinical symptoms. If concomitant use is deemed necessary, monitor serum transaminases and bilirubin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Obeticholic acid is contraindicated in patients with:",
        "items": [
          "Decompensated cirrhosis (e.g., Child-Pugh Class B or C) or a prior decompensation event",
          "Compensated cirrhosis who have evidence of portal hypertension (e.g., ascites, gastroesophageal varices, persistent thrombocytopenia)",
          "Complete biliary obstruction"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects of Choliva include: Pruritus, Fatigue & Stomach pain and discomfort. Other common side effects include rash, arthralgia (joint pain), oropharyngeal pain (pain in the middle part of the throat), dizziness, constipation, abnormal thyroid function, and eczema (inflammation of the skin).",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": The limited available human data on the use of obeticholic acid during pregnancy are not sufficient to inform a drug-associated risk. In animal reproduction studies, no developmental abnormalities or fetal harm was observed when pregnant rats or rabbits were administered obeticholic acid during the period of organogenesis at exposures approximately 13-times and 6-times human exposures, respectively, at the maximum recommended human dose (MRHD) of 10 mg.",
        "items": []
      },
      {
        "title": "Lactation",
        "information": ": There is no information on the presence of obeticholic acid in human milk, the effects on the breastfed infant or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Obeticholic acid and any potential adverse effects on the breastfed infant from Obeticholic acid or from the underlying maternal condition.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hepatic Decompensation and Failure in PBC Patients with Cirrhosis",
        "information": ": Hepatic decompensation and failure, sometimes fatal or resulting in liver transplant have been reported with Choliva treatment in PBC patients with cirrhosis either compensated or decompensated. Among postmarketing cases reporting it, median time to hepatic decompensation (e.g., new onset ascites) was 4 months for patients with compensated cirrhosis; median time to a new decompensation event (e.g., hepatic encephalopathy) was 2.5 months for patients with decom- pensated cirrhosis. Some of these cases occurred in patients with decompensated cirrhosis when they were treated with higher than the recommended dosage for that patient population; however, case of hepatic decompensation and failure have continued to be reported in patients with decompensated cirrhosis even when they received the recommended dosage. Hepatotoxicity was observed in the Choliva clinical trials. A dose-response relationship was observed for the occurrence of hepatic adverse reactions including jaundice, worsening ascites and primary biliary cholangitis flare with dosages of Choliva of 10mg once daily to 50mg once daily (up to 5-times the highest recommended dosage) as early as one month after starting treatment with Choliva in two 3-month, placebo-controlled clinical trials in patients with primarily early stage PBC. In a pooled analysis of three placebo-controlled clinical trials in patients with primarily early-stage PBC the exposure-adjusted incidence rates for all serious and otherwise clinically significant hepatic adverse reactions and isolated elevations in liver biochemical tests per 100 patient exposure years (PEY) were: 5.2 in the Choliva 10mg group (highest recommended dosage) 19.8 in the Choliva 25mg group (2.5-times the highest recommended dosage) and 54.5 in the Choliva 50mg group (5-times the highest recommended dosage) compared to 2.4 in the placebo group.",
        "items": []
      },
      {
        "title": "Severe Pruritus",
        "information": ": Severe pruritus was reported in 23% of patients in the Choliva 10mg arm, 19% of patients in the Choliva titration arm and 7% of patients in the placebo arm in Trial 1, a 12-month double-blind randomized controlled clinical trial of 216 patients. Severe pruritus was defined as intense or widespread itching, interfering with activities of daily living or causing severe sleep disturbance or intolerable discomfort and typically requiring medical interventions. In the subgroup of patients in the Choliva titration arm who increased their dosage from 5mg once daily to 10mg once daily after 6 months of treatment (n=33), the incidence of severe pruritus was 0% from months 0 to 6 and 15% from months 6 to 12. The median time to onset of severe pruritus was 11, 158 and 75 days for patients in the Choliva 10 mg, Choliva titration and placebo arms respectively. Consider clinical evaluation of patients with new onset or worsening severe pruritus. Management strategies include the addition of bile acid binding resins or antihistamines, Choliva dosage reduction and/or temporary interruption of Choliva dosing.",
        "items": []
      },
      {
        "title": "Reduction in HDL-C",
        "information": ": Patients with PBC generally exhibit hyperlipidemia characterized by a significant elevation in total cholesterol primarily due to increased levels of high-density lipoprotein-cholesterol (HDL-C). In Trial, dose-dependent reductions from baseline in mean HDL-C levels were observed at 2 weeks in Choliva-treated patients, 20% and 9% in the 10 mg and titration arms respectively, compared to 2% in the placebo arm. At Month 12, the reduction from baseline in mean HDL-C level was 19% in the Choliva 10 mg arm, 12% in the Choliva titration arm and 2% in the placebo arm. Nine patients in the Choliva 10mg arm, 6 patients in the Choliva titration arm versus 3 patients in the placebo arm had reductions in HDL-C to less than 40 mg/dL. Monitor patients for changes in serum lipid levels during treatment. For patients who do not respond to Choliva after 1 year at the highest recommended dosage that can be tolerated (maximum of 10 mg once daily) and who experience a reduction in HDL-C, weigh the potential risks against the benefits of continuing treatment.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": The safety and effectiveness of Choliva in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Of the 201 patients in clinical trials of Choliva who received the recommended dosage (5mg or 10mg once daily), 41 (20%) were 65 years of age & older while 9 (4%) were 75 years of age & older. No overall differences in safety or effectiveness were observed between these subjects and subjects less than 65 years of age but greater sensitivity of some older individuals cannot be ruled out.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": Hepatic decompensation and failure, sometimes fatal or resulting in liver transplant have been reported with Choliva treatment in PBC patients with cirrhosis either compensated or decompensated. Choliva is contraindicated in patients with decompensated cirrhosis (e.g., Child-Pugh Class B or C) in those with a prior decompensation event or with compensated cirrhosis who have evidence of portal hypertension (e.g., ascites, gastroesophageal varices, persistent thrombocytopenia). In PBC clinical trials, a dose-response relationship was observed for the occurrence of hepatic adverse reactions with Choliva.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the clinical trials, PBC patients who received Choliva 25mg once daily (2.5 times the highest recommended dosage) or 50mg once daily (5 times the highest recommended dosage) experienced a dose-dependent increase in the incidence of hepatic adverse reactions, including elevations in liver biochemical tests, ascites, jaundice, portal hypertension and primary biliary cholangitis flares. Serious hepatic adverse reactions have been reported postmarketing in PBC patients with decompensated cirrhosis when Choliva was dosed more frequently than the recommended dosage; these adverse reactions were also reported in some patients who received the recommended dosage. In the case of overdosage, patients should be carefully observed and supportive care administered as appropriate.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C in a dry place, and protect from light. Keep out of children’s reach.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Farnesoid X Receptor Agonists",
    "dosage": [
      {
        "medication_type": "Important Dosage and Administration Instructions",
        "information": ": Prior to the initiation of Obeticholic acid, healthcare providers should determine whether the patient has decompensated cirrhosis (e.g., Child-Pugh Class B or C) has had a prior decompensation event or has compensated cirrhosis with evidence of portal hypertension (e.g., ascites, gastroesophageal varices, persistent thrombocytopenia) because Obeticholic acid is contraindicated in these patients.",
        "instructions": []
      },
      {
        "medication_type": "Recommended Dosage Regimen",
        "information": ": The recommended dosage of Obeticholic acid for PBC patients without cirrhosis or with compensated cirrhosis who do not have evidence of portal hypertension, who have not achieved an adequate biochemical response to an appropriate dosage of UDCA for at least 1 year or are intolerant to UDCA follows below:",
        "instructions": [
          "Start with a dosage of 5 mg once daily for the first 3 months.",
          "After the first 3 months, for patients who have not achieved an adequate reduction in ALP and/or total bilirubin and who are tolerating Obeticholic acid increase to a maximum dosage of 10 mg once daily."
        ]
      },
      {
        "medication_type": "Monitoring to Assess Safety, Need for Obeticholic acid Discontinuation",
        "information": ": Routinely monitor patients during Obeticholic acid treatment for biochemical response, tolerability and progression of PBC. Closely monitor patients with compensated cirrhosis, concomitant hepatic disease (e.g., autoimmune hepatitis, alcoholic liver disease) and/or severe intercurrent illness for new evidence of portal hypertension (e.g., ascites, gastroesophageal varices, persistent thrombocytopenia) or increases above the upper limit of normal in total bilirubin, direct bilirubin or prothrombin time. Permanently discontinue Obeticholic acid in patients who develop laboratory or clinical evidence of hepatic decompensation, have compensated cirrhosis and develop evidence of portal hypertension, experience clinically significant hepatic adverse reactions, or develop complete biliary obstruction.",
        "instructions": []
      },
      {
        "medication_type": "Management of Patients with Intolerable Pruritus on Obeticholic acid",
        "information": ": For patients with intolerable pruritus on Obeticholic acid consider one or more of the following management strategies. Add an antihistamine or bile acid-binding resin. Reduce the dosage of Obeticholic acid to:",
        "instructions": [
          "5 mg every other day, for patients intolerant to 5 mg once daily.",
          "5 mg once daily, for patients intolerant to 10 mg once daily.",
          "Temporarily interrupt Obeticholic acid dosing for up to 2 weeks. Restart at a reduced dosage. For patients whose dosage is reduced or interrupted, titrate the dosage based on biochemical response and tolerability. Consider discontinuing Obeticholic acid treatment in patients who continue to experience persistent, intolerable pruritus despite management strategies."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:41.174Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c3f",
    "original_record": {
      "input_index": 4416,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c3f"
        },
        "name": "Choliva",
        "strength": "10 mg",
        "generic": "Obeticholic Acid",
        "company": "UniMed UniHealth Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/34077/choliva-10-mg-tablet",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26162/choriofactor-5000-iu-injection",
    "name": "Choriofactor",
    "dosage_form": "IM/SC Injection",
    "generic": "Human Chorionic Gonadotrophin",
    "strength": "5000 IU/vial",
    "company": "Biofactor GmbH-Germany",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2,300.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5000 IU vial",
          "price": "৳ 2,300.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/547/human-chorionic-gonadotrophin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "In the female: In ... Read moreIn the female: In the male:",
        "items": [
          "Ovulation induction in infertility due to anovulation or impaired follicle-ripening.",
          "Preparation of follicles for puncture in controlled ovarian hyperstimulation programs (ART).",
          "Luteal phase support.",
          "Threatened and habitual abortion",
          "Ovulation induction in infertility due to anovulation or impaired follicle-ripening.",
          "Preparation of follicles for puncture in controlled ovarian hyperstimulation programs (ART).",
          "Luteal phase support.",
          "Threatened and habitual abortion",
          "Hypogonadotropic hypogonadism (also cases of idiopathic dysspermias have shown a positive response to gonadotropins).",
          "Delayed puberty associated with insufficient gonadotropic pituitary function.",
          "Cryptorchidism, (not due to anatomical obstruction)",
          "Used to treat oligospermia"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": "Pharmacodynamic Properties",
        "information": ": Highly Purified Human Chorionic Gonadotrophin has LH activity. LH is indispensable in normal female and male gamete growth and maturation, and gonadal steroid production.",
        "items": [
          "In the female: Human Chorionic Gonadotrophin is given as a substitute for the endogenous mid-cycle LH surge to induce the final phase of follicular maturation, leading to ovulation. Human Chorionic Gonadotrophin is also given as a substitute for endogenous LH during the luteal phase.",
          "In the male: Human Chorionic Gonadotrophin is given to stimulate Leydig cells to promote the production of testosterone."
        ]
      },
      {
        "title": "Pharmacokinetic Properties",
        "information": ": Maximal Human Chorionic Gonadotrophin plasma levels will be reached approximately six hours after a single injection of Human Chorionic Gonadotrophin . Human Chorionic Gonadotrophin is for approximately 80 percent metabolized, predominantly in the kidneys. Following intramuscular injection (IM) the apparent elimination half-life of Human Chorionic Gonadotrophin is about 2 days. On basis of the recommended dose regimens and elimination half-life, accumulation does not occur.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interactions of clinical relevance are known.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Known or suspected androgen-dependent tumours, such as prostatic carcinoma or breast carcinoma in the male.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Allergic reactions have occasionally been reported with the use of urinary gonadotrophin preparations. These mostly involve local reactions such as pain and rash at the injection site, and generalized reactions such as rash and fever.",
        "items": []
      },
      {
        "title": "In the female",
        "information": ": Unwanted ovarian hyperstimulation syndrome. Which is Characteristic symptoms of unwanted ovarian hyperstimulation and the ovarian hyperstimulation syndrome are included under 'Special warnings and special precautions for use'.",
        "items": []
      },
      {
        "title": "In the Male",
        "information": ": Water and sodium retention is occasionally seen after administration of high dosages; this is regarded as a result of excessive androgen production. Treatment with Choriofactor leads to increased androgen production.",
        "items": []
      },
      {
        "title": "Therefore",
        "information": ": Patients with latent or overt cardiac failure, renal dysfunction, hypertension, epilepsy or migraine (or a history of these conditions) should be kept under close medical supervision, since aggravation or recurrence may occasionally be induced as a result of increased androgen production. Choriofactor should be used cautiously in prepubertal boys to avoid premature epiphyseal closure or precocious sexual development. Skeletal maturation should be monitored regularly.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": "Category X. Studies in animals or human beings have demonstrated foetal abnormalities or there is evidence of foetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.",
        "items": []
      },
      {
        "title": "Use in lactation",
        "information": ": It must not be used during lactation",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In pregnancies occurring after induction of ovulation with gonadotropic preparations, there is an increased risk of multiplets birth. Unwanted ovarianhyperstimulation: In patients treated for infertility due to anovulation or impaired follicular ripening, the prior administration of an FSH containing preparation may lead to unwanted ovarian hyperstimulation. Therefore ultrasonic assessment of follicular development and determinations nations of estrogen levels should be performed prior to FSH-treatment and at regular intervals during FSH-treatment. Estrogen levels may rise very rapidly, e.g. more than a daily doubling for two or three consecutive days, and possibly reach excessively high values. If this unwanted ovarian hyperstimulation occurs (i.e. not as part of a treatment preparing for IVF/ET or GIFT/ZIFT), the administration of the FSH-containing preparation should be discontinued immediately. In that case Choriofactor must not be given, because the administration of an LH-active gonadotrophin at this stage may induce, in addition to multiple ovulations, the ovarian hyperstimulation syndrome. This warning is particularly important with respect to patients with polycystic ovarian disease. Clinical symptoms of mild ovarian hyperstimulation syndrome are gastro-intestinal problems (pain, nausea, diarrhoea), painful breasts, and mild to moderate enlargement of ovaries and ovarian cysts. In rare cases severe ovarian hyperstimulation syndrome occurs, which may be life-threatening. This is characterized by large ovarian cysts (prone to rupture), ascites, often hydrothorax and occasionally",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Induction of androgen secretion by HCG may induce precocious puberty in pediatric patients treated for cryptorchidism. Therapy should be discontinued if signs of precocious puberty occur.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Clinical studies of Chorionic gonadotropin for injection did not include subjects aged 65 and over.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The acute toxicity of urinary gonadotropin preparations has been shown to be very low. There are no symptoms of an acute parenteral overdose known in humans.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "There are two options: Protect from light & keep in dry place.",
        "items": [
          "Store at 2°C-8°C (in refrigerator). Do not freeze.",
          "Store below 25°C for a single period of not more than 3 months."
        ]
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Female Sex hormones",
    "dosage": [
      {
        "medication_type": null,
        "information": "After addition of the solvent to the freeze-dried substance, the reconstituted Human Menopausal Gonadotrophin solution should be slowly administered intramuscularly.",
        "instructions": []
      },
      {
        "medication_type": "In the female",
        "information": ": Ovulation induction and preparation of follicles for puncture: Usually, one injection of 5000- 10000IU Human Menopausal Gonadotrophin to complete treatment with an FSH-containing preparation.",
        "instructions": []
      },
      {
        "medication_type": "Luteal phase support",
        "information": ": Two repeat injections of 2500 to 5000IU. Each may be given within nine days following ovulation or embryo transfer (for example on day 3, 6 and 9 after ovulation induction).",
        "instructions": []
      },
      {
        "medication_type": "Threatened & habitual abortion",
        "information": ": 5000IU Human Menopausal Gonadotrophin will be given as deep intramuscular injection twice weekly from the time of diagnosis (all before the 7th week of gestation)",
        "instructions": []
      },
      {
        "medication_type": "In the male",
        "information": ": Hypogonadotropic hypogonadism: 2500 to 5000 IU Human Menopausal Gonadotrophin, two times per week. If the main complaint is sterility, additional doses of an FSH-containing (50IU FSH) are to be administered daily or two to three times a week. This treatment should be continued for at least three months before any improvement in spermatogenesis can be expected. During this treatment testosterone replacement therapy should be suspended. Once achieved, the improvement may in some cases be maintained by Human Menopausal Gonadotrophin alone.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:42.429Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c41",
    "original_record": {
      "input_index": 4417,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c41"
        },
        "name": "Choriofactor",
        "strength": "5000 IU/vial",
        "generic": "Human Chorionic Gonadotrophin",
        "company": "ZAS Corporation",
        "medicine_type": "IM/SC Injection",
        "source_url": "https://medex.com.bd/brands/26162/choriofactor-5000-iu-injection",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/24222/chrocee-200-mg-capsule",
    "name": "Chrocee",
    "dosage_form": "Capsule",
    "generic": "Ribavirin",
    "strength": "200 mg",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": "৳ 140.00",
      "pack_size_info": "(5 x 4: ৳ 700.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 35.00",
          "pack_size_info": "(5 x 4: ৳ 700.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 140.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/954/ribavirin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Chrocee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Chrocee as monotherapy is not effective and Chrocee must not be used alone.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ribavirin is a synthetic nucleoside which has inhibitory action against respiratory syncytial virus, influenza virus and herpes simplex virus. The mechanism of action is not clear. It may act at several sites including cellular enzymes to interfere with viral nucleic acid synthesis. The mono- and triphosphate derivatives are known to be responsible for the antiviral action of the compound.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Chrocee should not be used with following medications: Didanosine, Zidovudine, Azathioprine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This medicine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients, women who are pregnant, men whose female partners are pregnant, patients with haemoglobinopathies ( e.g. thalassemia major or sickle cell anemia), autoimmune hepatitis or hepatic decompensation before or during treatment.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The primary adverse reaction of Chrocee is haemolytic anaemia. Patients who have received combination therapy of interferon alfa or polyglycated interferon alfa with Chrocee are: cough, anxiety, depression, dizziness, nausea, vomiting, flu-like symptoms (e.g. fever, chills, sore throat, muscle aches), headache, abdominal pain, diarrhoea, constipation, chest pain, tachycardia, dyspnoea, neutropenia, thrombocytopenia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Ribavirin must not be used by pregnant women or who are expecting child since the drug may have teratogenic effect. Male patients and their female partners of childbearing age must be counselled to use 2 forms of effective contraception during treatment with ribavirin and for 6 months after treatment has been concluded. Ribavirin should not be initiated until a report of a negative pregnancy test has been obtained immediately prior to initiation of therapy. Patients must perform a pregnancy test monthly during therapy and for 6 months post therapy.",
        "items": []
      },
      {
        "title": "Brestfeeding",
        "information": ": It is not known whether ribavirin is excreted in human milk. Because of the potential for adverse reactions in nursing infants, a decision should be made either to discontinue nursing or not to initiate therapy.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Chrocee used in combination therapy should be administered under the guidance of a qualified physician experienced in hepatitis C treatment. Sometimes it may lead to moderate to severe adverse reactions requiring dose reduction, temporary dose cessation or discontinuation of further therapy. Because cardiac disease may be worsened by Chrocee induced anaemia, patients should be assessed before initiation of therapy and should be appropriately monitored during therapy. If there is any deterioration of cardiovascular status, Chrocee therapy should be suspended or discontinued. It is recommended that patients who have pre-existing cardiac abnormalities have an electrocardiogram prior to initiation of Chrocee therapy. The most common adverse reactions include kidney disease, blood disorders (e.g. sickle cell anemia, low hemoglobin), other types of hepatitis (autoimmune hepatitis), diabetes, allergy etc. Caution should be taken in the elderly patients. Complete blood count (CBC), differential count, platelet count, electrolytes, serum creatinine, liver function tests and uric acid must be conducted in all patients prior to initiating therapy. After initiation of Chrocee therapy, haematological tests should be performed at 2 and 4 weeks and biochemical tests should be performed at 4 weeks of therapy.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at temperature not exceeding 30°C in a dry place. Protect from light. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Hepatic viral infections (Hepatitis C)",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended duration of treatment for patients previously untreated with Interferon/Peginterferon is 24 to 48 weeks. The daily dose of Ribavirin is 800 mg to 1200 mg administered orally in two divided doses (morning and evening). Genotypes 2 and 3 showed no increased response to treatment beyond 24 weeks.",
        "instructions": []
      },
      {
        "medication_type": "Special dosage instructions",
        "information": ": If severe adverse reactions or laboratory abnormalities develop during therapy with ribavirin, modification of the dosages are required until the adverse reactions abate. Because of the recognized heamolysis associated with ribavirin therapy, separate guidelines are provided for patients with a history of cardiovascular disease.",
        "instructions": []
      },
      {
        "medication_type": "Use in renal impairment",
        "information": ": The total daily dose of Ribavirin should be reduced for patients with creatinine clearance less than or equal to 50 ml/minute.",
        "instructions": []
      },
      {
        "medication_type": "Use in the elderly ( 65 years of age)",
        "information": ": There is no sufficient clinical studies about the effectiveness and safety of Ribavirin in combination with interferon alfa or pegylated interferon alfa in these patients.",
        "instructions": []
      },
      {
        "medication_type": "Use in patients under the age of 5 years",
        "information": ": Safety and effectiveness of Ribavirin in combination with interferon alfa or pegylated interferon alfa in these patients have not been evaluated.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:43.605Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c42",
    "original_record": {
      "input_index": 4418,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c42"
        },
        "name": "Chrocee",
        "strength": "200 mg",
        "generic": "Ribavirin",
        "company": "ACI Limited",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/24222/chrocee-200-mg-capsule",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6068/ciaton-5-mg-tablet",
    "name": "Ciaton",
    "dosage_form": "Tablet",
    "generic": "Tadalafil",
    "strength": "5 mg",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 18.05",
      "strip_price": "৳ 72.20",
      "pack_size_info": "(1 x 4: ৳ 72.20)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 18.05",
          "pack_size_info": "(1 x 4: ৳ 72.20)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 72.20",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/6069/ciaton-10-mg-tablet?ref=1"
      },
      {
        "text": "20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/6070/ciaton-20-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1029/tadalafil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ciaton is indicated in-",
        "items": [
          "Erectile Dysfunction (ED)",
          "Benign Prostatic Hyperplasia (BPH)",
          "Both Erectile Dysfunction and signs and symptoms of Benign Prostatic Hyperplasia"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor. Inhibition of PDE5 increases cGMP in smooth muscle cells. cGMP causes smooth muscle relaxation and increased blood flow into the corpus cavernosum, causing penile erection. PDE5 also is present in smooth muscles of the prostate and bladder wall. Inhibiting PDE5 increases cGMP concentrations leading to relaxation of smooth muscle in the prostate and bladder. Smooth muscle relaxation may improve blood flow to the urinary tract and widen the opening of the bladder neck, resulting in improved voiding.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "May interact with Nitrates for example, Isosorbide, Nitroglycerin, Alpha adrenergic blockers, Antihypertensives, Alcohol, Antacids (magnesuim hydroxide/aluminum hydroxide), Ketoconazole, Ritonavir, Erythromycin, Itraconazole, Grapefruit juice, other HIV protease inhibitors, Rifampin, Carbamazepine, Phenytoin & Phenobarbital.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Use of Nitrates (for example, Nitroglycerine, Isosorbide): may increase hypotensive effects of Nitrates",
          "Hypersensitivity reactions to Tadalafil"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Headache, Dyspepsia, Back pain, Myalgia, Nasal pharyngitis, Nasal congestion are common side effects. Change in Color Vision, Sudden vision loss, Hearing loss, Stevens-Johnson Syndrome, Exfoliative dermatitis, Angina, Stroke, Myocardial infarction, Severe hypotension, Tachycardia may also occur rarely.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Tadalafil has been assigned to pregnancy category B by the USFDA. Tadalafil is only recommended for use during pregnancy when benefit outweighs risk. There are no data on the excretion of Tadalafil in human milk. Caution should be used when administering tadalafil to nursing women.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Angina, renal impairment, hepatic impairment, bleeding concomitant with Nitrates, Alpha Blockers, Alcohol, CYP3A4 Inhibitors (for example, Ritonavir, Ketoconazole, Itraconazole), other PDE5 inhibitors precaution should be taken in all these conditions.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Erectile Dysfunction",
    "dosage": [
      {
        "medication_type": null,
        "information": "Erectile Dysfunction: For most patients the recommended starting dose is 10 mg. The dose may be increased to 20 mg or decreased to 5 mg based on requirement. The maximum dosing frequency is once daily. Tadalafil is effective for up to 36 hours.Benign prostatic hyperplasia: The recommended dose is 5 mg taken at the same time every day.Combined Erectile Dysfunction and Benign prostatic hyperplasia: The recommended dose is 5 mg at the same time every day.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:44.697Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c48",
    "original_record": {
      "input_index": 4419,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c48"
        },
        "name": "Ciaton",
        "strength": "5 mg",
        "generic": "Tadalafil",
        "company": "ACI Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/6068/ciaton-5-mg-tablet",
        "_page": 146,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/9158/cibact-500-mg-tablet",
    "name": "Cibact",
    "dosage_form": "Tablet",
    "generic": "Ciprofloxacin",
    "strength": "500 mg",
    "company": "Euro Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 150.00",
      "pack_size_info": "(3 x 10: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(3 x 10: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "750 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27225/cibact-750-mg-tablet?ref=1"
      },
      {
        "text": "250 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/27226/cibact-250-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/263/ciprofloxacin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cibact is indicated for the treatment of single infection or mixed infections caused by two or more susceptible organisms. It can also be used for infections caused by organisms resistant to other antibiotics including Aminoglycosides, Penicillins and Cephalosporins.As antibacterial ... Read moreCibact is indicated for the treatment of single infection or mixed infections caused by two or more susceptible organisms. It can also be used for infections caused by organisms resistant to other antibiotics including Aminoglycosides, Penicillins and Cephalosporins.As antibacterial concentrations of Cibact are obtained in serum and body tissues as well as in the urine following administration by mouth, Cibact has been suggested for use in the treatment of a wide range of infections caused by susceptible organisms including infections of the urinary, respiratory and gastrointestinal tracts, gonorrhoea and septicaemia. The extensive tissue penetration of Cibact combined with its enhanced antibacterial activity (including antipseudomonal activity), enables Cibact to be used alone (pending sensitivity results) or in combination with an Aminoglycoside or with beta lactam antibiotics for instance when severe neutropenia is present or with an antibiotic active against anaerobes where the presence of bacteroides fragilis is suspected. Cibact is indicated for the treatment of the following infections caused by sensitive bacteria:",
        "items": [
          "Severe systemic infections: e.g. septicaemia, bacteraemia, peritionitis, infections in immunosuppressed patients with haematological or solid tumors and in patients in intensive care unit with specific problems such as infected burns.",
          "Respiratory tract infections: Lobar and bronchopneumonia, acute and chronic bronchitis, acute exacerbation of cystic fibrosis, bronchiectasis, empyema.",
          "Urinary tract infections: Uncomplicated and complicated urethritis, cystitis, pyelonephritis, prostatitis, epididymitis.",
          "Skin and soft tissue infections: e.g. infected ulcers, wound infections, abscesses, cellulitis, otitis externa, erysipelas, infected burns.",
          "Gastro-intestinal infections: e.g. enteric fever, infective diarrhea.",
          "Infection of the biliary tract: e.g. cholangitis, cholecystitis, empyema of the gall bladder.",
          "Intra abdominal infections: e.g. peritonitis, intra abdominal abscesses.",
          "Bone and joint infection: Osteomyelitis, septic arthritis.",
          "Pelvic infections: e.g. salpingitis, endometritis, pelvic inflammatory diseases.",
          "Eye, ear, nose and throat infections: e.g. otitis media, sinusitis, mastoiditis, tonsillitis.",
          "Gonorrhoea: Including urethral, rectal and pharyngeal gonorrhoea caused by beta-lactamase producing organisms or organisms moderately sensitive to penicillin."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ciprofloxacin is a synthetic quinolone anti-infective agent. Ciprofloxacion has broad spectrum of activity. It is active against most gram negative aerobic bacteria including Enterobacteriaceae and Pseudomonas aeruginosa. Ciprofloxacin is also active against gram-positive aerobic bacteria including penicillinase producing, non penicillinase producing, and methicillin resistant staphylococci, although many strains of streptococci are relatively resistant to the drug. The bactericidal action of Ciprofloxacin results from interference with the enzyme DNA gyrase needed for the synthesis of bacterial DNA. Following oral administration it is rapidly and well absorbed from the G.I. tract. It is widely distributed into the body tissues and fluids. The half life is about 3.5 hours. About 30% to 50% of an oral dose of Ciprofloxacin is excreted in the urine within 24 hours as unchanged drug and biologically active metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent administration of Cibact should be avoided with Magnesium or Aluminum containing antacids or sucralfate or with other products containing Calcium, Iron or Zinc. These products may be taken two hours after or six hours before Cibact. Cibact should not be taken concurrently with milk or other dairy products, since absorption of Cibact may be significantly reduced. Dietary calcium is a part of a meal, however, does not significantly affect the absorption of Cibact.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with a history of hypersensitivity to Ciprofloxacin or to other quinolones.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances e.g. nausea, diarrhoea, vomiting, dyspepsia, abdominal pain. Disturbances of the central nervous system e.g. headache, dizziness, tiredness, confusion, convulsion & risk of retinal detachment. Hypersensitivity reactions e.g. skin rash (very rarely Stevens-Johnson syndrome and toxic epidermal necrolysis), pruritus and possible systemic reactions. The other less reported reactions are joint pain, mild photosensitivity and transient increase in liver enzymes (particularly in patients with previous liver damage), serum bilirubin, urea or creatinine levels. Risk of hypoglycemia & mental health adverse effects.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Reproduction studies performed in mice, rats and rabbits using parenteral and oral administration did not reveal any evidence of teratogenicity, impairment of fertility or impairment of peri/post natal development. However as with other quinolones, Ciprofloxacin has been shown to cause arthropathy in immature animals and therefore its use during pregnancy is not recommended. Studies in rats have indicated that Ciprofloxacin is secreted in milk, administration to nursing mothers is thus not recommended.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "It should be used with caution in patients with suspected or known CNS disorders such as arteriosclerosis or epilepsy or other factors which predispose to seizures and convulsion.",
        "items": [
          "Cibact may be taken with or without meals and to drink fluids liberally.",
          "Concurrent administration of Cibact should be avoided with magnesium / aluminium antacids, or sucralfate or with other products containing calcium, iron and zinc. These products may be taken two hours after or six hours before Cibact.",
          "Cibact should not be taken concurrently with milk or yogurt alone, since absorption of Cibact may be significantly reduced. Dietary calcium is a part of a meal, however, does not significantly affect the Cibact absorption."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Although effective in clinical trials, Cibact is not a drug of first choice in pediatric population.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdose following Cibact administration may lead to seizures, hallucinations, confusion, abdominal discomfort, renal and hepatic impairment as well as crystalluria, haematuria, & reversible renal toxicity.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Instruction for the use of Ciprofloxacin IV infusion-",
        "items": [
          "Check the bag for minute leaks by squeezing the inner bag firmly. If leaks are found, or if seal is not intact, discard the solution.",
          "Do not use if the solution is cloudy or a precipitate is present.",
          "Do not use flexible bags in series connections.",
          "Close flow control clamp of administration set.",
          "Remove cover from port at bottom of bag.",
          "Insert piercing pin of administration set into port with a twisting motion until the pin is firmly seated.",
          "Suspend bag from hanger.",
          "Squeeze and release drip chamber to establish proper fluid level in chamber during infusion of Ciprofloxacin IV infusion.",
          "Open flow control clamp to expel air from set.Close clamp.",
          "Regulate rate of administration with flow control clamp."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "4-Quinolone preparations, Anti-diarrhoeal Antimicrobial drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "General dosage recommendations: The dosage of the Ciprofloxacin is determined by the severity and type of infection, the sensitivity of the causative organism(s) and the age, weight and renal function of the patient.",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": The dosage range for adults is 100-750 mg twice daily.",
        "instructions": []
      },
      {
        "medication_type": "In infections of the lower and upper urinary tract (depending on severity)",
        "information": ": 250-500 mg twice daily.",
        "instructions": []
      },
      {
        "medication_type": "In respiratory tract infections",
        "information": ": 250-500mg twice daily for both upper and lower respiratory tract infections, depending on the severity. For the treatment of known Streptococcus pneumonia infection, the recommended dosage is 750 mg twice daily.",
        "instructions": []
      },
      {
        "medication_type": "In gonorrhea",
        "information": ": A single dose of 250 or 500 mg.",
        "instructions": []
      },
      {
        "medication_type": "In the majority other infections",
        "information": ": 500-750 mg twice daily should be administered.",
        "instructions": []
      },
      {
        "medication_type": "Cystic fibrosis",
        "information": ": In adults with pseudomonal infections of the lower respiratory tract , the normal dose is 750 mg twice daily. As the pharmacokinetics of Ciprofloxacin remain unchanged in patients with cystic fibrosis, the low body weight of these patients would be fallen into consideration when determining dosage.",
        "instructions": []
      },
      {
        "medication_type": "Impaired renal function",
        "information": ": Dosage adjustment is not usually required except in patients with several renal impairment. (serum creatinine >265 micro mol/l or creatinine clearance <20 ml/minute). If adjustment is necessary, this may be achieved by reducing the total daily dose by half, although monitoring of drug serum levels provide the most reliable basis for dose adjustment.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Although higher Ciprofloxacin serum levels are found in the elderly, no adjustment of dosage is necessary.",
        "instructions": []
      },
      {
        "medication_type": "Adeloscents and children",
        "information": ": As with other drugs in its class, Ciprofloxacin has been shown to cause arthropathy in weight bearing joints of immature animals. Although the relevance of this to man is unknown, its use in children, growing children and growing adolescents is not recommended. However, where the benefit of using Ciprofloxacin is considered to outweigh the potential risk, the dosage should be 7.5-15 mg/kg/day depending upon the severity of infection, administered in two divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Duration of treatment",
        "information": ": The duration of treatment depends upon the severity of infection, clinical response and bacteriological findings.",
        "instructions": []
      },
      {
        "medication_type": "For acute infections",
        "information": ": The usual treatment period is 5 to 10 days with Ciprofloxacin tablets. Generally treatment should be continued for three days after the signs and symptoms of the infection have disappeared. Extended-release tablet: For IV infusion:",
        "instructions": [
          "In uncomplicated urinary tract infection (acute cystitis), the recommended dose of extended-release tablet is 1000 mg tablet once daily for three days."
        ]
      },
      {
        "medication_type": "Urinary Tract Infection",
        "information": ": Mild to Moderate: 200 mg 12 hourly for 7-14 days; Severe or Complicated: 400 mg 12 hourly for 7-14 days",
        "instructions": []
      },
      {
        "medication_type": "Lower Respiratory Tract infection",
        "information": ": Mild to Moderate: 400 mg 12 hourly for 7-14 days; Severe or Complicated: 400 mg 8 hourly for 7-14 days",
        "instructions": []
      },
      {
        "medication_type": "Nosocomial Pneumonia",
        "information": ": Mild/Moderate/Severe: 400 mg 8 hourly for 10-14 days",
        "instructions": []
      },
      {
        "medication_type": "Skin and Skin Structure",
        "information": ": Mild to Moderate: 400 mg 12 hourly for 7-14 days; Severe or Complicated: 400 mg 8 hourly for 7-14 days",
        "instructions": []
      },
      {
        "medication_type": "Bone and Joint Infection",
        "information": ": Mild to Moderate: 400 mg 12 hourly for more than 4-6 weeks; Severe/Complicated: 400 mg 8 hourly for more than 4-6weeks",
        "instructions": []
      },
      {
        "medication_type": "Intraabdominal (Acute abdomen)",
        "information": ": Complicated: 400 mg 12 hourly for 7-14 days",
        "instructions": []
      },
      {
        "medication_type": "Acute Sinusitis",
        "information": ": Mild/Moderate: 400 mg 12 hourly for 10 days",
        "instructions": []
      },
      {
        "medication_type": "Chronic Bacterial Prostatitis",
        "information": ": Mild/Moderate: 400 mg 12 hourly for 28 Days.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:46.076Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c4a",
    "original_record": {
      "input_index": 4421,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c4a"
        },
        "name": "Cibact",
        "strength": "500 mg",
        "generic": "Ciprofloxacin",
        "company": "Euro Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/9158/cibact-500-mg-tablet",
        "_page": 147,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34559/cibrate-100-mg-tablet",
    "name": "Cibrate",
    "dosage_form": "Tablet",
    "generic": "Ciprofibrate",
    "strength": "100 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 225.00",
      "pack_size_info": "(2 x 15: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(2 x 15: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 225.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1884/ciprofibrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following:",
        "items": [
          "Treatment of severe hypertriglyceridemia with or without low HDL cholesterol.",
          "Mixed hyperlipidemia when a statin is contraindicated or not tolerated."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ciprofbrate reduces both LDL & VLDL and hence the levels of triglyceride and cholesterol associated with these lipoprotein fractions. It also increases levels of HDL cholesterol. Ciprofbrate is effective in the treatment of hyperlipidemia associated with high plasma concentrations of LDL and VLDL. There is evidence that treatment with fibrates may reduce coronary heart disease events.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Other fibrates & HMG CoA reductase inhibitors",
        "information": ": As Risk of myopathy, rhabdomyolysis and myoglobinuria may be increased if Ciprofbrate is used in combination with other fibrates and HMG CoA reductase inhibitors.",
        "items": []
      },
      {
        "title": "Oral anticoagulant therapy",
        "information": ": Caution should be exercised when Ciprofbrate is taken with oral anticoagulants. Concomitant oral anticoagulant therapy should be given at a reduced dosage and adjusted according to INR.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to the active substance or to any of the excipients",
          "Severe hepatic impairment",
          "Severe renal impairment (creatinine clearance <30 ml/min/1.73 m2)",
          "Pregnancy and lactation or when pregnancy is suspected",
          "Concurrent use with another fibrate"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Headache, Dizziness, Somnolence, Vertigo, Nausea, Vomiting, Diarrhoea, Dyspepsia, Abdominal pain, Rash, Alopecia, Myalgia, Fatigue.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is no evidence that Ciprofbrate is teratogenic but signs of toxicity at high doses were observed in teratogenicity tests in animals. As there are no data on its use in human pregnancy, Ciprofbrate is contraindicated during pregnancy. As there are no data on its use in lactation, Ciprofbrate is contraindicated in nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Special warnings",
        "information": ": Patients with rare hereditary problems of galactose intolerance, lactose deficiency or glucose-galactose malabsorption should not take this medicine.",
        "items": []
      },
      {
        "title": "Myalgia/myopathy",
        "information": ": Patients should be advised to report unexplained muscle pain, tenderness or weakness immediately.",
        "items": []
      },
      {
        "title": "Patients with impaired hepatic function",
        "information": ": Periodic hepatic function tests are recommended (every 3 months for the first 12 months of treatment). Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Protect from light and moisture. Keep the medicine out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-hypertensive, Other Anti-anginal & Anti-ischaemic drugs",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": The recommended dose is Ciprofbrate 100 mg per day. This dose should not be exceeded.",
        "instructions": []
      },
      {
        "medication_type": "Patients with renal insufficiency",
        "information": ": In moderate renal impairment (creatinine clearance 30-80 ml/min/1.73 m 2 ) it is recommended that dosage be reduced to one tablet every other day. Patients should be carefully monitored. Ciprofbrate should not be used in severe renal impairment (creatinine clearance <30 ml/min/1.73 m 2 ).",
        "instructions": []
      },
      {
        "medication_type": "Patients with hepatic insufficiency",
        "information": ": Use with caution in patients with impaired hepatic function. Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": As for adults but precautions should be taken for Age more than 70 years.",
        "instructions": []
      },
      {
        "medication_type": "Paediatric population",
        "information": ": Not recommended since safety and efficacy in children has not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:47.475Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c4d",
    "original_record": {
      "input_index": 4422,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c4d"
        },
        "name": "Cibrate",
        "strength": "100 mg",
        "generic": "Ciprofibrate",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/34559/cibrate-100-mg-tablet",
        "_page": 147,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34707/ciclorox-1-cream",
    "name": "Ciclorox",
    "dosage_form": "Cream",
    "generic": "Ciclopirox Olamine",
    "strength": "1%",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 110.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 gm tube",
          "price": "৳ 110.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/293/ciclopirox-olamine-cream/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ciclorox Cream is indicated for the topical treatment of the following dermal infections: Tinea pedis, Tinea cruris and Tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum and Microsporum canis, candidiasis (moniliasis) due to Candida albicans, and Tinea ... Read moreCiclorox Cream is indicated for the topical treatment of the following dermal infections: Tinea pedis, Tinea cruris and Tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum and Microsporum canis, candidiasis (moniliasis) due to Candida albicans, and Tinea (pityriasis) versicolor due to Malassezia furfur. Ciclorox Cream is also highly effective against some gram negative & some gram-positive bacteria. Owing to its anti-inflammatory effects, Ciclorox alone is sufficient to treat mild to moderate inflammatory fungal infections.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ciclopirox Olamine is a synthetic broad spectrum antifungal agent that inhibits the growth of pathogenic dermatophytes, yeasts, and Malassezia furfur. Ciclopirox Olamine exhibits fungicidal activity in vitro against isolates of Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis, and Candida albicans. The mode of action of Ciclopirox Olamine was studied mainly in Candida albicans. It is presumed that Ciclopirox Olamine mediated growth inhibition or death of fungal cells is primarily caused by in vitro cellular depletion of some essential substrates and/or ions and that such effects are brought about through blockage of their uptake from the medium.In addition to its broad spectrum of antifungal action, Ciclopirox also exerts antibacterial activity against many Gram-positive and Gram-negative bacteria. Theanti-inflammatory effects of Ciclopirox have been demonstratedin human polymorphonuclear cells, where Ciclopirox has inhibited the synthesis of prostaglandin and leukotriene. Ciclopirox can also exhibit its anti-inflammatory effects by inhibiting the formation of 5-lipoxygenase and cyclooxygenase.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "Ciclopirox Olamine cream is contraindicated in individuals who have shown hypersensitivity to any of its components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Ciclorox cream is well tolerated with a low incidence of adverse reactions reported in clinical trials.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy category B. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Ciclopirox Olamine cream or is administered to nursing women.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ciclorox cream is not for ophthalmic use.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 25°C, protect from light.Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Topical Antifungal preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Ciclopirox Cream should be gently massaged onto the affected and surrounding skin areas twice daily for four weeks. Clinical improvement with relief of pruritus and other symptoms usually occurs within the first week of treatment. If a patient shows no clinical improvement after four weeks of treatment with Ciclopirox cream, the diagnosis should be redetermined. Patients with Tinea versicolor usually exhibit clinical and mycological clearing after two weeks of treatment. Use in children: Safety and effectiveness in children below the age of 10 years have not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:48.932Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c53",
    "original_record": {
      "input_index": 4423,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c53"
        },
        "name": "Ciclorox",
        "strength": "1%",
        "generic": "Ciclopirox Olamine (Cream)",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Cream",
        "source_url": "https://medex.com.bd/brands/34707/ciclorox-1-cream",
        "_page": 147,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37850/cicol-d-500-mg-tablet",
    "name": "Cicol-D",
    "dosage_form": "Tablet",
    "generic": "Coral Calcium + Vitamin D3",
    "strength": "500 mg+200 IU",
    "company": "Save Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": null,
      "pack_size_info": "(5 x 10: ৳ 500.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(5 x 10: ৳ 500.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1200/coral-calcium-vitamin-d3/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cicol-D tablet is indicated for the treatment & prevention of- Cicol-D tablet also used as supplement in case of inadequate intake of calcium in childhood diet, rickets, pregnancy & lactation, elderly patients. Other indications include pancreatitis, phosphate binder in chronic renal failure etc.",
        "items": [
          "Osteoporosis",
          "Osteomalacia",
          "Tetany",
          "Hypoparathyroidism",
          "Disorders of osteogenesis."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Adequate Calcium in the blood is so vital to a wide variety of bodily functions that our internal biochemistry will not tolerate a deficiency even for short periods. Clinical evidence suggests that Calcium is useful for the prevention and treatment of Osteoporosis and associated fractures. Vitamin D is also essential for healthy bones as it aids in Calcium absorption from the GI tract. In addition to this it stimulates bone formation. Clinical studies also show that Calcium and vitamin D has synergistic effects on bone growth as well as in Osteoporosis and fracture prevention. In this preparation, Calcium Carbonate is sourced from coral origin. This Coral Calcium has a chemical structure which is very similar to the composition of human bone. Coral Calcium is similar to other sources but ensures better absorption. Vitamin D3 aids in the absorption of Calcium from GI tract and helps to maintain Calcium balance in the body.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Thiazide diuretics reduce the urinary excretion of calcium. Due to increased risk of hypercalcaemia, serum calcium should be regularly monitored during concomitant use of thiazide diuretics. Systemic corticosteroids reduce calcium absorption. During concomitant use, it may be necessary to increase the dose of calcium tablet. Simultaneous treatment with ion exchange resins such as cholestyramine or laxatives such as paraffin oil may reduce the gastrointestinal absorption of vitamin D. Calcium carbonate may interfere with the absorption of concomitantly administered tetracycline preparations. For this reason, tetracycline preparations should be administered at least two hours before, or four to six hours after, oral intake of calcium. Hypercalcaemia may increase the toxicity of cardiac glycosides during treatment with calcium and vitamin D. Patients should be monitored with regard to electrocardiogram (ECG) and serum calcium levels. If a bisphosphonate or sodium fluoride is used concomitantly, Cicol-D should be administered at least three hours before the intake of calcium tablet since gastrointestinal absorption may be reduced. Oxalic acid (found in spinach and rhubarb) and phytic acid (found in whole cereals) may inhibit calcium absorption through formation of insoluble calcium salts. The patient should not take calcium products within two hours of eating foods high in oxalic acid and phytic acid.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypercalcemia and hyperparathyroidism",
          "Hypercalciuria and nephrolithiasis",
          "Hypersensitivity to the component of this preparation",
          "Severe renal insufficiencies",
          "Concomitant digoxin therapy (requires careful monitoring of serum Calcium level)"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Orally administered Calcium Carbonate may be irritating to the GI tract. It may also cause constipation. Hypercalcemia is rarely produced by administration of Calcium alone but may occur when large doses are given to patients with chronic renal failure. Also there may be allergic reactions, irregular heartbeats, nausea, vomiting, decreased appetite dry mouth and drowsiness. Following administration of Vitamin D Supplements occasion skin rash has been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy the daily intake should not exceed 1500 mg calcium and 600 IU cholecalciferol (15 mcg vitamin D). Studies in animals have shown reproductive toxicity with high dose of vitamin D. In pregnant women, overdoses of calcium and vitamin D should be avoided as permanent hypercalcaemia has been related to adverse effects on the developing foetus. There are no indications that vitamin D at therapeutic doses is teratogenic in humans. Elemental Calcium & Vitamin D3 tablet can be used during pregnancy, in case of a calcium and vitamin D deficiency. Elemental Calcium & Vitamin D3 tablet can be used during breast-feeding. Calcium and vitamin D3 pass into breast milk. This should be considered when giving additional vitamin D to the child.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "During long-term treatment, serum calcium levels should be followed and renal function should be monitored through measurement of serum creatinine. Monitoring is especially important in elderly patients on concomitant treatment with cardiac glycosides or diuretics and in patients with a high tendency to calculus formation. In case of hypercalcaemia or signs of impaired renal function, the dose should be reduced or the treatment discontinued. Vitamin D should be used with caution in patients with impairment of renal function and the effect on calcium and phosphate levels should be monitored. The risk of soft tissue calcification should be taken into account. In patients with severe renal insufficiency, vitamin D in the form of cholecalciferol is not metabolised normally and other forms of vitamin D should be used. Elemental Calcium & Vitamin D3 tablet should be prescribed with caution to patients suffering from sarcoidosis because of the risk of increased metabolism of vitamin D to its active metabolite. In these patients, serum calcium levels and urinary calcium excretion must be monitored. Elemental Calcium & Vitamin D3 tablet should be used with caution in immobilised patients with osteoporosis due to the increased risk of hypercalcaemia. The dose of vitamin D in Elemental Calcium & Vitamin D3 tablet should be considered when prescribing other drugs containing vitamin D. Additional doses of calcium or vitamin D should be taken under close medical supervision. In such cases it is necessary to monitor serum calcium levels and urinary calcium excretion frequently.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdose can lead to hypervitaminosis D and hypercalcaemia. Symptoms of hypercalcaemia may include anorexia, thirst, nausea, vomiting, constipation, abdominal pain, muscle weakness, fatigue, mental disturbances, polydipsia, polyuria, bone pain, nephrocalcinosis, nephrolithiasis and in severe cases, cardiac arrhythmias. Extreme hypercalcaemia may result in coma and death. Persistently high calcium levels may lead to irreversible renal damage and soft tissue calcification. Treatment of hypercalcaemia: The treatment with calcium must be discontinued. Treatment with thiazide diuretics, lithium, vitamin A and cardiac glycosides must also be discontinued. Emptying of the stomach in patients with impaired consciousness. Rehydration, and, according to severity, isolated or combined treatment with loop diuretics, bisphosphonates, calcitonin and corticosteroids. Serum electrolytes, renal function and diuresis must be monitored. In severe cases, ECG and CVP should be followed.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at temperature of below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific mineral & vitamin combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet once or twice daily with plenty of water or as directed by the physician. Taking in full stomach ensures better absorption. Dissolve 1 effervescent tablet in a glass of water to drink orally. Stir the solution with spoon before drinking. Taking in full stomach ensures better absorption.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Cicol-D 500 mg+200 IU Tablet?",
        "answer": [
          "Cicol-D 500 mg+200 IU Tablet is a combination of calcium carbonate and vitamin D3. It is used to prevent and treat calcium and vitamin D deficiency. Calcium is important for building and maintaining strong bones and teeth. Vitamin D helps the body absorb calcium."
        ]
      },
      {
        "question": "What are the benefits of taking Cicol-D 500 mg+200 IU Tablet?",
        "answer": [
          "The benefits of taking Cicol-D 500 mg+200 IU Tablet include:",
          "Prevention and treatment of calcium and vitamin D deficiency",
          "Prevention of osteoporosis",
          "Treatment of rickets",
          "Treatment of osteomalacia",
          "Improvement of bone health in the elderly"
        ]
      },
      {
        "question": "Who should not take the Cicol-D 500 mg+200 IU Tablet?",
        "answer": [
          "People with these issues shouldn’t take Cicol-D 500 mg+200 IU Tablet-",
          "High level of calcium or vitamin D in the blood.",
          "Kidney stones.",
          "Sarcoidosis",
          "Allergic to ingredients in Coralcal D."
        ]
      },
      {
        "question": "What are the side effects of Cicol-D 500 mg+200 IU Tablet?",
        "answer": [
          "The most common side effects of Cicol-D 500 mg+200 IU Tablet are- Constipation, Nausea, Vomiting, Diarrhea, Headache, Drowsiness, and Dry mouth."
        ]
      },
      {
        "question": "How should I take Cicol-D 500 mg+200 IU Tablet?",
        "answer": [
          "Cicol-D 500 mg+200 IU Tablet should be taken with food. The usual dose is one tablet per day. However, the dosage may vary depending on your individual needs. Talk to your doctor about the best dosage for you."
        ]
      },
      {
        "question": "What are the precautions for taking Cicol-D 500 mg+200 IU Tablet?",
        "answer": [
          "You shouldn't take Cicol-D 500 mg+200 IU Tablet if:",
          "you are pregnant or breastfeeding,",
          "you have high levels of calcium or vitamin D in your blood,",
          "you have kidney stones,",
          "and you are allergic to any of the medicine’s ingredients."
        ]
      }
    ],
    "fetched_at": "2025-09-20T02:05:50.045Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c56",
    "original_record": {
      "input_index": 4424,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c56"
        },
        "name": "Cicol-D",
        "strength": "500 mg+200 IU",
        "generic": "Coral Calcium + Vitamin D3",
        "company": "Save Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/37850/cicol-d-500-mg-tablet",
        "_page": 147,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28151/cidogrel-75-mg-tablet",
    "name": "Cidogrel",
    "dosage_form": "Tablet",
    "generic": "Clopidogrel Bisulphate",
    "strength": "75 mg",
    "company": "Apex Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(3 x 10: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(3 x 10: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/286/clopidogrel-bisulphate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Acute Coronary Syndrome (ACS): Cidogrel tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial ... Read moreAcute Coronary Syndrome (ACS): Cidogrel tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Cidogrel tablet is indicated to reduce the rate of MI and stroke.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Clopidogrel is a prodrug. It inhibits platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Dose-dependent inhibition of platelet aggregation can be seen 2 hours after single oral doses. Repeated doses of 75 mg per day inhibit ADP-induced platelet aggregation on the first day, and inhibition reaches steady state between Day 3 and Day 7.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "NSAIDs, warfarin, selective serotonin and serotonin norepinephrine reuptake inhibitors (SSRIs, SNRIs): Increases risk of bleeding",
          "CYP2C19 inhibitors (omeprazole or esomeprazole): Avoid concomitant use of omeprazole or esomeprazole",
          "Repaglinide (CYP2C8 substrates): Avoid concomitant use of Cidogrel with Repaglinide as it increases plasma concentrations of Repaglinide"
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Clopidogrel is contraindicated in the following conditions: Hypersensitivity to the drug substance or any component of the product. Active pathological bleeding such as peptic ulcer or intracranial hemorrhage.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Cidogrel is generally well tolerated drug.",
        "items": [
          "Common side effects: Bleeding, Diarrhoea, gastrointestinal discomfort, haemorrhage, Skin reactions.",
          "Rare side effects: Acquired haemophilia, anaemia, angioedema, arthralgia, arthritis, bone marrow disorders."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed. It is unknown whether clopidogrel is excreted in human breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "As it is a prodrug, so metabolism to its active metabolite is impaired by genetic variations in CYP2C19 (poor metabolizer) and by the drugs that inhibit CYP2C19 such as Omeprazole and Esomeprazole. Concomitant use with these drugs and in CYP2C19 poor metaboliser may reduce the antiplatelet activity of Cidogrel.",
          "As it inhibits platelet aggregation for the lifetime of the platelet (7-10 days), risk of bleeding may increase. To restore hemostasis, platelet transfusions within 4 hours of the loading dose or 2 hours of the maintenance dose may be less effective.",
          "Discontinuation of Cidogrel increases the risk of cardiovascular events. Discontinue 5 days prior to elective surgery that has a major risk of bleeding. Resume Cidogrel as soon as hemostasis is achieved.",
          "Thrombotic Thrombocytopenic Purpura (TTP) has been reported that requires urgent treatment including plasmapheresis (plasma exchange).",
          "Hypersensitivity including rash, angioedema or hematologic reaction has been reported in patients receiving clopidogrel or history of hypersensitivity to other thienopyridines."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Safety and effectiveness in pediatric populations have not been established. No dosage adjustment is necessary in elderly patients.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdose following clopidogrel administration may lead to bleeding complications. Based on biological plausibility, platelet transfusion may restore clotting ability.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature in a dry place. Protected from light. Do not freeze. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-platelet drugs",
    "dosage": [
      {
        "medication_type": "Acute Coronary Syndrome",
        "information": ": In patients who need an antiplatelet effect within hours, initiate clopidogrel with a single 300 mg (4 tablets) oral loading dose and then continue at 75 mg once daily. Initiating it without a loading dose will delay establishment of an antiplatelet effect by several days.",
        "instructions": []
      },
      {
        "medication_type": "Recent MI, Recent Stroke, or Established Peripheral Arterial Disease",
        "information": ": 75 mg once daily orally without a loading dose. It is given orally with or without food.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:51.362Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c57",
    "original_record": {
      "input_index": 4425,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c57"
        },
        "name": "Cidogrel",
        "strength": "75 mg",
        "generic": "Clopidogrel Bisulphate",
        "company": "Credence Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/28151/cidogrel-75-mg-tablet",
        "_page": 147,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15822/ciflodex-03-01-eye-drop",
    "name": "Ciflodex",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Ciprofloxacin + Dexamethasone",
    "strength": "0.3%+0.1%",
    "company": "Reman Drug Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 75.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 75.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/264/ciprofloxacin-dexamethasone/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Eye: This is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection ... Read moreEye: This is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.Ear: This is also indicated in the treatment of ear infections accompanied by inflammation such as otitis externa, acute and chronic otitis media etc. The combination may also be used post-operatively in the ear.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": "Dexamethasone",
        "information": "is glucocorticoid. It has an anti-inflammatory and anti-allergic action. It is used topically in the treatment of inflammatory conditions of the anterior segment of the eye. It reduces prostaglandin synthesis by inhibiting the enzyme phospholipase A2. Also, Dexamethasone inhibits the chemotactic infiltration of neutrophils into the site of inflammation.",
        "items": []
      },
      {
        "title": "Ciprofloxacin",
        "information": "has in vitro activity against a wide range of gram-negative and gram-positive organisms, possessing the greatest antibacterial activity of all quinolones. The bactericidal action of Ciprofloxacin results from interference with the enzyme DNA gyrase which is needed for the synthesis of bacterial DNA.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Specific drug interaction studies have not been conducted with ophthalmic Ciprofloxacin and Dexamethasone. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant warfarin and its derivatives and have been associated with transient elevations in serum creatinine in patients receiving cyclosporin concomitantly.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to any ingredient of the product. Herpes simplex and other viral conditions, mycosis, glaucoma, newborn babies, fungal diseases of ocular or auricular structures.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Eye",
        "information": ": The most frequently reported drug-related adverse reactions seen with Ciprofloxacin are transient ocular burning or discomfort. Other reported reactions include stinging, redness, itching, conjunctivitis/keratitis, periocular/facial edema, foreign body sensation, photophobia, blurred vision, tearing, dryness, and eye pain. Rare reports of dizziness have been received. The reactions due to the steroid component are elevation of intraocular pressure (IOP) with possible development of glaucoma, and infrequent optic nerve damage; posterior subcapsular cataract formation; and delayed wound healing.",
        "items": []
      },
      {
        "title": "Ear",
        "information": ": The most common adverse effects are discomfort and ear pain. Others reported reactions are irritability, dizziness, erythema etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy: There are no adequate and well controlled studies in pregnant women. This Sterile Eye & Ear Drops should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus. Nursing Mothers: It is not known whether this drug is excreted in human milk. So, caution should be exercised when using this Sterile Eye & Ear Drops to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The possibility of fungal infections of the cornea should be considered after long-term steroid dosing and in patients with persistent corneal ulceration. Prolonged use of antibiotic may result in overgrowth of non-susceptible organisms. Prolonged use of topical ophthalmic steroids may result in glaucoma, with damage to the optic nerve, defects in visual acuity and fields of vision and posterior subcapsular cataract formation. Intraocular pressure should be routinely monitored.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, away from light. Keep out of reach of children. Shake well before each use. The drug is to be used within 30 days after first opening. The bottle is to be closed strongly immediately after use.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Aural steroid & antibiotic combined preparations",
    "dosage": [
      {
        "medication_type": "For Eye",
        "information": ": 1 drop to be instilled into conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to 1 drop every two hours.",
        "instructions": []
      },
      {
        "medication_type": "For Ear",
        "information": ":",
        "instructions": [
          "Acute otitis media in pediatric patients with typanastomy tube: 4 drops instilled into the affected ear 2 times daily for 7 days.",
          "Acute otitis externa: 4 drops instilled into the affected ear 2 times daily for 7 days."
        ]
      },
      {
        "medication_type": "Pediatric Use",
        "information": ": Safety and effectiveness in pediatric patients below 1 year have not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:52.370Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c5b",
    "original_record": {
      "input_index": 4426,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c5b"
        },
        "name": "Ciflodex",
        "strength": "0.3%+0.1%",
        "generic": "Ciprofloxacin + Dexamethasone",
        "company": "Reman Drug Laboratories Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15822/ciflodex-03-01-eye-drop",
        "_page": 147,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27762/cildocal-10-mg-tablet",
    "name": "Cildocal",
    "dosage_form": "Tablet",
    "generic": "Cilnidipine",
    "strength": "10 mg",
    "company": "Delta Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.00",
      "strip_price": "৳ 50.00",
      "pack_size_info": "(3 x 10: ৳ 150.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.00",
          "pack_size_info": "(3 x 10: ৳ 150.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27761/cildocal-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1377/cilnidipine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cildocal is indicated for the management of hypertension for end-organ protection. It is reported to be useful in elderly patients and in those with diabetes and albuminuria. Cildocal has been increasingly used in patients with chronic kidney diseaseHypertension is the term used to ... Read moreCildocal is indicated for the management of hypertension for end-organ protection. It is reported to be useful in elderly patients and in those with diabetes and albuminuria. Cildocal has been increasingly used in patients with chronic kidney diseaseHypertension is the term used to describe the presence of high blood pressure. The blood pressure is generated by the force of the blood pumped from the heart against the blood vessels. Thus hypertension is caused when there is too much pressure on the blood vessels and this effect can damage the blood vessel.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cilnidipine is a dihydropyridine calcium-channel blocker. Cilnidipine binds to the dihydropy-ridine binding sites of the L-type voltage dependent calcium channel and inhibits Ca 2+ influx across the cell membranes of vascular smooth muscle cells via this channel, consequently vascular smooth muscle is relaxed, causing vasodilation. Cilnidipine inhibits Ca 2+ influx via N-type voltage dependent calcium channels in the sympathetic nerve cell membrane. The inhibition of Ca 2+ influx via N-type voltage dependent calcium channel was observed over a similar range of drug concentrations to those inhibiting L-type voltage dependent Ca 2+ channels. Consequently, release of norepinephrine from sympathetic nerve terminals would be inhibited. Cilnidipine is considered to suppress the reflex increase in heart rate after blood pressure reduction.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Other anti-hypertensive, antipsychotics that cause hypotension, quinidine, carbamazepine, phenytoin, rifampicin, cimetidine, erythromycin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cilnidipine is contraindicated in patients with known sensitivity to Cilnidipine or any of the excipients or patients having cardiogenic shock, recent MI or acute unstable angina and severe aortic stenosis.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects of Cildocal are: Dizziness; flushing; headache; hypotension; peripheral oedema; palpitations; GI disturbances; increased micturition frequency; lethargy; eye pain; depression.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Cilnidipine should not be administered in pregnant woman or woman having possibilities of being pregnant. It is also advisable to avoid the administration of Cilnidipine to nursing mothers. However, if the administration is indispensable, the patient should be instructed to discontinue lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cildocal should be administered with care in the following patients: patients with serious hepatic dysfunction, patients with a history of serious adverse reactions to calcium antagonists. During the discontinuation, the dosage should be gradually decreased under close observation.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C, protected from light and moisture. Keep away from reach out of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Calcium-channel blockers",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": 5-10 mg once daily after breakfast. Maximum dose: 20 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric use",
        "information": ": The safety of Cilnidipine in pediatric patients has not been established.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": Since the elderly may be more susceptible to hypotension, therapy should be initiated with the lowest possible dose (5 mg).",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-20T02:05:53.397Z",
    "medicine_id": "68c3c0d7ef5b8f2b163a9c65",
    "original_record": {
      "input_index": 4427,
      "brand_record": {
        "_id": {
          "$oid": "68c3c0d7ef5b8f2b163a9c65"
        },
        "name": "Cildocal",
        "strength": "10 mg",
        "generic": "Cilnidipine",
        "company": "Delta Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/27762/cildocal-10-mg-tablet",
        "_page": 147,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  }
]